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SUMM ARY
Four tem perature-sensitive DNA"*" mutants, ts l201 , ts l203 , ts l204 
and W 208, each of which contain a lesion in HSV DNA fragm ent EcoRI _f 
(mu 0.312-0.415), have been characterised in th is study.
Tsl204 has a tem perature-sensitive lesion located w ith in  a 400bp 
region between mu 0.322-0.324 on the HSV genome. This m utant adsorbed 
normally to the ce ll surface at the NPT, but fa iled to penetrate the cell 
membrane. T^1204 appeared to bind to specific ce llu la r receptors fo r 
HSV-1, since high m u ltip lic itie s  of in fection  o f the m utant blocked 
subsequent superinfection of cells by HSV-1, but not by HSV-2. The 
penetration defect could be overcome e ither by b rie f incubation of ts l204 - 
infected cells at the PT before temperature upshift to the NPT, or by 
treatm ent of the cells w ith  polyethylene glycol, a compound which 
promotes fusion of membranes. Upon continued incubation of mutant 
virus-infected cells a t the NPT, low numbers o f capsids were assembled. 
Although these capsids contained some in terna l structure , they did not 
contain DNA.
Another m utant, ^120 8 , lies in the same com plementation group as 
^1204. This m utant penetrated cells norm ally at the NPT but, like 
^1204, assembled low numbers o f capsids which did not contain DNA. 
Marker rescue experiments mapped the ^1208  lesion to the le ft  of the 
^1204 lesion, w ith in  Bam HI u.
The ab ility  of high m u ltip lic itie s  o f _U1204 to block superinfection 
of cells by HSV-1 but not by HSV-2 was u tilised to determine the virus 
polypeptides involved in the recognition of specific ce ll surface receptors. 
A series of in te rtyp ic  recombinant viruses, which induced both HSV-1- and 
HSV-2-specific envelope glycoproteins, were a ll found to be capable of 
penetrating cells previously in fected w ith  ^120 4  at the NPT. This result 
suggests tha t the virus attachm ent complex may be composed of more than
( i v )
one glycoprotein, and tha t a m ixture of both HSV-1 and HSV-2 
glycoproteins are able to recognise and bind to ce llu la r receptors specific 
for HSV-2, since no HSV-2 sequence was common to a ll recombinants. The 
alternative explanation tha t the recombinants contained undetected 
crossovers cannot, however, be ruled out.
^120 3  has a ^  lesion which maps in a 450bp fragm ent located 
between mu 0.377-0.380 on the HSV-1 genome. This m utant assembled 
large numbers of capsids at the NPT, but fa iled to encapsidate DNA. In 
this respect W 203 resembled _^1201, a mutant which lies in a d iffe ren t 
complementation group but also has a defect in packaging of virus DNA 
into capsids (Preston et a l., 1983). A t the PT, DNA encapsidation was less 
e ffic ien t in ^1203-in fec ted  cells than in w ild -type v irus-in fected cells. In 
addition, the defect in ^120 3  appeared to be irreversib le upon temperature 
downshift in the absence of fu rthe r protein synthesis. Greater than 99% 
of the DNA synthesized in both _^1203- and ^120 1 -in fec te d  cells at the 
NPT was endless, suggesting tha t the unpackaged m utant virus DNA 
remained in a concatemeric form .
Complementation experiments, using other ^  mutants which had 
lesions in HSV DNA fragm ent EcoRI f, showed tha t ^120 3  represents a 
novel complementation group. In preparation fo r DNA sequencing 
experiments to determine the base change responsible fo r the ts l203 
phenotype, the DNA fragm ent containing the ^120 3  lesion, and the 
corresponding fragm ent from  ^1203  rev-1, a spontaneous revertan t of 
^1203, have been cloned into plasmid vector pUC9.
Preston et al. (1983) demonstrated tha t ^1201  fa iled  to process the 
polypeptide p40 to its  lower molecular weight forms at the NPT. This 
result, together w ith  the earlie r observations by Gibson and Roizman 
(1974), strongly suggested tha t p40 was involved in the virus DNA 
encapsidation process. In contrast to ^1201 , however, ^1203  was found to 
process p40 correctly  at the NPT. Immune electron microscopic
(v)
experiments showed that p40 was associated w ith  both _U1203 and ts l201 
empty capsids at the NPT.
Experiments were performed to investigate the reason fo r the 
fa ilu re  of p40 to be processed co rrectly  in ^1201-in fec ted  cells at the 
NPT. It was found that the high MW forms of p40 were translocated 
normally from  the cytoplasm to the nucleus in these cells. I t  was also 
shown that p40 synthesized in cells infected w ith  HSV-1 strain 17 syn+ was 
not phosphorylated to any detectable extent, in contrast to results obtained 
w ith  other HSV-1 strains (Heilman, 1979; Braun et a l., 1984). Thus, 
defects in e ither of these events are unlikely to be responsible fo r the 
fa ilu re  of p40 to be processed correctly  to its  lower molecular weight 
forms in ts l201 -in fected  cells at the NPT.
ABBREVIATIONS
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ACG acycloguanosine
APS ammonium persulphate
BHK baby hamster kidney cells
bp base pairs
BSA bovine serum albumin
BUdR 5-bromo-2'-deoxy uridine
BVdU brom ovinyl deoxyuridine
Ci Curies
Cl complementation index
cm centim etre
CMV cytomegalovirus
CPE cytopath ic e ffe c t
cpm counts per minute
dATP deoxyadenosine triphosphate
dCTP deoxycytidine triphosphate
dGTP deoxyguanosine triphosphate
DMSO dim ethyl sulphoxide
DNA deoxyribonucleic acid
DNase deoxyribonuclease
ds double-stranded
dTTP deoxythymidine triphosphate
EBV Epstein-Barr virus
E. coli Escherichia coli
EDTA sodium ethylene diamine te tra -ace tic  acid
EHV equine herpesvirus
eop effic iency  of plating
g grams
h hour
HA hydroxylam ine
(vil)
HCl
HFL
HSV
HVS
ICP
lE
IgG
K
kd
kb
1
M
MI
min
ml
mM
mm
moi
mRNA
mu
MW
NA
ng
NP40
NPC
NPT
OD
ori
PAA
PAGE
hydrochloric acid 
human foeta l lung 
herpes simplex virus 
herpesvirus sa im iri 
in fected ce ll polypeptide 
immediate early 
immunoglobulin G 
k ilo
kilodalton
kilobase
litre
molar
m ock-infected
minute
m ill i l it re
m illim o la r
m illim e tre
m u lt ip lic ity  o f in fection  
messenger ribonucle ic acid 
map units 
molecular weight 
n itrous acid 
nanograms 
nonidet p40 
nucleoprotein complex 
non-permissive tem perature 
optica l density
orig in o f v ira l DNA rep lica tion  
phosphonoacetic acid 
polyacrylam ide gel electrophoresis
( v i i i )
PBS phosphate buffered saline
PEG polyethylene glycol
pfu plaque form ing units
pi post in fection
PRV pseudorabies virus
PT permissive tem perature
RNA ribonucleic acid
RNase ribonuclease
rpm revolutions per minute
RT room temperature
SDS sodium dodecyl sulphate
sec seconds
syn syncytial
syn+ non-syncytial
TCA trich lo race tic  acid
TEMED N,N,N '-N '-te tram ethylethylenediam ine
TK- thym idine kinase-minus
TK+ thym idine kinase-positive
tem perature-sensitive
ts'*' w ild -type fo r tem pera ture-sensitiv ity
UV u ltra -v io le t
V volts
v/v volume per volume
Vmw molecular weight of virus-induced polypeptide
VP virion protein
VZV varice lla  zoster virus
w/v weight per volume
wt w ild -type
uCi m icrocuries
ug microgram
ul m ic ro litre
% percentage
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CH A PTER  1
The subject o f this thesis is the characterisation of herpes simplex 
virus type 1 mutants w ith  potentia l s truc tu ra l defects, in order to 
elucidate the functions of herpes simplex virus v irion  polypeptides. The 
aim of the Introduction is to provide background in form ation on the 
general biology of herpes simplex virus. P articu lar reference w ill be made 
to the advances in understanding of the virus rep lica tion  cycle gained from  
the analysis of mutants. A b rie f review of current herpes simplex virus 
genetics w ill also be provided.
IN TR O D U C T IO N
1.1 CLA SSIF IC A TIO N  OF HERPESVIRUSES
Members o f the fam ily  Herpesviridae have been isolated from  more 
than eighty organisms, ranging from  many vertebrates to molluscs and even 
fungi (Nahmias, 1972). Herpesvirus virions are enveloped, and have a 
diameter of approximately 150-200nm. The genome is a linear ds DNA 
molecule which is enclosed w ith in  an icosahedral-shaped capsid. In 
addition, viruses in this fam ily  rep licate in the ce ll nucleus, and acquire 
the ir envelope by budding through the nuclear membrane.
Three sub-fam ilies have been established on the basis o f the 
biological properties o f the ir members (Roizman et a l., 1978; Matthews, 
1982; Roizman, 1982).
Alphaherpesviruses usually cause acute, s e lf- lim itin g  diseases in 
the ir natural hosts. The prim ary in fec tion  is o ften followed by 
establishment of la ten t in fection, frequently but not exclusively, in the 
ganglia. Latent virus can be reactivated by a varie ty  of s tim u li, giving 
rise to recurrent disease. In v itro , the virus rep lica tion  cycle is re la tive ly  
short (<24h), and results in rapid destruction o f susceptible cells. These
viruses have a genome of MW 85-110x10^.
The prototype w ith in  this group is herpes simplex virus type 1 
(HSV-1), which is prim arily  responsible fo r vesicular lesions of the mouth 
and lips in man, but also causes ocular ke ra titis , and occasionally 
encephalitis. Herpes simplex virus type 2 (HSV-2), which is norm ally 
isolated from  genital lesions (Dowdle et a l., 1967), is closely re lated to
HSV-1. They share extensive homology in about 50% of the ir DNA 
sequences (K ie ff et a l., 1972), and the ir genomes are largely colinear 
(Wilkie et a l., 1979; Davison and W ilkie, 1983). The disease associations 
fo r these two viruses, however, are not absolute. For example, HSV-1 can 
cause genital lesions and HSV-2 can be isolated from  lip lesions. Other 
members of this sub-fam ily include varice lla  zoster virus (VZV) which gives 
rise to chicken-pox in man, pseudorabies virus (PRV) (Aujeszky's disease) 
which infects pigs, and equine herpesviruses (EHV) types -1, -2 and -3.
Betaherpesviruses exhib it a narrow in vivo host range. These 
viruses normally cause asymptomatic in fections in immunocompetent adults, 
however, severe generalised disease may occur in immunosuppressed
patients and neonates. Latent virus has been demonstrated in secretory 
glands, lym phoreticular cells, kidneys and other tissues. The in v itro  host 
range fo r viruses in this sub-fam ily is narrow, and the rep lica tion cycle is 
re la tive ly slow (>24h). A large genome (MW 130-150x10^) is a unify ing 
feature of this group, which includes cytomegaloviruses (CMV) isolated 
from  man, non-human primates, pigs and mice.
Qammaherpesviruses form  the lym phopro liferative virus group. 
These viruses have a narrow in vivo host range, and rep lica tion can be
demonstrated in B or T lymphocytes, depending on the virus. Latency can
be established in lymphoid tissue. In v itro , a ll members of this sub-fam ily 
w ill replicate in lymphocytes. The genome size is s im ila r to tha t o f the 
Alphaherpesviruses. Epstein-Barr virus (EBV) is the prototype w ith in  th is
group, and is the causative agent o f in fectious mononucleosis in man. This 
virus is also strongly associated w ith  B urk itt's  lymphoma and 
nasopharyngeal carcinoma. Other members o f the sub-fam ily include 
herpesvirus saim iri (HVS) which in fects the squirrel monkey, and Marek's 
disease virus which causes an economically im portant disease o f chickens.
1.2 STRUC TUR AL FEATURES OF THE V IR IO N
1.2.1 Morphology
The herpesvirion is a large, complex, virus pa rtic le  consisting of 
five  structura l components referred to as the core, pericore, capsid, 
tegument and envelope (Fig. 1).
(i) The virus envelope: The pa rtic le  has an external lip id  envelope
(Wildy et a l., 1960) which is norm ally acquired by budding of 
intranuclear partic les through the inner nuclear membrane 
(Darlington and Moss, 1968). The envelope contains numerous 
spikes calculated to be approxim ately 8nm long (Wildy et a l., 1960).
(ii) The tegument: Between the capsid and envelope lies an amorphous
layer known as the tegument (Roizman and Furlong, 1974), which 
appears to be attached to the capsid, probably at the vertices, and 
to the inner surface of the envelope (Vernon et a l., 1982). The 
thickness o f the tegument varies among d iffe re n t herpesviruses, and 
is genetically determined (McCombs et a l., 1971).
( iii)  The capsid: The capsid is icosohedral in shape and has been
calculated to consist of 162 hollow capsomers, comprising 150 
hexamers w ith  s ix-fo ld  sym metry, and 12 pentamers (Wildy et a l., 
1960; Furlong, 1978). The overall diam eter of the p a rtic le  is
&
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FIG URE 1
(a) D iagram matic representation of a section through a herpesvirus 
partic le  (adapted from  Roizman et a i., 1975 and Perdue et a l., 
1976).
(b) HSV-1 stra in  17 in tranuclear capsid pa rtic le  isolated by detergent 
trea tm ent o f BHK cells (see Section 2.2.6).
lOOnm (Wildy et a l., 1960; Abodeely et a l., 1970). E lectron 
microscopy has revealed sub-structural components of the capsid 
such as intercapsomeric fib r ils , 2nm in w idth, which appear to 
connect adjacent capsomeres (Vernon et a l., 1974; Palmer et a l., 
1975). I t  is possible that these fib r ils  contribu te to the remarkable 
s tab ility  of the capsid, which is resistant to disruption methods 
such as freezing and thawing, pH changes, trypsin trea tm ent and 
detergents.
(iv) The core; A cy lindrica l core structure , around which the v ira l 
DNA is tig h tly  spooled, is held w ith in  the capsid pa rtic le  (Furlong 
et a l., 1972; N ii and Yasuda, 1975). The core is probably 
attached to the inner surface o f the capsid at its  poles (Nazerian, 
1974; Haguenau and Michelson-Fiske, 1975). The existence o f a 
pericore or inner capsid, which surrounds the core, has been 
suggested on the basis o f electron m icroscopic observations of 
negatively stained, disrupted herpesvirus capsids (Abodeely et a l., 
1970; Palmer et a l., 1975; Vernon et a l., 1976). Although several 
core morphologies have been visualised by electron microscopy 
(Perdue et a l., 1976), i t  is like ly  tha t several o f these are aberrant 
forms, or result from  staining procedures, and i t  is d if f ic u lt  to 
define steps in core m aturation from  this evidence alone.
1.2.2 Structure o f the v ira l genome
The HSV-1 genome is a linear ds DNA molecule of MW 95-100x10^ 
or approximately 150-155kbp in length (Becker et a l., 1968; Frenkel and 
Roizman, 1971; K ie ff  et a l., 1971; Grafstrom  et a l., 1974; Wagner 
Gt a l., 1974; Clements et a l., 1976; Davison, 1981). The DNA molecule 
consists o f two unique sequence components, U(_ (long) and US (short), each
of which is bounded by inverted repeat sequences TR[_, IR|_, IRg and TRg 
(Fig. 2) (Sheldrick and Berthelot, 1974). A 250-550bp sequence, designated 
the a sequence, is present as a d irect repeat at both te rm in i, and in an 
inverted orienta tion at the L-S junction (Sheldrick and Berthelot, 1974; 
Wadsworth et a l., 1975; Skare and Summers, 1977; W ilkie, 1976; Davison 
and W ilkie, 1981). Sequence analysis o f the L-S junction and adjacent 
regions has revealed the existence o f tandemly re ite ra ted  DNA sequences 
w ith in  the a sequence itse lf (Fig. 3) (Davison and W ilkie, 1981; Mocarski 
and Roizman, 1981). Single a sequences are flanked by 20bp d irect repeats 
(D R l), whilst m u ltip le  a sequences, which are present at the L-S junction 
and L-term inus, but not at the S-terminus, share a single D R l sequence 
between them (Wagner and Summers, 1978; Locker and Frenkel, 1979). 
The a sequence is involved in DNA encapsidation and inversion of the L 
and S segments (see Sections 1.5.2 and 1.7.2). As a consequence of 
inversion, four isomeric form s of the genome are generated which d iffe r in 
the re la tive  orien ta tion  o f Ug and U|_. These arrangements are designated 
P (prototype), Ig (inversion of the S component), I|_ (inversion of the L 
component), and Ig|_ (inversion of both S and L components (Fig. 2) (Delius 
and Clements, 1976; Hayward et a l., 1975; Morse et a l., 1977). Although 
the overall base composition of the HSV-1 genome is 67% G+C moles 
(K ie ff et a l., 1971), th is value varies fo r specific regions of the DNA 
molecule. For example, the short repeat sequence has a G+C content of 
approximately 78% (Davison and W ilkie, 1981; Murchie and McGeoch, 
1982). These values d iffe r  widely from  tha t o f BHK C13 DNA which has 
a G+C content of 42% (Subak-Sharpe et a l., 1966).
DNA sequence analysis o f the short region o f the HSV-1 genome 
has revealed several in teresting features about gene arrangement (McGeoch 
et a l., 1985). This region has quite a compact gene layout, w ith  
approximately 79% o f the DNA coding fo r proteins. Overlapping genes have
or □ ao
O )
>n
CD
U1
ID
' 8
: o
00
CD
0 : ID
j
3
J D
O
C O T Î  U
'V \ y
o _
-I m 10
< ÛÛ
FIG U RE 2
(a) The genome arrangement of HSV-1. The long region (L) is
composed of a unique region (U[_) bounded by a te rm ina l sequence 
(TR[_) which is repeated in terna lly  in an inverted orien ta tion  (IR|_). 
Sim ilarly the short region (S) is composed of a unique region (Ug) 
which is bounded by a term inal sequence (TRg) which is repeated 
in terna lly  in an inverted orienta tion (IRg). Term inally redundant 
sequences are designated a (a'). The remaining sequences w ith in  
TR|_/IR|_ and TR g/IRg are designated b/b' and c /c ' respective ly.
(b) The four genome isomers:
P = prototype orientation
Ij_ = inversion o f long region (L)
Ig = inversion of short region (S)
IgL = inversion of short and long regions
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FIG U R E 3
Structure of the a sequence of HSV-1 strain F (taken from  Chou and 
Roizman, 1985). The components of the a sequence are described in the 
tex t. Arrows indicate orien ta tion o f the a sequence.
been identified  w ith  3 '-coterm in i and unique 5 '-te rm in i (Rixon and 
McGeoch, 1984; McGeoch et a l., 1985) and, in addition, genes on opposite 
DMA strands have been found to overlap. Tandemly re ite ra ted  sequences 
both in non-coding (Murchie and McGeoch, 1982; Davison and W ilkie, 1981) 
and coding regions (Rixon and McGeoch, 1984) have also been found.
1.2.3 S tructural polypeptides
Although more than th ir ty  HSV-induced polypeptides have been 
designated as s truc tu ra l components of the v irion (Spear and Roizman, 
1972; Heine et a l., 1974; Marsden et a l., 1976), i t  is d if f ic u lt  to
distinguish whether some minor polypeptides are essential fo r v irion  
structura l in te g rity  or are passively acquired during capsid m aturation.
Capsid polypeptides
Polypeptides present in herpesvirus capsids have been determ ined by 
the pu rifica tion  o f in tranuclear partic les. Under the electron microscope, 
various types o f capsids can be detected in the nuclei o f v irus-in fected 
cells, in th in  section. These capsids can be broadly classified in to three 
types: empty capsids which lack any core structure , in term ediate capsids
which lack DMA but contain some in terna l structure  and heavy capsids 
which contain a complete DMA core (Fig. 4). In EHV, a ll three form s
have been purified  by ve loc ity  gradient centrifugation  techniques (Perdue 
et a l., 1975) whereas in HSV, only two capsid populations have been 
resolved (Gibson and Roizman, 1972; Heilman et a l., 1979; Cohen et a l.,
1980). Table 1 summarises the approximate MW of the HSV-1 capsid
polypeptides, and compares the polypeptide nomenclatures used by each 
group. It is generally accepted tha t HSV-1 capsids contain seven 
polypeptides ranging in MW from  155,000 to 12,000. Capsids which lack 
DMA contain five  v irus-specific  polypeptides, whereas capsids which contain
% W " - f
p  ^ > “  '-- d'.
. awr y ' .W»)
FIG U R E 4
Types of intranuclear capsid partic les detected in th in-section preparations 
of w t H S V-l-in fected HFL cells. HFL cells were in fected at 38.5° w ith  5 
pfu per ce ll o f w t HSV-1 stra in 17, harvested at 9h pi and prepared fo r 
e lectron microscopy.
Narrow arrows represent capsids which lack any in terna l structure .
Broad arrows represent capsids which lack DMA but contain some in te rna l 
s tructure.
Open arrows represent capsids which contain an electron-dense DNA core. 
The bar represents 0.5uM.
TABLE 1
Apparent 
m olecular 
weight 
(x 10^)
Nomenclatures
1 2 3
155 VP5 p l55 NC-1
50 VP19C p50 NC-2
40 VP21/22/22a p40 NC-3/4
33-32 VP23 p32 NC-5
26-25 VP24 p25 NC-6
12 ND p l2 NC-7
TABLE 1
Approximate MWs of HSV-1 capsid polypeptides and comparison of capsid 
polypeptide nomenclatures. Apparent MWs are an average from  all these 
groups listed.
Nomenclature 1 is taken from  Gibson and Roizman (1972). These workers 
designated capsid polypeptides according to the v irion  protein (VP) 
nomenclature of Spear and Roizman (1972). ND = not detected.
Nomenclature 2 is taken from  Heilman et al. (1979) and is a general 
nomenclature used fo r both HSV-1 and HSV-2 capsid polypeptides by these 
workers.
Nomenclature 3 is taken from  Cohen et al. (1980).
DNA contain two additional polypeptides, VP21 and VP22a, which are 
probably related (Gibson and Roizman, 1974; Cohen et a l., 1980).
Localisation of the s tructura l polypeptides w ith in  the capsid was 
attempted by Vernon et al. (1981) using immune electron m icroscopy. The 
major capsid protein, Vm wl55, was distributed over the entire  capsid 
surface, and is probably the major constituent of the hexamers. Vmw50 
was located on the capsid surface at the vertices in th is study. Braun 
et al. (1984a), however, reported tha t th is polypeptide was an in te rna l 
component o f the capsid and, in addition, was capable of binding DNA. 
These results suggest tha t Vmw50 may be a constituent of the core, 
involved in DNA packaging and/or anchorage. Immune electron microscopy 
also showed tha t Vmw40 coated the entire  surface of capsids. The other 
nucleocapsid polypeptides could not be precisely localised by immune 
electron microscopy, and may occupy in terna l locations.
Nucleocapsid polypeptide p40 has been subjected to detailed 
structura l and functional analysis since its  presence in capsids containing 
DNA and absence from  empty capsids suggested a role in DNA 
encapsidation fo r this polypeptide (Gibson and Roizman, 1972, 1974). The 
genetically and im m unologically related fam ily  of polypeptides designated 
p40 (Heilman et a l., 1979; Zweig et a l., 1980) is recognised under 
alternative polypeptide nomenclatures as VP22a (Gibson and Roizman, 1972) 
and ICP35 (Braun et a l., 1983, 1984b). Generally, between four and six 
related polypeptides, ranging in molecular weight from  37,000 to 50,000 
can be resolved by one-dimensional SDS-PAGE (Zweig et a l., 1980; Braun 
Gt a l., 1984b). On the basis o f virus in fec ted -ce ll frac tio na tion  
experiments, Braun et al. (1984b) reported tha t the slowest m igrating form s 
of p40 (ICP35 a to d) were the cytoplasm ic precursors to faster m igra ting 
nuclear products (ICP35 e and f). Two-dimensional PAGE revealed the 
presence o f approximately twenty re lated polypeptides w ith in  the fa m ily .
8although the nature of the structu ra l changes responsible fo r a lterations in 
isoelectric properties and electrophoretic m obilities are poorly understood 
(Braun et a l., 1984b). The fastest m igrating polypeptides in the fam ily  are 
the predominant forms of p40 found in fu ll nucleocapsids (Heilman, 1982; 
Braun et a l., 1984b). Surface iodination of capsids showed tha t these 
polypeptides coat the entire  capsid surface (Braun et a l., 1984b). Since a 
mutant of HSV-1, _U1201, which fa ils  to encapsidate virus DNA at the 
NPT, also fa ils  to process p40 to its lower MW forms, i t  seems like ly  tha t 
this processing step is essential fo r encapsidation of DNA.
Analogous polypeptides have been identified  in PRV (Ladin et a l., 
1982), CMV strains Colburn (Gibson, 1981) and AD169 (Irm iere and Gibson, 
1985), EHV-1 (Perdue et a l., 1975) and possibly HVS (Randall et a l., 1983).
Tegument polypeptides
Assignment o f s truc tu ra l polypeptides to the tegument is based on 
the ir presence in capsid-tegument structures (de-enveloped virions), and 
the ir absence from  capsids extracted from  nuclei in the presence of 
detergents (Gibson and Roizman, 1972; Lemaster and Roizman, 1980). 
Several of these may, however, be constituents o f the underside o f the 
envelope. Of note is the large 273,000 MW polypeptide (Heine et a l., 
1974), the function of which is unclear, and the 65,000 MW "v irion  
component" which is responsible fo r switch-on o f IE transcrip tion (see 
Section 1.4.2; Roizman and Furlong, 1974). The presence o f a v irion - 
associated protein kinase a c tiv ity  in the tegument has been described 
(Lemaster and Roizman, 1980). Stevely et al. (1985), however, reported 
sim ilarities between the virion kinase and host caesin kinase II, suggesting 
that this enzyme may not be virus-coded.
Envelope polypeptides
Although the HSV v irion  envelope is norm ally acquired by budding 
through the host ce ll nuclear membrane, i t  is enriched fo r virus-specified 
polypeptides (Spear and Roizman, 1972; Heine et a l., 1972; Honess and
Roizman, 1975). Four major glycoproteins have been identified  in HSV-1- 
and HSV-2-infected cells and in v irion envelopes; gB, gC, gD and gE
(Spear, 1976; Bauke and Spear, 1979; Para et a l., 1980; Eberle and
Courtney, 1980; Para et a l., 1982; Zezulak and Spear, 1983; Cohen 
et a l., 1984). The map positions o f these glycoproteins are shown in 
figure 5. M inor glycoproteins gH (Buckmaster e t a l., 1984), and gY
(Palfreyman et a l., 1983), have been detected in H S V -l-in fec ted  cells, and
g92K (Marsden et a l., 1984) and gG (Roizman et a l., 1984) have been 
detected in HSV-2-infected cells. The la tte r  two glycoproteins are, in 
fa c t, identical (O loffson e t a l., subm itted fo r pub lication), and the HSV-1 
counterpart fo r th is HSV-2 glycoprotein has recently been iden tified  (Frame 
et a l., 1985b). As ye t, these glycoproteins have not been assigned to the 
v irion envelope. Several puta tive  glycoprotein genes have been id en tified  
in the short unique (Ug) region of the HSV-1 genome, and i t  is possible 
tha t these may encode in tegra l polypeptides of the v irion  envelope 
(McGeoch et a l., 1985).
1.3 THE L Y T IC  C Y C LE  OF HSV
1.3.1 Adsorption and penetration
Infection o f cells w ith  HSV is in itia ted  by adsorption o f virus 
particles onto the ce ll surface, followed by penetration of virus through 
the ce ll membrane in to  the cytoplasm.
r e l a t i v e l y
Adsorption is a rapid, ^tem perature-independent process, which 
occurs m aximally w ith in  the f irs t 30min a fte r addition of virus to cells 
(Hochberg and Becker, 1968). The in it ia l v irus-ce ll in te raction  is probably
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Map locations of the major HSV-1 glycoproteins and syn loc i on the HSV-1 
genome.
Citations fo r map positions are given in the tex t.
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weak and e lectrosta tic  in nature, since adsorbed virions can be removed 
from  the ce ll surface by heparin, a negatively charged polysaccharide 
(Hochberg and Becker, 1968). The subsequent irreversib le m u ltiva len t 
v irus-ce ll attachment probably involves many virus g lycoprote in-ce ll surface 
receptor interactions (Kohn, 1979). Biochemical evidence fo r th is 
m ultiva lent attachment was obtained by Rosenthal et al. (1984) who 
demonstrated tha t binding of HSV to ce ll surfaces caused a reduction in 
the m obility  of cell surface proteins, s im ilar to tha t caused by m u ltiva len t 
attachment of ligands such as lectins or anti-immunoglobulins (Gall and 
Edelman, 1981). This e ffe c t, which occurs prior to virus penetration, is 
thought to be caused by the cross-linking o f ce llu la r receptor proteins to 
cytoskeletal elements. Interesting ly, type-specific  ce ll surface receptors 
fo r HSV-1 and HSV-2 have been described by Vahlne et al. (1979) on the 
basis o f com petition assays w ith  heterotyp ic and UV-irrad iated virus.
The virion polypeptide(s) which in te rac t w ith  ce llu la r receptors have 
not yet been identified , however, such attachm ent polypeptides are most 
like ly to be one or more of the virus envelope glycoproteins. The a b ility  
o f polyclonal and monoclonal antibodies, directed against HSV-1 
glycoproteins gC and gD, to inh ib it HSV-1 adsorption to cells, suggests tha t 
these glycoproteins are involved in v irion attachm ent (Fuller and Spear, 
1985). Since glycoprotein gE binds the Fc portion o f IgG (Baucke and 
Spear, 1979), the observation tha t high concentrations o f the Fc portion o f 
IgG partia lly  inh ib it attachm ent o f virus to cells indicates tha t gE may 
also play a role in virus adsorption (Para et a l., 1982; Fuller and Spear, 
1985). Other work has im plicated gB in th is process. A r t if ic ia l liposomes 
or 'virosomes', enriched fo r HSV glycoproteins, bound to cells more 
e ffic ie n tly  when gB was present than when i t  was absent (Johnson e t a l., 
1984).
In contrast to adsorption, penetration o f virions through the ce ll
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membrane is a temperature-dependent event (Farnam and Newton, 1959; 
Duyckinck-Smith and de Harven, 1974). E lectron microscopic studies of 
virus-in fected cells suggested tha t in terna lisa tion of virions occurs 
predominantly by fusion of the v ira l envelope w ith  the ce ll membrane 
(Morgan et a l., 1968; Abodeely et a l., 1970), ra ther than by phagocytosis 
of the virus pa rtic le , as proposed by Dales and Silverberg (1969) and 
Hummeler et al. (1969). Biochemical evidence fo r the fusion model o f 
virus penetration was obtained by Para et al. (1980), who showed tha t 
glycoprotein gE was transferred from  v irion  envelopes to the ce ll 
membrane, when cells were infected w ith  virus in the presence of a 
protein synthesis inh ib ito r.
G lycoprotein gB has been im plicated as one like ly  candidate fo r a 
virus polypeptide involved in the membrane fusion event. Characterisation 
of ^  mutants, tsB5 and _kJ12, revealed tha t at the NPT these mutants 
assemble virions containing gB-defic ient envelopes. These progeny virions 
adsorb to cells norm ally, but fa il to penetrate the ce ll membrane 
(Sarmiento et a l., 1979; L it t le  et a l., 1980). The finding tha t 
polyethylene glycol (PEG), a membrane fusion prom oter, s ign ifican tly  
enhanced the in fe c tiv ity  o f the adsorbed virions, gives support to the 
fusion model of virus entry. Genetic analysis o f the s tructura l gene fo r 
gB identified  a locus a ffecting  rate of virus entry at 31°, and a syn locus 
responsible fo r fusion of neighbouring HSV-infected cells (DeLuca et a l., 
1981, 1982; Bond et a l., 1982; Bzik et a l., 1984). These data suggest 
that gB has an im portant function in virus penetration.
Although glycoprotein gC is not essential fo r virus in fe c tiv ity  
(Holland et a l., 1984), this polypeptide may be involved in the negative 
regulation of gB-promoted membrane fusion. Recombinants which lack gC 
in the ir envelopes entered cells at a faster ra te  than viruses which contain 
gC (DeLuca et a l., 1982). In addition, HSV-1 strains, which synthesize low
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levels of gC re la tive  to gB in a permissive ce ll line, were capable of 
penetrating the non-permissive ra t ce ll line XC, whereas viruses which 
induce normal amounts o f gC remained on the ce ll surface (Epstein et a l., 
1984).
Thus, although the precise mechanisms remain unclear, i t  seems 
reasonable to hypothesize tha t the in it ia l v irus-ce ll in te rac tion  is weak, but 
is followed by m u ltiva len t attachments between v irion  envelope and the 
correct ce llu lar receptor, such that fusion between the closely aligned 
membranes can occur. The virus envelope glycoproteins play im portant 
roles in both these processes.
1.3.2 Uncoating o f the v ira l genome
The te rm  uncoating refers to the release o f the v ira l genome from  
the capsid prio r to DNA rep lica tion . Uncoating o f the HSV-1 genome is a 
poorly understood process. Capsids can be detected in the perinuclear 
region of the ce ll w ith in  15-30min of virus penetration (Hummeler et a l., 
1969; M iyamoto and Morgan, 1971). Early reports tha t the capsids 
undergo sequential degradation during transport to  the nucleus (Morgan 
et a l., 1968) have not been substantiated, and i t  is like ly  tha t release of 
the genome from  the capsid occurs only at the nuclear membrane. A 
study in which m etabolic inh ib itors were added to cells from  the tim e of 
virus in fection, indicated tha t de novo RNA and prote in  synthesis are not 
required fo r virus uncoating. This finding suggested tha t e ither a 
structura l component o f the capsid and/or ce llu la r enzymes are responsible 
fo r the process (Hochberg and Becker, 1969). The observation tha t the 
pentamers were frequently  missing from  preparations o f fla ttened capsid 
sheets led to the proposal by Vernon et al. (1976) tha t removal o f these 
structures allows e x it o f the v ira l DNA from  the capsid. Nuclease- 
sensitive input virus DNA can be detected in the nucleus between 15-60min
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pi (Hochberg and Becker, 1969; Hummeler et a l., 1969), although the 
mechanism of translocation is not clear. Analysis of ^  m utant tsB7, 
which fa ils to uncoat v ira l DNA at the NPT, has provided fu rth e r clues as 
to the mechanism whereby input virus DNA reaches the nucleus. In tsB7- 
infected cells at the NPT m utant capsids containing DNA, accumulated at 
the nuclear pores and v ira l DNA was only released upon tem perature 
downshift to the PT. Under these conditions, in term ediate uncoating form s 
w ith partia lly  extruding DNA cores were seen (Knipe et a l., 1981; 
Batterson et a l., 1983), ind ica ting tha t nucleocapsids themselves did not 
penetrate the nucleus before release o f the v ira l genome. Juxtaposition 
of ^B 7  capsids at the nuclear pores suggests tha t v ira l DNA enters the 
nucleus using an active ce llu la r transport system.
1.3.3 Suppression of ce llu la r macromolecular synthesis
Infection o f cells w ith  HSV results in a decrease in host ce ll DNA, 
RNA and protein synthesis. Recent work, however, has centred on the 
inhibition of host prote in synthesis. An im m ediate consequence of 
infection is the disaggregation of polyribosomes, an event which is
mediated by a component of the in fecting  v irion. This process coincides
with the rapid inh ib ition  o f host protein synthesis (Roizman et a l., 1965; 
Sydiskis and Roizman, 1966, 1967; Fenwick and Walker, 1978; Nishioka
and Silverstein, 1978; Silverstein and Engelhardt, 1979). A v irion  
component is also responsible fo r the inactiva tion  o f host mRNAs, a 
process which is generally more rapid in HSV-2-infected cells than in HSV- 
l- in fec ted  cells (Fenwick and C larke, 1982; Fenwick and McMenamin, 
1984; Schek and Bachenheimer, 1985). These events are re fe rred  to as 
'early' shut-off of host prote in synthesis, but i t  is not known whether a 
single virion structu ra l component is involved in a ll o f these processes.
'Delayed' inhib ition o f host polypeptide synthesis, on the other hand, is
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dependent on virus gene expression, and results in the degradation o f host
transcripts (Nishioka and Silverstein, 1978; H ill e t a l., 1983).
The virion-associated shu t-o ff of host polypeptide synthesis is not 
essential fo r virus rep lica tion , since viable mutants, which are de fective  in 
this function, have been isolated (Read and Frenkel, 1983). The v irion  
function has been mapped to a region between 0.52 and 0.59mu on the
HSV genome (Fenwick et a l., 1979). The mechanism of action o f the
virion component is unclear, but i t  is thought tha t the polypeptide e ithe r 
acts d irectly  as a virion-associated nuclease, or a lte rna tive ly , acts 
ind irectly by stim ulating a ce llu lar RNase a c tiv ity .
HSV-induced inh ib ition of host DNA and RNA synthesis have been 
less extensively studied. Stenberg and Pizer (1982) observed tha t an IE 
gene function is responsible fo r the decrease in ce llu la r RNA synthesis 
which accompanies HSV in fection . Obviously, a decrease in the a va ila b ility  
of cellular mRNA is a contribu tory fac to r in the inh ib ition  o f host pro te in  
synthesis. HSV in fection  also decreases the ra te  o f host ce ll DNA 
synthesis (Roizman and Roane, 1964), however, the precise mechanisms 
underlying this inh ib ition remain unclear.
1.4 HSV m RNA SYNTHESIS
Transcription o f HSV DNA takes place in the host ce ll nucleus 
(Wagner and Roizman, 1969). The observation tha t HSV transcrip tion  is 
indistinguishable from  host ce ll mRNA synthesis in its  sens itiv ity  to 
amanitin inh ib ition (A lw ine et a l., 1974; Ben-Zeev et a l., 1976; Costanzo 
Gt al., 1977), suggests tha t HSV DNA is transcribed by a host ce ll D N A- 
dependent RNA polymerase II. This conclusion is supported by the find ing 
that naked HSV DNA is infectious (Graham et a l., 1973). In common w ith  
most eukaryotic mRNAs, HSV transcrip ts are capped at the ir 5 '-te rm in i and 
methylated at in ternal nucleosides (Moss et a l., 1977). The DNA specifying
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the 3 '-term in i of these transcripts contains the polyadenyiation signal 
AATAAA, which is essential fo r correct processing of mRNAs (McKnight,
1980); Cole and Santangelo, 1983). A G+T-rich element, located 
approximately 30bp downstream from  the polyadenyiation signal o f several 
HSV genes so fa r analysed, is also required fo r e ffic ie n t fo rm ation  of the 
mRNA 3’-term inus (McLauchlan et a l., 19883; W hitton et a l., 1983; 
McLauchlan et a l., 1985; Cole and Stacy, 1985). This sequence is 
conserved in many mammalian genes (Taya et a l., 1982; McLauchlan 
et a l., 1985).
To date only four spliced HSV mRNAs have been identified , a 
finding at odds w ith  the general view of eukaryotic mRNA processing, 
where splicing is commonplace. IE mRNAs -4 (Vmw68) and -5 (Vm wl2) 
share a common 5' leader sequence in the short repeat segments of the 
virus genome, which is spliced to polypeptide coding sequences in Ug 
(Watson et a l., 1981; Rixon and Clements, 1982; Watson and Vande- 
Woude, 1982). IE mRNA -1 (Vm wllO ) is also spliced (Perry et a l., 1985). 
The gene encoding glycoprotein gC also gives rise to a fam ily  o f spliced 
late mRNAs which share common 5'- and 3’- te rm in i (Frink ec a l., 1981; 
Frink et a l., 1983).
HSV mRNA is transported to the cytoplasm where i t  becomes 
associated w ith  polyribosomes, and is translated (Wagner and Roizman, 
1969).
1*4.1 Regulation of HSV gene expression
Virus-specific mRNAs and polypeptides have been classified in to 
three broad groups, im m ediate-early (IE or a ), early { f t )  and la te ( y ), 
whose synthesis is tem porally regulated (Honess and Roizman, 1973, 1974, 
1975; Swanstrom and Wagner, 1974; Clements et a l., 1977; Jones and 
Roizman, 1979). Recent work on the contro l of HSV gene expression has
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centred on the iden tifica tion  of cis- and trans- acting factors required fo r 
the cascade regulation of mRNA and polypeptide synthesis.
1.4.2 IE gene expression
IE transcripts are the f irs t class o f v irus-specific  mRNA detectable 
in the virus growth cycle, and do not require de novo virus pro te in  
synthesis fo r the ir production. Norm ally, in a ly t ic  in fection , IE mRNAs 
are present in small amounts, however, the five  major IE transcrip ts can 
be made in large amounts in the presence o f protein synthesis inh ib itors 
such as cycloheximide or anisomycin, added from  the tim e of virus 
in fection (Clements et a l., 1977; Jones e t a l., 1977; Clements et a l., 
1979; Watson et a l., 1979; Anderson et a l., 1980; H arris-H am ilton and 
Bachenheimer, 1985). Figure 6 shows the physical map location o f genes 
encoding these transcripts.
In the course of a normal virus in fection  at 37°, levels o f IE 
transcripts reach a peak w ith in  the f irs t  6h o f in fection , a fte r which tim e 
they decline, but s t il l remain detectable a t la te times a fte r in fec tion  
(Harris-Ham ilton and Bachenheimer, 1985). Upon removal o f the 
cycloheximide block, five  major IE polypeptides are synthesized (Clements 
et a l., 1977; Preston, 1979a; Watson et a l., 1979; Anderson et a l., 1980; 
Watson et a l., 1981), which have apparent MWs o f 175,000, 110,000, 68,000, 
63,000 and 12,000 (Preston, 1979b; Watson et a l., 1979; Preston et a l.,
1981). A ll the IE polypeptides, except Vm w l2, are phosphorylated (Pereira 
et a l., 1977; Marsden et a l., 1978; Marsden et a l., 1980) and, w ith  the 
exception of Vm w l2, a ll bind to DNA in v itro  (Hay and Hay, 1980).
Stim ulation o f IE transcrip tion  is mediated by a component o f the 
infecting v irion. Post et al. (1981) successfully transform ed cells from  a 
TK’  phenotype to a TK+ phenotype using plasmids in which the HSV-TK 
gene structura l sequences were fused to the 5'- non-coding regions o f IE-3
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FIG U R E 6
Genome map locations and orientations o f the IE mRNAs (numbered 1 to 
5) of HSV-1. The table indicates the presence or absence of splicing o f 
each IE transcrip t, and the MW of the polypeptide produced from  each 
mRNA species.
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gene (Vm wl75). Transcription from  the lE -TK gene constructs was 
stimulated by in fec tion  w ith  TK~ virus in the presence of cyclohexim ide. 
Further studies by Batterson and Roizman (1983) showed tha t this 
stim ulation of IE transcrip tion was mediated by one or more structura l 
polypeptides located on the outside of the HSV capsid. Iden tifica tion  of 
the virion component was obtained by Campbell et al. (1984), using a short 
term  expression assay in which cells were cotransfected w ith  cloned HSV 
DNA fragments and lE -TK  gene constructs. Stim ulation o f the synthesis 
was e lic ited  by a subclone of HSV-1 DNA fragm ent Bam HI 2 (mu 0.64-0.69, 
pM Cl), which contains a single in tac t gene encoding the tegument protein, 
Vmw65. This transcrip tiona l stim ulation by Vmw65 was only observed fo r 
genes containing IE promoters.
Detailed analyses o f IE-3 gene upstream prom oter sequences have 
identified regulatory and prom oter regions (Mackem and Roizman, 1980, 
1982a, 1982b, 1982c). Im portant transcrip tiona l elements include a TATA 
homology, located between positions -16 and -37 in the prom oter, which is 
required fo r accurate in itia tio n  of transcrip tion. In addition, proxim al 
promoter sequences from  position -37 to -108, which are required fo r 
transcriptional in itia tio n  in the absence of fu rthe r upstream sequences, and 
a far-upstream region (-174 to -331), containing positive regulatory signals 
resembling enhancer sequences, have been iden tified  (Cordingley et a l., 
1983; Preston and Tannahill, 1984; Lang et a l., 1984). A consensus 
sequence, TAATGARAT, located w ith in  the far-upstream  regions o f a ll the 
IE gene promoters (Mackem and Roizman, 1982; W hitton and Clements, 
1984), forms part o f the ta rge t sequence fo r v irion  component stim ulation 
(Preston et a l., 1984). G C-rich regions flanking the TAATGARAT sequence 
appear to be im portant in modulating transcrip tiona l a c tiv ity , and may be 
involved in in teractions w ith  the ce llu lar transcrip tion fac to r Spl (Jones 
and Tjian, 1985; see Section 1.4.3).
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1.4.3 Early gene expression
One or more functiona l IE polypeptides are required fo r the sw itch 
from  IE to early gene expression, and fo r the continuous synthesis o f early 
transcripts which reaches a maximum before the onset of virus DNA 
replication (Honess and Roizman, 1974, 1975). Vm wl75 was f irs t  im plicated 
in the switch-on o f early gene transcrip tion by the characterisation o f tsK 
(Preston, 1979b), a m utant w ith  a lesion in the gene encoding Vm wl75 
(Stow et a l., 1978; Davison et a l., 1984). In fection of cells w ith  this 
mutant at the NPT led to overproduction o f IE polypeptides. In addition, 
Vmwl75 was not processed co rrec tly  to its  higher MW forms in these cells, 
and the abnormal polypeptide was not com plete ly translocated from  
cytoplasm to nucleus (Preston, 1979b). The normal progression to early 
gene expression occurred upon tem perature downshift o f tsK -in fec ted  cells 
to the PT, in the presence of cyclohexim ide to prevent fu rthe r prote in 
synthesis (Watson and Clements, 1978; Preston, 1979b). However, the 
mutant phenotype could be reintroduced upon subsequent tem perature 
upshift. These results suggest tha t functiona l Vm wl75 is required fo r a 
normal trans ition  from  IE to early polypeptide synthesis, and tha t this 
a c tiv ity  is required throughout the virus growth cycle. S im ilar findings have 
been obtained fo r other mutants w ith  ^  defects in Vm wl75 (Parris et a l., 
1978; Dixon and Schaffer, 1980).
A lte rna tive  experim ental approaches have clearly im plica ted IE 
polypeptides in the transactiva tion  o f early genes. Expression o f early 
genes, stably in tegrated in to mammalian ce ll genomes, is induced by 
in fection w ith  Vm w l75 mutants o f HSV-1 at the PT but not at the NPT. 
This result confirm s tha t these early genes are dependent on the presence 
of functional Vm w l75 fo r the ir e ffic ie n t expression (K it et a l., 1978; 
Sandri-Goldin et a l., 1983). Conversely, cells which cons titu tive ly  
expressed Vm wl75 allowed the transactiva tion of several early genes
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introduced by virus in fection  in the absence of v ira l prote in synthesis 
(Person et a i., 1985). The fa c t that one early gene was not expressed 
under these conditions indicates tha t additional factors, fo r example, other 
IE polypeptides, are required fo r the e ffic ie n t transactiva tion  o f a subset 
of early genes. Cotransfection o f cells w ith  plasmids encoding early genes 
and im m ediate-early genes, singly and in various combinations, has provided 
additional evidence tha t both Vm wl75 and Vm w llO  play essential roles in 
the transactivation o f early genes. Everett (1984) reported tha t Vm w llO , 
together w ith  Vm wl75, could stim ulate early gene expression to a greater 
level than was achieved by the action o f Vm wl75 alone. However, 
Vm wllO  alone was unable to activate early gene transcrip tion . In
contrast, both O'Hare and Hayward (1985) and Quinlan and Knipe (1985) 
showed evidence tha t these two IE polypeptides could act separately to 
induce early gene expression, although the ir a c tiv ity  was apparently
synergistic. Tentative evidence also exists tha t V m w l2 can augment early 
gene activation by Vm wl75 and Vm w llO  (O'Hare and Hayward, 1984).
Recent characterisation of mutants w ith  lesions in the gene 
encoding Vmw63 (ICP27), has indicated tha t th is polypeptide has a
regulatory function. The polypeptide is required a fte r the onset o f early 
gene expression (Sacks et a l., 1985), since drastica lly  reduced levels o f la te 
virus polypeptides are synthesized in cells in fected at the NPT w ith  these 
mutants. Together w ith  the fa c t tha t some ^  mutants w ith  lesions in 
Vmwl75 are permissive fo r early gene expression (DeLuca et a l., 1984), 
these results support the idea tha t several IE polypeptides have regulatory 
functions which are required throughout the virus rep lica tion  cycle.
Several elegant analyses of early gene prom oter regions have been 
undertaken w ith  the aim of id en t^ng  cis- and trans- acting transcrip tiona l 
control signals. Investigation o f the TK prom oter region by both deletion 
analysis and insertion of clustered sets o f point m utations at random
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locations, enabled three d istinct cis-acting contro l signals to be identified  
w ith in the 105bp upstream sequence required fo r e ffic ie n t transcrip tion of 
the TK gene (McKnight et a l., 1981; M cKnight and Kingsbury, 1982; 
McKnight et a l., 1984). These included a proxim al TATA homology, and 
two upstream dista l signals which exhibited sequence homology and were
required fo r quantita tive  transcriptional contro l. Experiments designed to 
determine early gene promoter sequences which respond to transactivation 
by virus IE polypeptides yielded con flic ting  results. Zipser et al. (1981)
and Elkareh et al. (1985) reported tha t functiona l domains which had 
d iffe ren tia l roles in constitu tive and virus-induced expression of the gene, 
could be defined w ith in  the TK promoter region. Everett (1984) and
McKnight et al. (1985), however, using genes containing the gD and TK 
promoters respectively in trans-induction assays, could not detect any 
specific sequences required fo r transactivation by IE polypeptides.
Recent experiments revealed tha t the same early gene upstream
sequences are required fo r e ffic ie n t expression o f early genes in 
constitutive (frog oocyte) and regulated (HSV-infected fibroblast ce ll)
environments (Eisenberg et a l., 1985). Taken together w ith  evidence tha t 
the mammalian transcrip tion fac to r Spl binds strongly to  IE and early gene 
promoters (Jones and Tjian, 1985), these findings indicate tha t IE 
polypeptides transactivate early genes in conjunction w ith , or by
m odification of, ce llu la r transcription factors.
Two classes o f early polypeptides, 1 and ^ 2, have been 
distinguished on the basis of the ir synthesis in the presence o f d iffe re n t 
amino acid analogues (Pereira et a l., 1977) and the analysis of polypeptides 
induced by _UK at the NPT (Preston, 1979b). The early class of
polypeptides includes many enzymes involved in virus nucleic acid
metabolism and several s tructura l polypeptides.
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1.4.4 Autoregulation of IE gene expression
An added com plexity to the pattern of mRNA and polypeptide 
synthesis in HSV-infected cells, is the apparent negative regulation o f IE 
gene expression by the IE gene products themselves, i.e. autoregulation. In 
the course of a normal in fection, IE polypeptide synthesis declines once 
early polypeptide synthesis is underway. On the basis o f tem pera ture-sh ift 
experiments w ith  tsK and other ^  mutants w ith  lesions in Vm wl75 
(Preston, 1979b; Dixon and Schaffer, 1980), i t  appeared tha t Vm wl75 was 
responsible fo r this sw itch -o ff o f IE gene transcrip tion. However, Vm wl75 
alone may not be su ffic ien t to maintain the negative regulation of IE gene 
expression fo r the fo llow ing resions: (i) ^  mutants have been isolated
which synthesize functional Vm wl75, yet s t il l overproduce IE polypeptides 
at the NPT (Sacks et a l., 1985), and (ii) both a s truc tu ra l component of 
the in fecting v irion (Read and Frenkel, 1983), and a la te gene function 
(DeLuca et a l., 1984), have been im plicated in the sw itch -o ff o f IE gene 
expression.
1.4.5 Late transcription
Late or F mRNAs have been subdivided in to two classes: V
( or early-late) transcripts, which are easily detectable in the absence 
of virus DNA replication but which reach maximum abundance once DNA 
synthesis has begun (Clements et a l., 1977), and /J 2 (true-la te ) transcrip ts, 
whose synthesis is strongly dependent on DNA rep lica tion  (Powell et a l., 
1975; Holland et a l., 1980). Functional IE and early polypeptides are 
required fo r expression of la te genes (Honess and Roizman, 1975; Watson 
and Clements, 1980). Transactivation o f the la te prom oter fo r Vm wl55 
(VP5) has been described (Dennis and Smiley, 1984), but as yet the overall 
mechanism responsible fo r la te gene expression is poorly understood. Early 
and late genes can be distinguished in in v itro  transcrip tion systems
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prepared from  uninfected cells (Frink et a l., 1981). In the absence of 
transactivation, early genes are expressed whereas la te genes remain 
transcriptiona lly s ilent. One possible explanation is tha t la te  promoters are 
in trins ica lly  weak, requiring transactivation fo r e ffic ie n t expression. Late 
genes may also be subject to negative contro l by the major DNA binding 
protein Vmwl36 (ICP8), since ^  mutants w ith  lesions in this gene exhib it 
increased levels o f la te  gene expression at the NPT (Godowski and Knipe, 
1983, 1985). An increase in gene dosage may also play a s ign ificant role 
in late gene expression, as a result o f tem plate am p lifica tion  when the 
virus genome is rep licated.
1.5 R E P LIC A TIO N  OF V IR A L D N A
Since much in form ation concerning the rep lica tion  o f herpesvirus 
DNA has been gained from  studies on PRV, as w e ll as HSV, the fo llow ing 
section encompasses aspects o f both PRV and HSV DNA rep lica tion .
Jacob and Roizman (1977) reported tha t less than 5% of input HSV 
DNA entered the rep lica tion  cycle, whereas greater than 80% of parental 
PRV genomes undergo rep lica tion (Ben-Porat et a l., 1976). Over 90% of 
mature herpesvirus DNA contains single-stranded nicks or gaps, many of 
which are repaired during replication (Frenkel and Roizman, 1972; W ilkie, 
1973; Wadsworth e t a l., 1976; Hyman et a l., 1977; Ben-Porat and Rixon, 
1979). Replacement o f short stretches o f DNA w ith  ribonucleotides has 
also been reported (Biswal et a l., 1974).
Semi-conservative HSV DNA rep lica tion  at 37° can be detected in 
the BHK cell nucleus as early as 3h pi, reaches a maximum between 9 - l lh  
pi, and is v ir tu a lly  completed by 16h pi (Rixon, 1977). E lectron 
microscopic analysis o f parental DNA molecules, before the onset o f, and 
during the f irs t  round o f DNA rep lica tion , revealed the presence o f u n it­
sized molecules w ith  single-stranded ends and also c ircu la r molecules (Jean
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and Ben-Porat, 1976; Jacob and Roizman, 1977). C ircu larisa tion o f the 
HSV linear genome is thought to occur by d irect liga tion  o f the te rm in i 
(Davison and W ilkie, 1983) rather than by ligation o f complementary single­
stranded term in i as proposed by Jacob and Roizman (1977), and this 
process can take place in the absence of de novo virus prote in synthesis 
(Poffenberger and Roizman, 1985). This model would also be feasible fo r 
PRV DNA which, unlike the HSV genome, does not possess te rm ina lly  
redundant term in i (A.J. Davison, personal communication). C ircu la r VZV 
DNA molecules have also been described (Ecker et a l., 1984; K inchington 
et a l., 1985). A t la te r tim es in in fection , DNA molecules w ith  rep lica tive  
'eyes', internal la ria ts, te rm ina l loops and also Y-shaped molecules can be 
detected. In addition, molecules which are larger than unit-s ize w ith  
internal eyes and forks, c ircu la r molecules w ith  linear ta ils , and large 
tangles of DNA are seen (Schlomai et a l., 1976; Ben-Porat e t a l., 1976; 
Friedmann et a l., 1977; Hirsch et a l., 1977; Jacob and Roizman, 1977; 
Jean et a l., 1977; Becker et a l., 1978). Together w ith  the observation 
that there is a decrease in the number of term ina l fragments detectable in 
replicating virus DNA compared to v irion DNA (Jacob et a l., 1979; 
Jongeneel and Bachenheimer, 1981; Ben-Porat and Rixon, 1979), these data 
suggest that circularised un it-length molecules are replicated by a ro llin g - 
circle mechanism yielding head-to -ta il concatemeric DNA.
1.5.1 The orig in o f rep lica tion
Three origins of rep lica tion have been id en tified  in the HSV-1 
genome, two of which were in it ia lly  suggested from  electron m icroscopic 
analysis of rep lica ting DNA; one located in U|^ and one in each o f the 
short repeat sequences (Schlomai et a l., 1976; Friedmann et a l., 1977; 
Hirsch et a l., 1977). Further evidence came from  the study of defective 
HSV-1 genomes which are generated during serial passage of virus stocks
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at high m u ltip lic ity  of in fection. Two classes of defective genomes have 
been described: class I defectives contain the whole of TRg and also
sequences from  Ug (Frenkel et a l., 1976; Graham et a l., 1978; Kaerner 
et a l., 1979; Locker and Frenkel, 1979; Kaerner et a l., 1981), whereas 
class II defectives contain sequences from  U|_ and also the a sequence 
from TRg (Kaerner et a l., 1979; Schroder et a l., 1975). Three origins of 
replication were identified  from  the study of defective genomes; two in 
the diploid c sequences from  TRg (orig), and one in U|_ (ori|_) (Vlazny and 
Frenkel, 1981; Spaete and Frenkel, 1982, 1985). Three comparable origins 
of replication have been identified  in PRV (Jean et a l., 1977; Rixon and 
Ben-Porat, 1979; Ben-Porat and Veach, 1980).
The cis-acting signals in orig which are essential fo r DNA 
replication were localised to the c sequences in TRg and IRg by Stow 
(1982) and independently by Mocarski and Roizman (1982), and fu rthe r 
defined to a 90bp untranscribed region located between the 5' ends o f two 
divergently transcribed mRNAs by Stow and McMonagle (1983). Gray and 
Kaerner (1984) f irs t determined the sequence of the putative ori|_ region in 
HSV-1 strain Angelotti defective virus DNA. Precise localisation o f ori|_ 
in standard HSV-1 DNA was hindered, however, by the in ab ility  to clone 
this origin in an undeleted form  in conventional plasmid or lambda vectors. 
Successful cloning of the region between mu 0.407-0.429 in to a yeast 
vector (Weller et a l., 1985) and the analysis of uncloned HSV-1 stra in  17 
genomic DNA (Quinn and McGeoch, 1985) allowed sequencing across the 
origin. A palindromic sequence was identified  in ori|_ which bore great 
s im ila rity  to tha t in orig. This palindrome may well be the functiona l 
origin of replication since cotransfection of a deleted ori|_ clone w ith  
helper virus DNA results in am plifica tion  o f the clone in which the 
palindromic sequence had been restored, presumably by recom bination w ith  
w ild-type DNA (Spaete and Frenkel, 1982). Ori|_ is situated between two
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divergently transcribed early genes which code fo r the virus DNA 
polymerase and the major DNA binding protein (Quinn and McGeoch, 1985), 
a gene layout which is also observed fo r orig. The significance, i f  any, of 
the fac t that the genes flanking ori|_ encode proteins o f major importance 
in HSV DNA rep lica tion , is unclear. In addition, i t  is unknown whether 
one origin of rep lica tion  is used pre ferentia lly  during virus DNA synthesis.
1.5.2 M aturation of v ira l DNA
Replicating herpesvirus DNA forms a pool of concatemeric 
molecules from  which DNA is withdrawn at random fo r cleavage in to unit 
length molecules, and packaging (Ben-Porat and Kaplan, 1963; Jacob 
et a l., 1979).
The mature, linear HSV genome has te rm ina lly  redundant ends
which must be generated as a result of s ite -specific  cleavage of
concatemeric DNA. Since defective virus DNA, containing sequences from  
the S region o f the HSV genome, (see Section 1.5.1) is cleaved and
packaged in to capsids, i t  fo llows that sequences from  th is  pa rt o f standard 
HSV DNA must contain the signal fo r cleavage (Vlazny e t a l., 1982). 
Subsequently, Stow et al. (1983) localised the cleavage signal to the 400bp 
a sequence which is common to TR|_ and TRg. Sequence analysis of 
standard HSV DNA molecules revealed tha t the a sequence at both the L 
and S term in i ends in a pa rtia l copy o f the D R l element (Davison and
Wilkie, 1981; Mocarski and Roizman, 1982). L igation o f the L and S 
term ini recreates the complete D R l sequence. Thus, as shown in figure 7, 
the term in i m ight arise as a result of cleavage at a ta rge t sequence w ith in  
the single D R l element located between two adjacent a sequences.
Recent analysis o f an HSV-1 strain Justin defective, which has a 
repeat unit comprising sequences from  Ug linked to the short repeat (ca) 
sequence, suggested, however, tha t the target sequences fo r cleavage are
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FIG URE 7
Generation o f the L and S te rm in i o f unit length HSV genomes by a single 
cleavage event w ith in  the D R l element of the a sequence. Taken from  
Mocarski and Roizman (1982) and Varmuza and Smiley (1985).
(a) Single a sequences are flanked by D R l elements.
(b) Tandemly re ite ra ted  a sequences share a single copy o f D R l.
(c) L and S te rm in i may arise as a result o f a single cleavage event 
w ith in  a D R l element separating two adjacent a sequences.
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not w ith in  D R l. The DNA sequence of the novel Ug-a junction, at which 
Ug sequences of one repeat unit jo in the a sequence of the adjacent
repeat un it, revealed tha t only 4bp o f the D R l element was retained
(Mocarski et a l., 1985). Therefore, since i t  was unlikely tha t this 4bp 
represents the functional cleavage ta rge t, these workers suggested tha t the 
signal fo r cleavage must be located elsewhere in the a sequence, and tha t 
cleavage takes place at a fixed distance from  th is signal. Thus, in 
standard genomes, cleavage w ith in  D R l would be fortu itous. This 
prediction was supported by work by Varmuza and Smiley (1985). Based on 
results from  a study of recombinant HSV genomes containing various 
subfragments o f the a sequence inserted in to the TK locus, these workers 
proposed two models fo r generation o f the L and S te rm in i o f HSV DNA. 
F irst, the L and S te rm in i m ight arise as a resu lt o f two d is tinc t cleavage 
events (Fig. 8), the positions of which are d icta ted by separate signals
w ith in the a sequence, possibly in Uy and (Fig. 3). The in troduction o f 
single-stranded nicks is followed by strand-repair synthesis to generate two 
term in i bearing partia l copies of D R l. L igation o f these te rm in i would
result in tandem re itera tions o f the a sequence. An additional feature o f 
this model is tha t junctions bearing two or more tandemly repeated copies 
of the a sequence m ight be processed by a ds cleavage, as a result o f co­
operation between two adjacent recognition signals (Fig. 8). These ds 
breaks m ight generate ends bearing a protruding 3' nucleotide, a feature  
observed in some te rm in i by Mocarski and Roizman (1982). The a lte rna tive  
model proposed by Varmuza and Smiley (1985) postulates tha t te rm in i are 
generated by two separate ds cleavage events (Fig. 9). A t any given L-S 
junction, a single cleavage event occurs, creating a term inus bearing an a 
sequence and a term inus lacking an a sequence. Packaging begins at the a 
sequence-bearing term inus, and continues u n til the next L-S junction in the 
same orienta tion is encountered. A t th is po int, cleavage occurs such tha t
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(A) The staggered n ick-repa ir model of HSV DNA m aturation proposed 
by Varmuza and Smiley (1985). Open and f ille d  triangles represent 
the S and L term inus recognition complexes bound to signals 
located in Uy and respectively.
(B) A model whereby junctions bearing two or more tandemly repeated 
a sequences give rise to te rm in i, as a resu lt of co-operation 
between L and S recognition complexes in adjacent a sequences 
producing a double stranded break.
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FIG U R E 9
'Theft' model fo r cleavage and packaging o f HSV DNA proposed by 
Varmuza and Smiley (1985). Open and fille d  triangles represent packaging 
signal(s) in a lternate phases. Cleavage/packaging complex is indicated as 
an empty capsid pa rtic le .
(A) Double-stranded cleavage occurs at an L term inus cleavage signal. 
This step creates an L term inus carrying an a sequence and an S 
term inus lacking an a sequence.
(B) Packaging proceeds u n til the next appropriately orienta ted L-S 
junction is encountered, at which point,
(C) a double-stranded S term inus cleavage is made, generating an S 
term inus w ith  an a sequence and an L term inus lacking an a 
sequence.
(D) The model proposes tha t ends lacking a sequences are discarded and 
rapidly degraded.
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the packaged genome contains term in i which both bear an a sequence. 
The model predicts tha t many DNA molecules w ith  L and S term in i which 
lack a sequences are also formed. Such molecules must then be rapidly 
degraded. Although both these models are feasible proposals fo r the 
packaging of HSV DNA into capsids, neither accounts fo r the observed 
asymmetric d is tribu tion of a sequences in standard HSV genomes, whereby 
L term in i bear varied numbers o f a sequences, while S te rm in i have only 
one (Wagner and Summers, 1978; Locker and Frenkel, 1979).
1.6 HSV PO LYPEPTIDES
Approxim ately f i f t y  HSV-induced polypeptides have been identified  
by one-dimensional SDS-PAGE (Honess and Roizman, 1973; Powell and 
Courtney, 1975; Marsden et a l., 1976) and over 230 polypeptides have 
been resolved using two-dimensional PAGE (Haarr and Marsden, 1981). 
This increased number is probably due in part to the resolution o f fam ilies 
of polypeptide species related through post-translationa l m od ifica tion , 
although additional virus-specific polypeptide species have certa in ly  been 
identified by th is method.
1.6.1 Post-translational m odifications o f HSV polypeptides
The fa ilu re  o f some in v itro  synthesized v ira l polypeptides to 
comigrate w ith  the ir in vivo synthesized counterparts on SDS- 
polyacrylamide gels indicates tha t many HSV-induced polypeptides undergo 
some form  of post-translational m odifica tion (Preston, 1977). Four main 
types of post-translational m odifica tion occur: g lycosylation,
phosphorylation, sulphation and cleavage, however, other forms o f HSV 
polypeptide m odifica tion have been reported, e.g. poly ribosylat ion 
(Notarianni and Preston, 1983) and fa tty  acylation of glycoproteins (Johnson 
and Spear, 1983).
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1.6.2 Glycosylation
HSV induces at least four major glycoproteins designated gB, gC, 
gD and gE (Honess and Roizman, 1975; Spear, 1976; Bauke and Spear, 
1979), and several m inor species (Palfreyman et a l., 1983; Buckmaster 
et a l., 1984; Marsden et a l., 1984; Roizman et a l., 1984; McGeoch 
et a l., 1985). Processing o f HSV glycoproteins occurs in discrete steps, as 
demonstrated by pulse-chase experiments and two-dimensional PAGE (Haarr 
and Marsden, 1981; Palfreyman et a l., 1983). Processing is inh ib ited by 
the drug tunicamycin, indicating tha t HSV glycoproteins contain N -linked 
oligosaccharides (Pizer et a l., 1980; Hope and Marsden, 1983). Addition 
of O-linked oligosaccharides also occurs as a la te  post-transla tiona l 
m odification of HSV glycoproteins (Hope and Marsden, 1983; Johnson and 
Spear, 1983).
1.6.3 Phosphorylation
Approximately sixteen HSV-1 and eighteen HSV-2 polypeptides are 
phosphorylated (Pereira et a l., 1977; Marsden et a l., 1978). W ilcox et al. 
(1980) demonstrated tha t phosphate cycles on and o ff  several HSV 
polypeptides, and suggested tha t these proteins may act as phosphate 
donors. These workers found tha t the e ffe c t o f phosphorylation on the 
ab ility  of proteins to bind DNA was specific  fo r each polypeptide. Thus, 
phosphorylation of ICP29 resulted in enhanced DNA-binding a c tiv ity , 
perhaps as a result o f a change in prote in secondary s tructure . In 
contrast, a weaker binding a c tiv ity  was observed fo r the phosphorylated 
form  of ICP6, compared w ith  the unphosphorylated fo rm . This e ffe c t 
probably results from  dissociation o f the D N A iprote in complex as a
consequence of the increased negative charge on the phosphoprotein (W ilcox 
et al., 1980).
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1.6.4 Sulphation
A t late times in in fection, inorganic sulphate is added to the major 
glycoprotein species (Hope et a l., 1982; Hope and Marsden, 1983), in most 
cases by attachm ent to the N-linked oligosaccharide moieties. The 
physiological function of sulphation is not c lear. Since i t  would result in a 
more polar glycoprotein, this extra m od ifica tion  m ight influence the 
orientation o f glycoproteins in the membrane.
1.6.5 P ro teo lytic  cleavage
P ro teo ly tic  cleavage has been poorly investigated as a form  of HSV 
polypeptide m odifica tion. IE polypeptides Vm wl75, 136, 110 and 63 
induced by tsK (see section 1.4.2) at the NPT, are broken down in to  lower 
MW products during an overnight virus in fec tion . Since this degradation 
did not occur in the presence of tosyl phenylchlorom ethyl ketone (TPCK), a 
protease inh ib ito r, i t  is like ly  that a de fin ite  cleavage step was involved, 
rather than non-specific proteolysis. However, the functiona l significance 
of this finding is not known. P ro teo ly tic  cleavage steps also seem to be 
involved in the m aturation of HSV glycoproteins. The prim ary amino acid 
sequences o f glycoproteins are altered by removal o f a peptide from  the 
N-term inus of the polypeptide. Eisenberg et al. (1984) showed tha t the 
firs t tw en ty -five  amino acids from  the predicted sequence of glycoprote in 
gD were missing from  the glycoprotein isolated from  in fected cells. This 
stretch of amino acids is largely hydrophobic, and is thought to constitu te  
a signal peptide, which is found at the amino term inus o f many 
transmembrane glycoproteins. Evidence also exists tha t mature 
glycoprotein gG (108K) arises from  p ro te o ly tic  cleavage of a precursor 
polypeptide pgG (120K) (Balachandran and H u tt-F le tche r, 1985).
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1.6.6 HSV-induced enzymes
A variety of enzymatic ac tiv ities  are induced by HSV during the
course of a normal ly t ic  in fection. Most o f these are involved in nucleic
acid metabolism, and some are associated w ith  the v irion pa rtic le . They
include the follow ing:
(i) The HSV-induced DNA polymerase a c tiv ity  is distinguished from  the 
host cell polymerase both on immunological grounds (K e ir and Gold, 
1963; Keir et a l., 1966) and in its  requirem ent fo r a high salt 
concentration fo r maximum a c tiv ity . This v irus-specific  enzyme has 
a MW of 136,272 in HSV-1 stra in 17, as deduced from  DNA 
sequence data (Quinn and McGeoch, 1985). One polypeptide o f MW 
54,000 is consistently observed in purified  DNA polymerase 
preparations (Powell and Purifoy, 1977; Vaughan et a l., 1985). The 
function of the polypeptide is as yet unclear. The DNA polymerase 
also has an associated 3’-5' exonuclease a c tiv ity  (Knopf, 1979; 
Weissbach et a l., 1973).
(ii) A pyrim idine deoxyribonucleoside kinase enzyme has been described 
(K it and Dubbs, 1963; Cooper, 1973; Jamieson et a l., 1974). The 
enzyme which is commonly re fe rred  to as thym idine kinase is non- 
essential in exponentially growing tissue-culture cells but is 
indispensible fo r virus growth in resting (serum-starved) cells 
(Jamieson et a l., 1974). The enzyme has a MW of 40,900, deduced 
from  DNA sequence data (Wagner et a l., 1981). In v ivo , TK" 
viruses are less able to establish a la ten t in fec tion  in nerve cells 
of experimental animals, and have reduced pathogenicity (F ield and 
Wildy, 1978).
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(iii) A deoxyuridine triphosphatase (dUTPase) a c tiv ity , which catalyses 
the conversion o f dUTP to dUMP and pyrophosphate, has been 
identified in HSV-1 and HSV-2-infected cells. This enzyme can be 
distinguished from  the host ce ll species on the basis o f a c tiv ity  at 
4°, MW and isoe lectric  focussing point (Wohlrab and Francke, 1980; 
Wohlrab et a l., 1982; Marshall, 1984). The role of the virus 
dUTPase is unclear. In uninfected cells, the host enzyme reduces 
incorporation of dUTP in to DNA by decreasing the concentration of 
dUTP in the ce ll. Provision of a pool of dUMP which can be 
converted to dTMP by thym idyla te  synthetase may be another 
function of this enzyme.
(iv) An HSV-induced ribonucleotide reductase a c tiv ity  has been reported 
by several workers (Cohen, 1972; Huszar and Bacchetti, 1981; 
Langelier and B u ttin , 1981; A ve re tt et a l., 1983). The virus- 
induced enzyme d iffe rs  from  the host ce ll enzyme in its  
insensitivity to dTTP and dATP inh ib ition and its  resistance to  high 
salt concentrations. The enzyme catalyses the synthesis of a ll four 
deoxyribonucleotides by reduction o f the corresponding 
ribonucleotides in order to provide a continuous supply of 
deoxyribonucleotides fo r DNA synthesis. A U  mutant o f HSV-1, 
^1207, which induces a therm olabile ribonucleotide reductase 
ac tiv ity  provided evidence tha t the enzyme is virus-coded (Dutia, 
1983; Preston e t a l., 1984), and is composed of a complex o f two 
polypeptides o f approxim ately 136,000 and 38,000 MW. These 
polypeptides can be coprecip ita ted from  extracts of cells in fected 
w ith  w ild-type virus, using monoclonal antibodies directed against 
Vmwl36 (Huszar and Bacchetti, 1981; Preston et a l., 1984), and 
using antisera d irected against an oligopeptide representing the
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carboxy term inal of Vmw38 (Frame et al», 1985). However, the 
finding tha t this coprecip ita tion is abolished in cells in fected w ith  
k l2 0 7  at the NPT, indicates tha t the active enzyme is a complex 
of the two polypeptides (Frame et a l., 1985).
(v) An alkaline exonuclease (DNase) a c tiv ity  is induced by HSV-1 
(Morrison and K e ir, 1968; S trobel-F id ler and Francke, 1980) and 
HSV-2 (Hay et a l., 1971; Hoffm an and Cheng, 1977). 
Characterisation o f a ^  mutant o f HSV-2, ts l3 , has shown tha t this 
virus induces an unstable exonuclease at the NPT. The gene 
encoding the exonuclease was mapped to a region between 0.12 and 
0.21mu on the HSV-2 genome (Francke et a l., 1978; Moss et a l., 
1979) and the enzyme has a MW of approxim ately 90,000 on SDS- 
polyacrylamide gels (S trobel-F id ler and Francke, 1980). An 
associated endonuclease a c tiv ity  has also been described (Hoffm an 
and Cheng, 1979).
(vi) A uracil-D N A glycosylase is induced by HSV but has not as yet 
been shown to be virus-coded. In uninfected cells, such an enzyme 
is responsible fo r removal of u rac il residues from  DNA, which are 
produced as a result of deamination of incorporated deoxycytidine 
monophosphate (dCMP) residues (C a^onna and Cheng, 1981). The 
enzyme prevents transition m utations occurring by in it ia tio n  of a 
base-excision repair process, and thus can be thought o f as an 
antim utator or editing enzyme.
(vii) A DNA topoisomerase a c tiv ity  (type 1) has been described in HSV 
virions (Muller et a l., 1985). These enzymes catalyse the breakage 
and rejoining o f phosphodiester bonds in DNA and may be involved
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in processes such as transcription, DNA synthesis, and 
c ircu larisation or relaxation of the HSV genome.
(v iii) A protein kinase a c tiv ity  is reported to be associated w ith  pu rified  
virions (Rubenstein et a l., 1972; Lemaster and Roizman, 1980). 
The enzyme is s im ilar in its  properties to the host enzyme ca^tjn  
kinase II, and thus may be acquired fo rtu itou s ly  in the v irion  
tegument (Stevely et a l., 1985).
1.6.7 HSV DNA binding proteins
Approxim ately sixteen HSV-l-induced polypeptides and twelve HSV- 
2-induced polypeptides possess DNA-binding properties (Bayliss et a l., 1975; 
Purifoy and Powell, 1976). Powell et al. (1981) showed tha t purified  
preparations of Vm wl36, the major HSV-1 DNA binding prote in , could bind 
DNA d irectly . In contrast, Vmwl75, the major HSV-1 im m ediate-early 
protein, binds DNA ind irec tly  by association w ith  a host ce ll DNA binding 
protein (Freeman and Powell, 1982). Several o f these virus proteins have 
enzymatic ac tiv ities  including Vmwl45 (DNA polymerase) and Vmw87 
(exonuclease). However, the functions of most DNA binding proteins are 
s till unknown.
1.7 ASSEMBLY OF VIRIONS  
1.7.1 Capsid assembly
Herpesvirus capsids are assembled in the ce ll nucleus (Morgan 
e t_ ^ ., 1954). Since virus proteins are synthesized in the cytoplasm, there 
must be a mechanism whereby structura l proteins are transported to , or 
are retained in, the nucleus. The available evidence suggests tha t th is 
process is linked w ith  tha t of capsid assembly. In PRV-infected cells 
which are depleted o f arginine, m igration o f virus s truc tu ra l polypeptides
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from cytoplasm to nucleus does not occur (Mark and Kaplan, 1971). 
Certain arginine-rich virus polypeptides, which are not synthesized under 
conditions of argin ine-starvation, are thought to be involved in the capsid 
assembly process (Chantier and Stevely, 1973), possibly acting as condensing 
factors fo r the aggregation of s tructura l proteins. More recently , a 
hypothesis was proposed by Ladin et al (1982) based on the analysis o f ts 
mutants o f PRV which synthesize DNA at the NPT, but fa il to assemble 
capsids. Since the major s tructura l polypeptides remained in the cytoplasm 
of cells infected at the re s tr ic tive  temperature w ith  these mutants, these 
workers suggested that virus s tructura l proteins are transported or diffuse 
into the nucleus, and tha t subsequent assembly of capsids promotes fu rthe r 
accumulation of virion proteins in the nucleus by creating a 'sink'.
The site of capsid assembly w ith in  the nucleus is thought to be the 
nuclear m atrix or nuclear 'cage'. This is a structure which is defined 
solely by its extraction procedure,and represents the insoluble m ateria l 
remaining a fte r sequential extraction  of purified nuclei w ith  non-ionic 
detergent, hypotonic low-magnesium bu ffe r, high-salt bu ffe r and trea tm ent 
w ith nuclease (Berezney and C o ffe r, 1974). E lectron microscopic 
examination of these structures revealed a nuclear 'lam ina' containing 
pores, nucleoli and an in ternal fibrous network (Berezney and C o ffe r, 1977). 
Since virus DNA, structura l polypeptides and empty capsids are often found 
associated w ith a nuclear matrices, i t  seems like ly tha t this is the site of 
both DNA replication and capsid assembly (McCready et a l., 1980; Pardoll 
et a l., 1980; Bibor-Hardy et a l., 1982a, 1982b, 1985).
1*7.2 Encapsidation of virus DNA
Cleavage of concatemeric DNA into unit length genomes is e ither a 
prerequisite to, or occurs concom itantly w ith , the packaging of DNA into 
capsids (Vlazny et a l., 1982). Analysis o f nine ^  mutants o f PRV which
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fa il to encapsidate DNA at the NPT, showed tha t th is process is complex 
and under the contro l of several virus gene products (Ladin et a l., 1980). 
Since the presence o f cycloheximide reduces the amount o f DNA 
encapsidation in w ild -type PRV-infected cells, i t  seems probable that the 
proteins necessary fo r this process are present in lim itin g  amounts in the 
virus-infected ce ll (Ben-Porat et a l., 1976; Ladin et a l., 1980). As 
described in Section 1.5.2, the a sequence of HSV is an essential c is-acting 
signal fo r cleavage and packaging of DNA into capsids. The search fo r 
cleavage/packaging polypeptides led to the id en tifica tio n  of two 
polypeptides (21K and 22K) which appeared to in te rac t spec ifica lly  w ith  the 
a sequence of HSV DNA (Dalziel and Marsden, 1984). These polypeptides 
may be analogous to a 20K polypeptide which remains bound to highly 
purified HSV DNA (Hyman, 1980). I t  is also tem pting to speculate tha t 
the 21/22K polypeptides correspond to proteins visualised by the electron 
microscope, which are apparently bound to the te rm in i and jo in t regions of 
the genome (Wu et a l., 1979).
The widely accepted model of DNA encapsidation suggested by 
Perdue et al. (1976) proposed tha t v ira l DNA is inserted into an 
intermediate form  of capsid, in which large cy lind rica l core structures 
serve as templates around which the v ira l DNA is wound. During this
stage, condensation o f the internal protein cylinder takes place. The fina l
core structure would be the densely staining toro id  seen under the electron 
microscope by Furlong et al. (1972) in th in sections o f HSV-infected cells. 
Similar models have been proposed fo r packaging of concatemeric DNA 
into the preformed proheads of bacteriophage T4 (Laemmli and Favre, 
1973; Earnshaw and Casjens, 1980) and salmonella phage P22 (King et al.,
1973). This model fo r herpesvirus DNA encapsidation is supported by the
observation, drawn from  pulse-chase experiments, tha t there is a precursor- 
product relationship between in term ediate capsids and heavy DNA-
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containing capsids. In these experiments, virus s truc tu ra l proteins were 
pulse-labelled w ith  radioactive amino acids, and a fte r a chase period in 
unlabelled medium, the types of radioactive ly labelled partic les isolated 
from the cells were determined. Ladin et al. (1980) in a study of PRV ts 
mutants which fa il to encapsidate DNA at the NPT, demonstrated tha t 
structural polypeptides were assembled into empty capsids during the chase 
period at the res tr ic tive  temperature, and tha t the labelled capsid proteins 
were transferred to enveloped virions upon subsequent tem perature 
downshift to the PT. In addition, Perdue et al. (1976) demonstrated tha t 
EHV capsids containing partia l cores disappeared from  cells a fte r a chase 
period, indicating tha t these particles are precursors to virions, whereas 
empty capsids which were s t ill detectable fo llow ing the chase, are not on 
the pathway of virion assembly. The pre lim inary characterisation o f other 
ts mutants w ith defects in encapsidation o f DNA at the NPT has supported 
these findings (Cabral and Schaffer, 1976; Atkinson et a l., 1978; Ladin 
et a l., 1980; Ben-Porat et a l., 1982; Preston et a l., 1983; Dargan and 
Subak-Sharpe, 1983). The most detailed characterisation has been carried 
out on ^1201, a mutant of HSV-1 which fa ils  both to encapsidate DNA 
and to process p4G to its  lower MW forms at the NPT (Preston et a l., 
1983). Thus, the correct processing of this polypeptide appears to be an 
essential step in the packaging of virus DNA in to capsids. Interm ediate 
capsids, which accumulate in cells infected w ith  th is m utant at the NPT, 
serve as the substrate fo r encapsidation of virus DNA, which occurs when 
the cells are transferred from the NPT to the PT, in the absence of 
further protein synthesis. Clearly detailed analysis o f other mutants which 
fa il to encapsidate DNA is necessary to determ ine the number, nature and 
function of the gene products involved in th is complex process.
An alternative model fo r form ation o f HSV capsids containing DNA 
has been presented by P ignatti and Cassai (1980), who proposed tha t newly
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replicated v ira l DNA is packed in to nucleoprotein complexes (NPC) which 
contain capsid s tructu ra l polypeptides Vmwl55 (VP5), 55 (VP19) and 26 
(VP24), as well as several minor polypeptide species. These NPC are
thought to represent an interm ediate stage in capsid assembly, and addition 
of further structura l polypeptides would produce mature nucleocapsids. I t  
should be noted tha t the possibility tha t these NPC are degraded 
nucleocapsids resulting from  the extraction procedure has not been ruled 
out.
DNA molecules which are shorter than standard genomes can be 
encapsidated, provided they contain the appropriate cleavage/packaging 
signal. Only nucleocapsids containing unit length DNA, however, are 
transported to the cytoplasm (Vlazny et a l., 1982). The mechanism
underlying this selective m aturation of nucleocapsids is not known.
1.7.3 Envelopment
The prim ary site fo r nucleocapsid envelopment is the inner lam ella 
of the nuclear membrane (Darlington and Moss, 1969; Watson, 1973; 
Roizman and Furlong, 1974). The mechanism involved appears to be a 
budding process, whereby nucleocapsids in te ract w ith  areas o f the nuclear 
membrane which are enriched fo r v ira l antigens (glycoproteins) whilst 
lacking the normal complement of cellu lar polypeptides (Asher et a l., 1969; 
Ben-Porat and Kaplan, 1971; Spear and Roizman, 1972). These areas may 
correspond to the distorted or duplicated regions o f the nuclear membrane
which are a common feature of herpesvirus-infected cells (N il e t a l., 1968;
N il, 1971). The in tranuclear particles become enveloped by budding 
outward into the perinuclear space. Gibson (1981) suggested tha t tegument 
polypeptides w ith  exposed hydrophobic regions on the nucleocapsid surface 
fac ilita te  the in teraction o f capsid and hydrophobic membrane components. 
It has also been reported tha t herpesviruses can acquire th e ir envelopes by
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budding in to  cytoplasmic vacuoles (N il, 1971; Haguenau and M ichelson- 
Fiske, 1975). Treatment of HSV-infected cells w ith  the ionophore 
monensin, which is thought to block the trans it o f membrane vesicles from  
the Golgi apparatus to the ce ll surface, d rastica lly  reduces transport of 
enveloped virions to the cytoplasmic membrane (Johnson and Spear, 1982). 
Hence, enveloped particles may move from  the perinuclear space to the 
Golgi apparatus, perhaps via membrane vesicles, and from  there to the ce ll 
surface and extracellu la r space. Since HSV partic les are retained w ith in  
the nuclei of cells treated w ith  cytochalasin B, an inh ib ito r of 
m icrofilam ent-induced cell movement, cytoplasm ic streaming may also play 
a part in transport of virions from  the nucleus to the ce ll surface 
(Marciano-Cabral et a l., 1977).
Virus egress, f irs t  seen at approxim ately 8h pi at 37°, appears to 
be mediated by a ’reverse phagocytosis’ process (N ii et a l., 1968; Schwartz 
and Roizman, 1969; Katsumoto et a l., 1981). Some evidence exists tha t 
HSV encodes a function which prevents uptake of progeny virus by in fected 
cells. Tognon et al. (1981) reported the isolation of m utant HSV-1 (50B) 
which exhibited delayed plaque production in Vero cells at 31°, but not at 
38.5°. Capsids lacking DMA cores accumulated la te in in fection  at the 
nuclear pores of cells in fected w ith  this m utant at 31°, indicating tha t 
progeny virions had re-in fected the cells, and had released v ira l DMA. The 
lesion in HSV-1 (50B) was mapped to DNA sequences encoding glycoproteins 
gD and gE (mu 0.9-0.94), and the authors suggest tha t these glycoproteins, 
which are incorporated in to the cytoplasm ic membrane of cells in fected 
w ith  w t HSV, may prevent readsorption o f released virus. Obviously, 
readsorption of progeny virions would account fo r the delay in plaque 
production by this mutant at 31°.
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1.8 LA TENCY
The ab ility  of HSV to establish a la ten t in fection  fo llow ing prim ary
infection of the skin, was f ir s t  postulated by Goodpasture (1929). 
Peripheral skin in fection norm ally involves the sensory nerve cells, and 
virus is transported in tra-axonally to the site of la tency. This has been 
demonstrated both in the mouse model (Stevens and Cook, 1971, 1973;
Cook et a l., 1974; McLennan and Darby, 1980) and in man (Baringer and 
Swoveland, 1973) to be in the neurons which are found in the sensory
ganglia. Latent virus may be reactiva ted in response to diverse s tim u li 
such as menstruation, fever, UV ligh t and trigem ina l nerve roo t section. 
Reactivation can result e ither in recrudescence w ith  the production of a 
peripheral lesion, or in recurrence w ith  asym ptomatic shedding o f virus.
During the in terva l between reactiva tion , the virus genome is thought to 
be harboured in a non-replicating form  in the nervous system, since
attempts to detect HSV-specific mRNA have been unsuccessful (Ruga
et a l., 1978). The question remains whether reactiva tion  results in death 
of the la ten tly  in fected neuron and re-establishment o f la tency in
neighbouring nerve cells (round-trip  theory), or whether la ten tly  in fected 
nerve cells survive reactiva tion  and re ta in  the in fo rm ation  necessary fo r 
renewed recurrences (one-way theory) (K le in, 1976). A low number of 
HSV-1 genomes (fewer than 0.1 copies per ce ll) can be detected in samples 
of la ten tly infected mouse ganglia or brain stem cells, however, the 
number of copies w ith in  a given single ce ll has not been determ ined 
(Cabrera et a l., 1980; Rock and Fraser, 1983). The state o f the v ira l 
DNA w ith in the neuron has been investigated. Rock and Fraser (1983,
1985) demonstrated the absence o f genomic te rm in i in la ten tly  in fected 
mouse brain stem cells, and instead, detected two copies o f the v irion
DNA jo in t fragment. This data suggested tha t the genome was 
concatemeric or circularised and was e ither maintained in the neuron in an
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FIG U R E 10
Alternative forms of la ten t HSV-1 DNA proposed by Rock and Frayer
(1985).
A. Integration via the repeat regions of the genome from  linear,
circu lar or concatemeric DNA results in 1 copy o f the jo in t region 
per integrated genome.
B. Integration via the unique regions of the genome from  c ircu la r or 
concatemeric DNA results in 2 copies of the jo in t region per
integrated genome. A 2 molar jo in t region would also be present
i f  the genome was in the form  of non-integrated circ les or 
concatemers.
Filled boxes represent repeat regions of HSV DNA.
Cross-hatched boxes represent ce llu la r DNA.
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unintegrated fo rm , or was in tegrated in to the ce ll genome via a site in the 
unique regions o f the virus DNA (Fig. 10).
In order to understand the molecular processes involved in the
establishment and maintenance of HSV la ten t in fections, in v itro  latency 
systems have been developed fo r HSV-1 and HSV-2. In these systems, 
virus rep lica tion is repressed by trea tm ent of in fected cells w ith drugs
such as BVDU, in conjunction w ith  in te rfe ron  (Wigdahl et a l., 1982a,
1982b), or by incubation of in fected cells at elevated temperatures (Russell 
and Preston, 1986). Virus reactiva tion  could be achieved in both systems 
by superinfection w ith  heterotyp ic virus or ^  mutants. Wigdahl et al.
(1984) demonstrated in th e ir system tha t la ten tly  in fected HFL cells or ra t 
neurons contained the HSV genome in a non-integrated, linear, non- 
concatemeric fo rm . Since these results c o n flic t w ith  those of Rock and 
Frazer (1983, 1985), i t  is possible tha t th is in v itro  latency system does 
not m im ic the in vivo state, and fu rthe r investigation is required to
resolve this d iffe rence.
1.9 M O R PH O LO G IC A L CELL TR ANSFO RM ATIO N AND
ONCOGENESIS
HSV has been considered a potentia l agent of human cancer, since 
many epidem iological surveys have established an association between 
cervical carcinoma and evidence of HSV in fection . Investigation of the 
oncogenic po ten tia l o f the virus has centred around in v itro  ce ll 
transform ation studies, and the search fo r HSV-specific macromolecules in 
neoplastic tissue.
Cell transform ation  by HSV was f irs t  achieved using non-permissive 
infection conditions such as UV-irrad iated virus, sub- or supra- optim al 
infection temperatures or ^  mutants. Subsequently, the observation that 
transfection o f prim ary ra t embryo cells w ith  sheared HSV-2 DNA resulted 
in morphological transform ation (W ilkie et a l., 1974), stim ulated research to
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define the transform ing sequence of HSV DNA by transfection w ith  
individual restric tion  endonuclease fragments. These experiments identified 
at least two transform ing sequences in HSV-2 DNA (Reyes et a l., 1979; 
Galloway and McDougall, 1981; Jariwalla et a l., 1983), and one in HSV-1 
DNA (Camacho and Spear, 1981) (Fig. 11). Detection of HSV-specific 
antigens in transformed cell lines has been reported (Macnab et a l., 1980; 
Suh et a l., 1980), however, no particu lar antigen has been consistently 
observed. Indeed, i t  is possible that an HSV polypeptide may not be 
involved in transform ation process, since Galloway et al. (1984) mapped the 
transform ing potentia l of the HSV-2 Bg lll n fragm ent to a 737bp sequence 
which bears s im ila rities  to an insertion sequence-like element. Reports of 
the detection of v ira l nucleic acid sequences in transformed ce ll lines 
(Galloway et a l., 1980) must also be considered care fu lly  in view of the 
observation that certa in HSV DNA and mammalian DNA sequences share 
homology (Peden et a l., 1982; Puga et a l., 1982; Jones and Hyman, 
1983). In addition, Galloway and McDougall (1983) and Cameron et al.
(1985) have reported tha t cells transformed by the HSV-2 B g lll n fragment 
do not reta in this DNA sequence, and concluded tha t this transform ing 
element is not required fo r maintenance of the transformed state.
These studies have been paralleled by attem pts to demonstrate the 
presence of HSV-specific macromolecules in cervical carcinoma tissue. The 
major DNA-binding protein of HSV-2 has been detected in cervical 
carcinoma specimens. HSV-2-specific RNA mapping in the le ft  hand end 
of the genome (mu 0.1-0.4) (Eglin et a l., 1981; McDougall et a l., 1982), 
and in the Bg lll n transform ing region of the HVS-2 genome, have also 
been found in cervica l carcinoma samples (McDougall et a l., 1982). These 
results, however, must be investigated fu rthe r in the ligh t o f the evidence 
that transcripts in rapidly dividing epithelia l cells hybridise to several 
regions of the HSV-2 genome (Maitland et a l., 1981). The detection of
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FIG U R E 11
Transforming sequences in HSV DNA. Transforming sequences of HSV-1 
and HSV-2 are represented by solid blocks above and below the genome 
respectively.
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HSV DNA sequences in a small percentage o f cervical carcinoma specimens 
has been achieved by Park et al. (1983) and Galloway and McDougall 
(1983). Thus, in contrast to existing models fo r virus-induced cell 
transform ation, the consistent presence of an HSV-specific antigen or 
oncogene in ce rv ica l carcinoma tissue or transformed cell lines has not 
been demonstrated, and a tten tion  has turned to more subtle possibilities fo r 
a mechanism of HSV oncogenesis.
A number o f studies have demonstrated tha t HSV in fection leads to 
chromosomal rearrangements (O 'Neill and Rapp, 1971; Nachtigal et a l., 
1982). In addition, HSV has been shown to act as a mutagen in mouse 
cells (Schlehofer and zur Hausen, 1982). I t  is possible that HSV acts as 
the in it ia to r o f a transform ing event through the production o f heritable 
mutational changes. These observations led to the reviva l of a 'h it and 
run' mechanism of HSV-induced ce ll transform ation (Galloway and 
McDougall, 1983).
By fa r the most exciting data has recently been reported by 
Macnab et al. (1985), who demonstrated tha t ce llu lar polypeptides which 
are upregulated in established ce ll lines are also upregulated upon HSV 
infection o f normal cells. C learly these results provide the basis fo r 
future investigations in to the importance of these polypeptides in the 
in itia tion and maintenance of ce ll transform ation by HSV.
1.10 G ENETICS OF HSV
One o f the most useful approaches in the elucidation of HSV gene 
function has been the isolation and analysis o f mutants of HSV. A wide 
variety o f m utants have been isolated, and these include the follow ing:
I ' lO . l D rug-resistant mutants
To date, the m ajority  of HSV drug-resistant mutants have lesions in
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either the virus TK or DNA polymerase genes. Analysis o f these mutants 
has made a s ign ifican t contribu tion to the understanding of the mechanisms 
of action of a n tiv ira l drugs directed against these enzymes, and has been 
useful in prediction o f the genetic e ffe c t o f these drugs on virus grown 
in vivo.
The mechanism of an tiv ira l action o f drugs directed against the 
virus TK depends on the enzyme converting harmless compounds, fo r 
example, certa in  nucleoside analogues, in to tox ic  compounds by 
phosphorylating them. The phosphorylated nucleosides can either inh ib it 
the virus DNA polymerase d irec tly  by binding irreversib ly to the active 
site, or can be incorporated in to the virus DNA, in te rfe ring  w ith  DNA 
synthesis or inducing m utation. Virus growth in the presence of thymidine 
analogues 5-bromo-2'-deoxyuridine (BUdR) (K it and Dubbs, 1963; Dubbs and 
K it, 1964), 5-iodo-2'-deoxyuridine (IdU) (Yamamoto et a l., 1972) or the 
deoxycytidine analogue 5-bromo-2'-deoxycytidine (BCdR) (Brown and 
Jamieson, 1978; Stow et a l., 1978) gives rise to TK" mutants which utilise 
the de novo pathway o f thym idine synthesis, and so avoid the incorporation 
of lethal quantities o f nucleotide analogues in to the virus DNA. Mutants 
resistant to acycloguanosine (ACG), more commonly re ferred to as the 
antiv ira l drug A cyc lov ir, have been identified . These mutants are mostly 
TK", but TK+ ACG-resistant viruses specifying a DNA polymerase which 
fails to recognise the phosphorylated form  of ACG have been isolated 
(Elion et a l., 1977; Field et a l., 1980; Crumpacker et a l., 1980; Darby
et al., 1981; Larder and Darby, 1985).
Some an tiv ira l drugs act d irec tly  on the virus DNA polymerase, e.g.
phosphonoacetic acid (PAA), and mutants resistant to  PAA have been
isolated (Hay and Subak-Sharpe, 1976; Purifoy and Powell, 1977; Lee 
et al., 1978). This drug acts by binding to the pyrophosphate-binding site 
of the virus DNA polymerase (Leinbach et a l., 1976).
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1.10.2 Plaque morphology mutants
Most HSV-1 strains, e.g. HSV-1 (mP) and HSV-1 strain 17 svn+ 
cause individual v irus-in fected  cells to round up. Variants have been 
isolated which, in contrast, cause extensive fusion of v irus-in fected cells, 
or produce a m ixture  o f rounded and m ultinucleate cells in tissue cu lture. 
Several loci in the L segment of the HSV-1 genome have been shown to 
influence the a b ility  o f the virus to cause ce ll fusion. Such loci have been 
referred to as syn (syncytia l) loci (Fig. 5). Ruyechan et al. (1979), on the 
basis of recombinant virus analysis, identified  two syn loci between mu 
0.68-0.82 on the HSV-1 (F) genome. This region is now thought to contain 
one syn locus only, and a marker which affects plaque size (Bond and 
Person, 1984; Pogue-Geile et a l., 1984). DNA sequence analysis of this 
syn locus (mu 0.732-0.745) revealed a gene specifying a polypeptide which 
contains extensive hydrophobic domains. It  is predicted that this 
polypeptide may be membrane-associated or may have a trans-membrane 
location (Debroy e t a l., 1985). Virus containing extensive deletions in the 
upstream regulatory sequences of the TK gene, have a syncytial phenotype 
(Sanders et a l., 1982). I t  is not known, however, in which gene this syn 
locus maps. L it t le  and Schaffer (1981) mapped the defect in the syncytia l 
mutant HSV-l(KG5)-804, to  DNA sequences between mu 0.04-0.64, thereby 
identifying another syn locus. Since a reduction in the gB dinner was 
detected in cells in fected w ith  this m utant, a role fo r gB in syncytia 
formation was suggested. A fourth syn locus was located d irectly  in the 
gB gene by Ruyechan et al. (1979). In a study o f UB5, a m utant of HSV- 
1 which fa ils  to incorporate gB in to the virus envelope at the NPT, 
DeLuca et al. (1982) showed that the ^  and syn loci in this gene were 
separable. DNA sequencing studies o f the gB gene located the syn locus 
to the carboxy term inus of the glycoprotein. Since virus-induced
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membrane proteins and, in pa rticu la r, glycoprotein gB are im plicated in 
syncytia fo rm ation , i t  seems reasonable to assume tha t this fusion process 
is analogous to the in te rac tion  between virus envelope and cell membrane, 
and the subsequent fusion event which leads to virus penetration. The 
significance o f syncytia fo rm ation  in vivo is unclear, and indeed, Roizman 
(1962) reported tha t the m a jo rity  o f c lin ica l isolates o f HSV were non- 
syncytial in tissue cu lture.
1.10.3 Immune cyto lysis-resistan t mutants
Immune cyto lysis-resistan t (icr) mutants exhibit altered synthesis, 
processing or incorporation o f glycoproteins into in fected ce ll membranes 
(Machtiger et a l., 1980; Glorioso et a l., 1980; Pancake et a l., 1983). 
These mutants render v irus-in fected  cells resistant to complement-mediated 
immune cytolysis w ith  antisera directed against HSV-specific glycoproteins. 
This approach has id en tified  novel genes contro lling the synthesis and 
processing of glycoproteins. Useful in form ation on the structure of 
glycoproteins may also be gained, fo r example, which regions of 
glycoproteins are exposed on the ce ll surface and recognised by antisera.
Monoclonal antibody-resistant (mar) mutants possess mutation(s) 
affecting the antigenic sites of glycoproteins exposed on the virion 
envelope, and hence are resistant to neutralisation by monoclonal antibodies 
plus complement (Holland et a l., 1983). These mutants should provide 
useful in form ation on the structure  and function o f glycoproteins. In 
addition, i t  may be possible to iden tify  glycoproteins which would be useful 
candidates fo r the production o f subunit vaccines against HSV.
1*10.4 Host range mutants
Host range mutants of HSV exist which are able to grow in some 
cell lines but not in others. Aurelian and Roizman (1964, 1965) observed
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that HSV-1 (MP) fa iled  to m ultip ly  in dog kidney cells. By passaging the 
virus several tim es through this ce ll line, these workers were able to 
select a variant which was able to rep lica te  in these cells. Ts host range 
mutants o f HSV-2 have been isolated by Koment and Rapp (1975, 1975a). 
These mutants were able to rep licate in hamster embryo fibroblasts at 33° 
but not at 39°, whereas virus rep lica tion  in rabbit kidney cells was 
unimpaired at e ithe r temperature. In te resting ly, the in v itro  replication 
characteristics of these mutants corre lated w ith  in vivo attenuation of 
mutant growth in hamsters, but not in m ice or rabbits (Koment and Rapp, 
1975b).
An im portan t recent development in this fie ld  has been the 
establishment o f ce ll lines which carry stably integrated HSV genes, fo r 
example, IE gene Vm wl75 (Davison and Stow, 1985; DeLuca et a l., 1985). 
HSV-1 mutants which synthesize inactive  Vm wl75, as a result of deletions 
w ithin the gene encoding this polypeptide, are incapable of growth on 
normal cells. However, in fection o f the biochem ically transformed cell 
lines w ith  these mutants results in the stim ulation o f expression o f the 
resident w ild -type Vm wl75 gene, and the m utant virus can be propagated 
(DeLuca et a l., 1985; N.D. Stow, personal communication). Analysis of 
such host range mutants should be invaluable in the elucidation of virus- 
induced polypeptide function.
1.10.5 Mutants lacking res tric tion  endonuclease sites
R estric tion  endonuclease site deletion mutants of HSV-1 have been 
isolated (Brown et a l., 1984) which lack Xbal recognition sites. A varie ty 
of uses are envisaged fo r these mutants, including analysis of the 
mechanism and k inetics of HSV recom bination, as well as the phenotypic 
characterisation o f the mutants.
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1,10,6 Temperature-sensitive (ts) mutants
Ts mutants constitu te  the m ajority of currently available 
conditional-lethal mutants o f HSV. Ts mutants w ith  defects in essential 
genes can replicate at the PT (usually 310. 340)^  but not at the NPT 
(usually 38°-39.5°). N orm ally, a lesion is produced by a missense 
mutation in a gene, which results in the synthesis of an aberrant gene 
product. Such a protein is e ither unstable or is unable to assume a
functional conformation at the NPT.
There is a low level o f spontaneous ^  m utation in w ild-type virus 
stocks. However, most mutations have been induced by trea tm ent of
replicating virus (DNA) w ith  BUdR, or by mutagenesis of virions w ith  
nitrous acid (NA), hydroxylam ine (HA), nitrosoguanidine or UV ligh t 
(Schaffer et a l., 1970; Timbury, 1971; Schaffer et a l., 1973; Manservigi, 
1974; Esparza et a l., 1974). One problem w ith  these procedures is the
selection of a mutagen dose which increases the frequency of mutation
above the background leve l, w h ilst m inimising the possibility o f m ultip le 
mutations. Analysis o f these mutants revealed the absence of ^  mutations 
in large regions o f the HSV genome. In an e ffo rt to increase the number 
of mutated HSV genes, emphasis has turned to the in troduction of 
mutations into specific HSV DNA fragments. In this approach, the DNA is 
treated in v itro  w ith  mutagens such as NA or HA, recombined into the
wild-type virus genome, and the progeny are screened fo r ^  virus (Chu 
et a l., 1979; Sandri-Goldin et a l., 1981). Although, theore tica lly , ^
mutations can be introduced in to any gene, the screening procedure results
in selection of ^  mutants w ith  defects in essential genes only. Over 
th irty -five  essential genes have been identified by the complementation 
analysis of HSV mutants (Schaffer et a l., 1978; Schaffer, 1985) and the 
genome location o f many o f these mutations has been determined by the 
marker rescue technique. In this method, cells are cotransfected w ith
4 8
intact mutant virus DNA, and purified or cloned res tric tion  endonuclease 
fragments of w ild -type virus DNA. A fte r incubation fo r three days at the
PT, the cells are harvested and progeny screened fo r virus. Ts+
recombinants w ill only be present i f  the m utation in the mutant virus DNA 
has been replaced by the corresponding w ild-type sequence. Marker rescue 
of HSV-1 mutations was f irs t demonstrated by Wilkie et al. (1974), and
subsequently the technique was refined by Stow (1978). Interestingly, the
physical map locations of ^  mutations of HSV-1 strain 17 did not correlate 
with the recom binational linkage map (Stow et a l., 1978; Stow and Wilkie, 
1978; Wilkie et a l., 1978). Since marker rescue can localise mutations
to DNA fragments as small as 320bp (Preston, 1981), this method has
enabled mutations to be assigned to specific genes.
The characterisation o f ^  mutants of HSV has yielded inform ation 
on widely varying aspects of the HSV replication cycle, from  the very 
early events such as virus penetration (Sarmiento et a l., 1979; L itt le  
et al., 1980; Addison et a l., 1984) and uncoating (Batterson et a l., 1983), 
to regulation o f virus gene expression (Preston, 1979b; Sacks et a l., 1985) 
and DNA encapsidation (Preston et a l., 1983).
1.10.7 Cold-sensitive (cs) mutants
Cs mutants are able to grow at high temperature (PT) but fa il to 
produce plaques at lower temperatures (NPT). There has only been one
published report to date of a c£ m utant which was isolated from  a HA
mutagenesis experiment. This m utant, HSV-1 (50B), exhibited delayed 
plaque production at 31° whilst growing normally at 38.5° (Tognon et a l., 
1981; see Section 1.7.3). Interesting ly, the lesion in this mutant maps in 
the Ug component o f the v ira l genome, a region in which i t  is particu larly  
d ifficu lt to isolate ts mutations.
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1.10.8 Complementation
U n til recen tly , most ^  mutations have been assigned to d iffe ren t 
regions on the basis o f complementation analysis (Schaffer et a l., 1978). 
Although two main quan tita tive  assays, the progeny yield test and the 
infectious centre tes t, have been used (Messer, 1978), the progeny yield 
test is generally considered more re liab le since fewer recombinant viruses 
are generated by th is  method. Generally, complementation indices greater 
than 4 or 2 are considered positive, tha t is the mutations under test lie  in 
d ifferent genes (T im bury, 1971; Brown et a l., 1973). In te ra lle lic  
complementation has been described between TK “ mutants, where i t  was 
detected biochem ically (Jamieson and Subak-Sharpe, 1978).
1.10.9 Recombination
Recombination between herpesviruses was f irs t  shown by Wildy 
(1955) using lesion morphology on chorio -a llanto ic membranes and virulence 
of progeny virus in mice as indicators of recombination. The ab ility  of
HSV to recombine was la te r confirm ed by Subak-Sharpe (1969), who
reported the detection o f recombinants among the progeny of crosses 
between pairs o f ^  mutants. Using recombination frequencies obtained 
from crosses o f ^  m utants, a linear linkage map of the HSV genome was 
obtained (Brown et a l., 1973; Schaffer et a l., 1974; Timbury and Calder, 
1976). However, la te r studies, using a varie ty  o f markers o f known
physical map loca tion  in addition to ^  mutations, argued fo r a c ircu lar
linkage map (Honess e t a l., 1980). This result is most simply explained i f  
intermolecular, generalised recombination takes place between c ircu lar 
molecules or concatem eric DNA. This model was supported by results 
obtained by Ben-Porat et al. (1982) in a study o f the behaviour o f labelled 
PRV DNA in density s h ift experiments, and in an analysis of the kinetics 
of appearance o f recombinant virus during in fection . These workers
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reported that recom bination in PRV involves mainly parental genomes, and 
precedes DNA rep lica tion . Thus, under these conditions, recombination 
would presumably occur between c ircu la r DNA molecules. In contrast, 
Ritchie et al. (1977) showed tha t recom bination in HSV-1 increases w ith  
time, indicating tha t both parental and progeny DNA molecules are 
involved. The production of linkage maps by recombination analysis of 
mutants has largely been supplanted by the physical location o f mutations 
by marker rescue. In te rtyp ic  (HSV-1 x HSV-2) recombination has been of 
great value, however, in the physical mapping of HSV polypeptides 
(Timbury and Subak-Sharpe, 1973; Halliburton et a l., 1977; Morse e t a l.,
1977; W ilkie et a l., 1978; Preston et a l., 1978; Marsden et a l., 1978).
A remarkable feature o f many herpesviruses is tha t s ite -specific  
recombinational events involving re ite ra ted  sequences w ith in  the genomes 
can occur. Several lines o f evidence have im plicated the HSV a sequence 
in the inversion o f L and S segments re la tive  to each other (see Section 
1.2.2). F irst, insertion o f DNA fragments containing the a sequence in to 
the TK gene locus results in additional inversion events about the novel 
junction (Mocarski e t a l., 1980; Mocarski and Roizman, 1981; Smiley
et al., 1981). DNA fragments flanked by a sequences in inverted 
orientation w ill inve rt, whereas those flanked by d irect repeats of the a 
sequence w ill not (Smiley et a l., 1981). Second, deletion of the a sequence 
at the L-S junction results in mutants which cannot invert (Poffenberger 
et al., 1983; Poffenberger and Roizman, 1985). Third, in te rtyp ic  
recombinants which possess hetero typ ic a sequences flanking unique 
segments w ill not in ve rt (Davison and W ilkie, 1983). Since a ll these non­
inverting mutants are viable in tissue cu lture , i t  remains unclear what
function, i f  any, inversion serves. The mechanism of inversion is not 
known, although Chou and Roizman (1985), using deleted subclones o f the a 
sequence inserted a t the TK locus, proposed tha t tandemly re ite ra ted
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sequences w ith in  the a sequence may be involved in s ite-specific  
recombination leading to inversion. Varmuza and Smiley (1985), however, 
using a sim ilar system, fa iled  to detect high-frequency recombination about 
the a sequence. Discrepancies between these two systems, fo r example, 
the number of re ite ra ted  sequences w ith in  the a sequences under 
investigation, must be resolved before any conclusions can be drawn.
Evidence fo r s ite -specific  recombination elsewhere in the HSV 
genome has been presented. For example, the size va riab ility  of DNA 
fragments containing the in tron o f the spliced Vmw68 and 12, is probably a 
reflection of d iffe r in g  copy numbers of re ite ra ted  sequences w ith in  the 
intron (Murchie and McGeoch, 1982). I t  is postulated tha t these sequences 
can act as s ite -specific  recom binational 'hot-spots' which, through unequal 
crossovers, w ill resu lt in expansion or contraction o f the intron, and hence 
the repeated sequences TRg and IRg (W hitton and Clements, 1984).
AIMS OF THE PROJECT
During HSV in fection  o f tissue culture cells, greater than 200 
virus-specific polypeptides have been detected by 2D-polyacrylamide gel 
analysis and these include prim ary translation products, processed 
intermediates and mature proteins. However, very few virus-induced 
polypeptides have so fa r been assigned specific functions. As described in 
the Introduction, several enzymes involved in nucleic acid metabolism have 
been identified while other polypepties are required fo r the regulation of 
virus transcrip tion. In addition, approximately th ir ty  polypeptides have 
been designated as s truc tu ra l proteins due to the ir presence in purified 
virions although, again, the functions of only a m inority  of these proteins 
are understood. The major HSV glycoproteins are found in the virion 
envelope, and i t  is known tha t glycoprotein gB plays an essential role in 
virus penetration o f the ce ll membrane. I t  is thought that glycoproteins
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are also involved in the attachm ent of virions to cell surface receptors. 
The functions o f tegument proteins are largely unknown, although one of 
the major tegument proteins, Vmw65, is involved in stim ulation of IE gene 
transcription. Seven struc tu ra l polypeptides are components of the capsid 
particle. Of these, i t  is thought tha t Vm wl55 is the major component of 
the hexamers and tha t Vmw40 (p40) plays a role in virus DNA 
encapsidation. However, the functions o f the remaining structura l proteins 
are unknown.
One approach to the elucidation of HSV gene function has been the 
isolation and characterisation of ^  mutants. Although greater than th ir ty -  
five genes encoded by HSV have so fa r been defined by ^  mutations, few 
mutants representing these genes have been characterised to any great 
extent. The aim of this study was to characterise in some detail HSV 
mutants which had potentia l s tructura l defects. Using this approach, it  
was hoped to extend the in form ation currently available on the roles of 
virion polypeptides in the in fectious process and in HSV nucleocapsid 
assembly.
During the course o f this study, four ^  mutants of HSV-1 which 
had defects in assembly o f functional nucleocapsids at the NPT were 
characterised. One of these mutants, ^1204 , also had a defect in a very 
early event in in fec tion . For this reason, characterisation of this mutant 
together w ith  ^120 8 , a m utant which lies in the same cistron, was placed 
in a separate section o f the thesis.
C H A P TE R  2
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M ATERIALS  
VIRUSES
The w ild -type HSV-2 stra in HG52 was used in th is study (Timbury, 
1971). In BHK cells, th is virus forms plaques which contain a m ixture of 
syncytial and rounded cells. The w ild-type HSV-1 was strain 17 svn+ 
(Brown et a l., 1973), which has a non-syncytial plaque morphology. The 
HSV-1 U  mutants 17UVP1201, 17UVP1203, 17UVP1204 and 17UVP1208, 
characterised in this study, were all isolated from  this strain. For brevity, 
these mutants w ill be re fe rred  to as ^1201 , _U1203, ^1204  and tsl208 
respectively. Ts l2Q l was derived from  the m utant 17tsJC116 (Coates, 
1982) which had m u ltip le  ^  lesions. The DNA fragm ent EcoRI £ from  this 
mutant, which contained one o f the ^  lesions, was cloned into the plasmid 
vector pACYC184 and recombined back into w ild-type HSV-1. Tsl201 was 
isolated from  th is transfec tion  experiment (Preston et a l., 1983). Tsl203,
W 204 and ^1 2 0 8  were a ll isolated from  experiments in which UV- 
mutagenised HSV-1 DNA fragments were recombined in to w ild-type HSV-1. 
Since none of the ^  lesions mapped in the mutagenised fragments, they 
were considered to have arisen spontaneously (Matz et a l., 1983; 
V.G. Preston, unpublished results). Revertants fo r growth at the NPT, 
W 204 rev-1 and ^1 2 0 3  rev-1 , were isolated from  m utant stocks which 
contained low levels o f reve rtan t virus (see Section 2.2.1). The mutant 
tsK syn+ was derived by D r. V.G. Preston from  a cross between w ild-type 
HSV-1 stra in 17 syn+ and syn, which forms syncytia l plaques at the PT 
(Crombie, 1975). A dd itiona l ^  mutants used in complementation and 
recombination studies were tsA svn+ (Brown et a l., 1973), and tsH 
(Crombie, 1975; Marsden et a l., 1976) obtained from  the Institu te  of 
Virology, Glasgow; _k656 (Hughes and Munyon, 1975) and _UZ47 (Pancake 
Gt a l., 1983) which were kind ly donated by Professor P.A. Schaffer, and
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tsl205 which was supplied by Dr. V.G. Preston.
In te rtyp ic  (HSV-l/HSV-2) recombinant viruses used in the receptor 
mapping studies were isolated in the Ins titu te  o f Virology and characterised 
as follows; R12-1, R12-3 (Chartrand et a l., 1981) and D x l (34-2), B x l 
(31-2) (Marsden et a l., 1978).
TISSUE C U LTU R E CELLS
Two tissue culture ce ll lines, BHK21 clone 13 and HFL cells were 
used throughout th is study. The BHK cells, a fib rob lastic  line established 
by Macpherson and Stoker (1962), were obtained from  Dr. V.G. Preston. 
Low passage HFL cells (Flow 2002) were supplied by Flow Laboratories.
TISSUE C U LTU R E  M EDIA  A N D  SOLUTIONS
Growth media
Cells were cultured in Glasgow modified Eagle's medium (Busby 
et al., 1964) which was supplied as a lOX concentrate by Gibco L im ited . 
Medium was supplemented w ith  lOOunits/ml pen ic illin , lOOug/ml 
streptomycin and 0.2ug/ml am photericin. Media are referred to in th is 
study as fo llow s:-
E(T)Cn Eagle's medium containing (10% tryptose
phosphate) n% ca lf serum.
EFn Eagle's medium containing n% foe ta l ca lf serum.
EHun Eagle's medium containing n% human serum.
Versene 0.6mM EOT A dissolved in PBS containing 0.002%
(w/v) phenol red.
Trypsin 0.25% (w /v) in tris-sa line (obtained as a solid
from  D ifco L im ited).
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Phosphate buffered 
saline (PBS)
T r i s - s a l i n e
Giemsa stain
TBE buffer (lOX)
SDS-polyacrylamide 
gel buffer (IX )
SSC buffer (IPX)
TE buffer ( IX )
HEPES buffered 
saline (HEB5)
L-broth
RIPA buffer
Washing buffer
Disruption bu ffe r
170mM NaCl, 3.4mM KC l, lOmM Na2HP04 and 
2mM K H 2PO4 pH7.2 (Dulbecco and Vogt, 1954). 
140mM NaCl, 30mM KC l, 280mM Na2HP04 , 
Im g /m l glucose, 0.0015% (w/v) phenol red, 25mM 
Tris -H C l pH7.4, lOOunits/ml pen ic illin , lOOug/ml 
streptom ycin .
1.5% (w/v) suspension of Giemsa in glycerol,
heated at 56° fo r 120min and diluted w ith  an 
equal volume of methanol.
8.9mM Tris-H C l pH8.3, 8.9mM boric acid, 0.3mM 
EOT A containing 0.5ug/ml ethidium bromide.
53mM Tris, 53mM glycine, 0.1% (w/v) SDS.
3M NaCl, 0.3M tri-sodium  c itra te .
Im M  EOT A, Im M  Tris-HC l pH7.4.
130mM NaCl, 4.9mM KC l, 1.6mM Na2HPO^
5.5mM d-glucose, 21mM HEPES (N-2- 
hydroxyethylpiperazine-N '-2-ethanesulphonic 
acid) pH7.05.
170mM NaCl, lOg/1 D ifco bactotryptone, 5g/l 
yeast ex trac t supplemented w ith  50ug/ml 
am p ic illin .
0.1% (w /v) SDS, 1% (w/v) sodium deoxycholate, 
1% (v/v) NP40, Im M  EDTA, 150mM NaCl, lOmM 
Tris-H C l pH7.4.
600mM L iC l, lOOmM Tris-HC l pH7.4, 1% (v/v) 
-mercaptoethanol.
2% (w /v) SDS, 10% (v/v) glycerol, 700mM B- 
m ercaptoethanol, 150mM Tris-HC l pH6.7, 0.004% 
(w /v) bromophenol blue.
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SDS-polyacrylamide 
gel tank buffer
D y e  f i c o l l
E l u t i o n  b u f f e r
Ligation buffer
STET buffer
RSB
NTE
Lysis buffer
Gel Soak I
Gel Soak II
Nick translation 
buffer
Denhardt's buffer
Resolving gel buffer
Stacking gel buffer
TA DNA polymerase 
buffer
53mM Tris, 53mM glycine, 0.1% (w/v) SDS.
15% (w/v) f ic o ll,  0.2% (w /v) bromophenol blue, 
lOOmM EDTA.
5mM sodium acetate, Im M  EDTA, AOmM Tris- 
HCl pH7.8.
20mM Tris-HC l pH7.5, lOmM MgCl£, lOmM DTT 
and Im M  ATP.
8% (w/v) sucrose, 5% (v/v) NPAO, 50mM EDTA, 
50mM Tris-HC l pH8.0.
lOmM KC l, 1.5mM M gCl2, lOmM Tris-H C l pH7.5. 
lOmM Tris-HC l pH7.5, lOmM NaCl, lOmM EDTA. 
0.6% SDS, lOmM EDTA, lOmM Tris-H C l pH7.4. 
200mM NaOH, 600mM NaCl.
IM  Tris-H C l pH8.0, 0.59M NaCl.
50mM Tris-HC l pH7.5, 5mM M gCl2> 50ug/ml 
BSA, Im M  DTT.
0.1% (w/v) F ico ll, 0.1% (w/v) po lyvinyl-
pyrollidone, 0.1% (w/v) BSA.
1.5M Tris-HC l pH8.9, 0.4% (w /v) SDS.
0.49M Tris-HC l pH6.7, 0.4% (w/v) SDS.
330mM Tris-acetate pH7.9, 660mM potassium 
acetate, lOOmM magnesium acetate, 5mM 
d ith io th re ito l, Im g /m l BSA.
RADIOCHEMICALS
A ll radiolabelled compounds were obtained from  Amersham 
International pic.
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CHEMICALS
Chemicals were supplied by five  companies: BDH Chemicals,
Poole, England; Pharmacia Fine Chemicals, Uppsala, Sweden; Koch-Light 
Laboratories, Suffolk, England; BioRad Laboratories, Californ ia, USA and 
Sigma (London) L im ited . A na lytica l grade chemicals were used wherever 
available. Reagents fo r electron microscopy were obtained from  two 
companies: Agar Aids, Stanstead, Essex and Taab Laboratories, Emmer
Green, Reading.
ENZYMES
R estric tion  endonucleases were supplied by Bethesda Research 
Laboratories (UK) L im ited , Cambridge, England.
IM M U N O LO G IC A L REAGENTS
Fluorescein isothiocyanate-conjugated rabbit anti-mouse IgG, and 
rabbit anti-mouse IgG were purchased from  Miles-Yeda Laboratories, Israel. 
Non-immune (pre-immune) rabb it serum was obtained from  the Scottish 
Antibody Production U n it (SAPU), Glasgow, Scotland. A 10% (w/v) 
suspension of fo rm a lin -fixed  Staphylococcus aureus strain Cowan I was 
supplied by Public Health Laboratories and Protein-A  Sepharose by 
Pharmacia Fine Chemicals, Sweden.
M ONOCLONAL ANTIBO DIES
Monoclonal antibodies were prepared in the Institu te  of Virology, 
Glasgow, essentially as described by Palfreyman et al. (1983), except tha t 
the SP2/0-Agl4 ce ll line (Shulman et a l., 1978) was used as the parental 
myeloma ce ll in ce ll fusions. MA1147 was specific fo r the major DNA 
binding prote in , Vm w l36 (ICP8) o f HSV-1, and the equivalent polypeptide of 
HSV-2. MA1098 was specific fo r the IE polypeptide Vmwl75 (ICP4) of
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HSV-1. Both these antibodies were prepared by Dr. J.W. Palfreyman. 
Monoclonal antibody 5010B was specific fo r p40 (ICP35) of HSV-1 and was 
prepared by Dr. A. Cross.
For immunofluorescence experiments, MA1147 and MA1098 were 
used at a d ilu tion o f 1/40 in PBS, whereas MA5G1GB was used at a d ilution 
of 1/ 2G w ith PBS. For im m unoprécipitation experiments, MA5G1GB was 
used undiluted.
PLASMIDS
The fo llow ing plasmids had been previously constructed in this 
Institute and were made available fo r use by Dr. V.G. Preston: 
pGX38 (contain the HSV-1 EcoRI £ fragm ent), 
pGX91 (contains the HSV-1 BamHI u fragm ent, 
pGX37 (contains the HSV-1 BamHI ^  fragm ent), 
pGX2 (contains the HSV-1 BamHI k fragm ent), 
pGX31 (contains the HSV-1 Sail d fragm ent), 
pGX134 (contains the HSV-1 Kpnl m fragm ent), and 
pGX142 (contains the HSV-1 Kpnl _t fragm ent).
BACTERIAL STOCKS
Escherichia co li s tra in  DH-1 (F“ , re c A l, gyrA96, endA l, supE44) 
(Hanahan, 1983) was the host bacteriumfor a ll the plasmids used.
MISCELLANEOUS
Plastic 85Gcm2 ro lle r bottles fo r ce ll cu lture were obtained from  
Becton Dickinson L td ., Oxford. P lastic pe tri dishes were supplied by 
Nunclon Ltd. N itroce llu lose membranes were purchased from  Schleicher 
and Schull, Dassel, West Germany. Photographic f ilm  was supplied by 
Kodak L im ited , London. Noble's Agar was obtained from  D ifco L im ited .
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METHODS
2.1 Cell culture
BHK cells were grown at 37° in ro ta ting plastic 850cm^ culture 
bottles containing 200ml ETCIO in an atmosphere of 5% CO2, 95% a ir. A
confluent monolayer of approxim ately 3xlo8 cells was su ffic ien t to seed
five 850cm^ bottles. Cells were harvested by washing the monolayer f irs t 
with 20ml versene followed by 40ml trypsin-versene (1:1, v/v). A fte r the 
cells had been shaken from  the bo ttle , they were resuspended in tissue 
culture medium.
HFL cells were grown in the same way as BHK cells except that 
EFIO was used as tissue cu lture  medium. Non-essential amino acids (1% 
v/v) were added to this medium every second ce ll passage. A confluent 
monolayer of 1x10® HFL cells in a ro lle r bottle  was su ffic ien t to seed
three 850cm^ bottles. 50mm and 30mm petri dishes were seeded at a
density of 2x10^ cells and 1x 10^ cells per dish respectively, to obtain 
confluent monolayers in 24h.
2.1.1 Cell storage
Low passage cells were stored at -140°. B rie fly , cells were 
harvested as described in Section 2.1, pelleted and resuspended in EC20 
(for BHK cells) or EF20 (fo r HFL cells) containing 10% (v/v) DMSO, at a 
concentration of 10^ ce lls /m l storage medium. Cells, aliquoted in to black 
cap vials, were frozen slowly to  -140°. Recovery of cells was achieved by 
thawing the cells quickly, d ilu ting  them in EClO or EFIO, pelle ting the ce ll 
suspension to remove the DMSO and fina lly  resuspending them in growth 
medium.
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2 . 2  P r o d u c t i o n  o f  v i r u s  s t o c k s
Virus stocks were routine ly prepared from  BHK cells grown in glass 
850cm^ ro lle r bottles. Growth medium was removed and the cells were
infected at a moi of 0.003 pfu per ce ll in 40ml EC5. Virus-infected cells
were incubated at 31° fo r 3-4 days un til extensive CPE had developed. 
Cells were harvested into the medium and pelleted at 1,500 rpm fo r 15min 
at 4°. Cell-released virus from  the supernatant medium was concentrated 
by centrifugation at 12,000 rpm fo r 2h at 4°. The virus pelle t from  this 
step was resuspended in supernatant medium, sonicated to disperse virus 
aggregates and stored at -70°. Cell-associated virus from  HSV-1 and HSV- 
2-infected cells was prepared by sonicating the cell pelle t in a small 
volume of EC5. Cell debris was removed by low-speed centrifugation and 
the sonication step repeated i f  necessary. The supernatants, containing 
cell-associated virions, were pooled and stored at -70°. S te rility  checks 
were performed by streaking medium from  virus-in fected cells onto blood 
agar plates and incubating the dishes at 31° fo r five days.
2.2.1 Isolation of spontaneous ts~*~ revertan t viruses
Spontaneous revertants were isolated from  a low passage stock 
of mutant ^1203 (obtained from  Dr. V.G. Preston) as follows:
Ten-fold dilutions o f the ts l203  stock were plated on BHK cells at 
the NPT. A fte r virus adsorption fo r Ih , the cells were washed tw ice w ith  
tissue culture medium, overlaid w ith  medium containing 0.6% Noble's agar
and 10% ca lf serum, and were incubated at 38.5° fo r two days. Plaques
were picked into 0.5ml PBS containing 10% ca lf serum, using a dissecting 
microscope. The cells were sonicated to release virus, which was then 
titrated at the PT and NPT. A ll the progeny virus tested had an eop
NPT/PT sim ilar to tha t of w ild -type virus. This result was taken as an
indication that ts l203 contained a single lesion. Two fu rthe r rounds of
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plaque purifica tion  at the PT were performed on several virus isolates. 
Finally, virus from  one plaque was used to in fec t a 50mm plate of
cells, and virus from  th is plate harvest was used to grow up a virus stock. 
The revertant thus obtained was named ^1203-rev  1.
2.2.2 Handling o f ts m utant infections
Infections w ith  ^  m utant used in this study were at 31° (PT) and 
38.5/39.5° (NPT). A ll virus inocula were maintained at 4° before addition 
to cells, unless otherwise stated. Cell monolayers were placed at the 
required temperature fo r 18-30min prior to in fection. A ll media fo r
washing cell monolayers or overlaying cells were prewarmed to the 
required temperature before use. Manipulations w ith  virus infected cells 
were carried out as rapid ly as possible, and incubator temperatures were 
monitored regularly.
2.2.3 T itra tion  o f virus stocks
Serial ten -fo ld  dilutions of virus stocks were made in PBS
containing 5% ca lf serum. 0.1ml of each d ilu tion was added to 80%
confluent BHK ce ll monolayers, from  which the growth medium had been 
removed. A fte r  adsorption o f virus fo r Ih  at the required temperature, 
the cells were overla id w ith  EHu5 to neutralise unadsorbed virus and 
prevent the form ation o f secondary plaques. Plates were incubated at the 
PT of 31° fo r three days or at the NPT of 38.5° or 39.5° (depending on 
the mutant virus) fo r two days, a fte r which tim e the medium was replaced 
with Giemsa stain. About 15min la te r, the stain was washed o ff and the 
virus plaques were counted under a dissecting microscope.
FIGURE 12
Pellet v irus-in fected cells at 1,500 rpm, lO m in., 4°
i
Resuspend pelle t in 5ml of NTE containing 0.5% NP40 (v/v)
i
Leave on ice fo r lOmin.
i
Pelle t ce ll debris and nuclei at 1,500 rpm , lOm in., 4°
I
Resuspend pelle t in 0.5ml o f TE bu ffe r
i
Add 1% (v/v) sodium deoxycholate and vortex 
u n til solution becomes viscous
i
Add DNAase I (150ug/ml) and incubate fo r 30min., 37°
i
Add urea (0.5M) and mix gently
i
Pelle t ce ll debris at 1,500 rpm, 20min., 4°
i
Layer c la rifie d  supernatant onto 80% Percoll gradient
FIG U R E 12
Flow diagram of the procedure fo r isolation of HSV nucleocapsids from  
virus-infected cells. Adapted from  a method described by Braun et al. 
(1984b). A ll solutions were kept at 4° during the procedure.
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2.2.4 Virus adsorption assay
The adsorption assay used was based on a procedure described by 
DeLuca et ai. (1981). Virus inoculum at 4°, 31° and 38.5° was added to 
cells which had been maintained at each temperature, at a moi of 0.01 pfu 
per cell in a volume of 0.2m l. A t 0, 15, 30, 45 and 60min post addition 
of virus, lOul samples were w ithdrawn in to 990ul PBS (containing 10% ca lf 
serum), and subsequently t itra te d  in duplicate at 31°.
2.2.5 Virus partic le  counts
Virus stock w ith  a t i t re  greater than 2xl08 pfu per ml was mixed 
with an equal volume of a la tex bead suspension of known concentration, 
and the same volume of phosphotungstic acid. A sample was spotted on a 
parlodium grid, a ir dried, and visualised under the electron microscope. 
The number of virus partic les and la tex beads were counted in at least ten 
fields of the grid, and the concentration o f particles in the virus stock 
calculated.
2.2.6 Isolation and p u rifica tion  o f HSV nucleocapsids
Isolation o f HSV nucleocapsids was performed using a procedure 
which was based on a method described by Braun et al. (1984b). A 
summary of this procedure is shown in fig . 12. B rie fly , 3x10® BHK cells 
were infected at a moi o f 10 pfu virus per ce ll, and were incubated at the 
required temperature fo r 5h in medium containing one -fifth  of the normal 
concentration of methionine. [ ^^S]-methionine was then added to the 
medium at a concentration o f 50uC i/m l, and incubation was continued fo r 
a further 12h. As described in fig . 12, in fected cells were harvested, and 
nuclei were isolated by non-ionic detergent trea tm ent. A ll solutions were 
maintained at 40 throughout the procedure. Nuclei were lysed w ith  sodium 
deoxycholate, and the viscosity o f the lysate was reduced by incubation
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with DNase I fo r 30min at 37°. The c la rified  lysate was layered onto a 
14ml 80% (starting density 1.25g/ml) Percoll density gradient (Perto ft, 
1980; Svennerholm et a l., 1980). Centrifugation of these gradients in a 
Ti65 fixed angle ro to r at 40,000 rpm fo r 30min should have resulted in a 
well-defined nucleocapsid band approximately tw o-th irds down the gradient, 
which could be collected by side puncture of the tube. Capsid bands
which were visib ly contam inated w ith  ce ll debris were rebanded on a 
second 14ml 80% Percoll gradient. Percoll was removed from  capsid- 
containing samples by layering onto a 3ml cushion of 60% (w/v) sucrose in 
PBS, followed by centrifugation  at 40,000 rpm fo r 60min in the AH650 
swing-out ro to r. Nucleocapsids formed a tigh t band at the in terface, and 
were collected w ith  a Pasteur p ipette . Samples were used d irec tly  fo r 
analysis by SDS-PAGE, or were diluted in lOmM Tris-HC l pH7.4, pelleted 
at 40,000 rpm fo r Ih , and resuspended in 50ul lOmM Tris-HC l pH7.4 fo r 
electron microscopic analysis.
2.2.7 Polyethylene g lyco l trea tm ent o f virus-in fected cells
Virus-infected cells were treated w ith  polyethylene glycol (PEG) 
following a procedure described by Sarmiento et al. (1979). B rie fly , 
sparsely seeded HFL cells on coverslips were infected w ith  5 pfu virus at 
the required tem perature. A fte r  Ih  virus adsorption, unbound virus was 
removed by washing the ce ll monolayers once w ith  PBS. The virus- 
infected monolayers were then treated w ith  PBS containing PEG 6000 (50% 
w/v) for Im in . Subsequent washes containing decreasing amounts o f PEG 
were carried out as described by Sarmiento et al. (1979). In addition, two 
washes w ith PBS alone were performed, to remove a ll traces o f the 
chemical. Following th is trea tm ent, the cells were incubated fo r a fu rther 
6h in growth medium before being fixed in methanol-acetone (3:1, v/v)) fo r 
immunofluorescence assay.
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2.3 P r e p a r a t i o n  o f  v i r i o n  DNA
Virus-infected cells from  5 to 10 850cm2 glass bottles, exhibiting 
extensive CPE, were shaken in to the medium and pelleted by low-speed 
centrifugation. Cytoplasm ic extracts were prepared from  the cell pellet by 
treatment w ith  10ml RSB containing 0.5% NP40 (v/v). A fte r incubation on 
ice for lOmin, the sample was centrifuged at 1,500 rpm fo r lOmin at 4° 
to remove nuclei and ce ll debris. The pelle t from  this step was 
resuspended in RSB-NP40 and treated as above. The two cytoplasmic 
supernatants were pooled w ith  the c la rified  virus-in fected cell medium and 
centrifuged at 12,000 rpm fo r 2-3h at 4°. The virus pelle t from  this step 
was resuspended in 5ml NTE by sonication and lysed by addition of SDS to 
a final concentration o f 2% (w/v). The virus DNA was extracted
sequentially w ith  phenohchloroform  (1:1) and w ith  chloroform . RNA was 
removed by trea tm ent w ith  RNase I (lOug/m l), overnight at RT. The DNA 
solution was then deproteinised w ith  proteinase K at 31° fo r 2-3h, re ­
extracted w ith  phenohchloroform  and chloroform , and precip itated w ith 
ethanol in the presence o f 0.3M sodium acetate.
2.3.1 Small-scale preparation o f v irus-in fected ce ll DNA
HFL cells (4x10^ cells per dish) were infected w ith  a moi of 5 pfu 
of virus per ce ll and incubated at the appropriate temperature fo r 18h 
before extraction of DNA.
2*3.2 Total v irus-in fected ce ll DNA
Growth medium was removed and cells were incubated fo r 4h at 
in 2ml lysis bu ffe r containing 500ug pronase per m l. A fte r the 
addition of NaCl to a fina l concentration of 200mM, the DNA solution was 
Extracted sequentially w ith  phenohchloroform (1:1) and chloroform , and 
precipitated in ethanol. DNA was pelleted, lyophilised and resuspended in
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ZOOul H2O containing lO ug/m l RNAase I.
2.3.3 Encapsidated DNA (DNAase-resistant DNA)
A fte r removal o f growth medium, cells were scraped into 0.5ml 
RSB, containing 0.5% (v/v) NP40 and lOOug/ml DNAase I, and incubated 
for 2h at 37°. SDS, EDTA and pronase were added to the sample at the 
same concentrations present in lysis bu ffe r, and digestion continued fo r a 
further 2h at 37°. The DNA was extracted as described fo r to ta l virus- 
infected ce ll DNA.
2.3.4 Restriction endonuclease digestion of DNA
R estriction endonuclease digestions were carried out under 
conditions specified by the suppliers fo r each enzyme.
2.3.5 Agarose gel electrophoresis
Concentrations o f agarose between 0.6% and 1.0% (w/v) in TBE 
buffer containing 0.5ug/m l ethid ium  bromide were used in horizontal gels, 
depending on the size of DNA fragments to be resolved. DNA samples in 
10% (v/v) dye f ic o ll were electrophoresed at 2V/cm^ fo r 16-20h and the 
separated fragments visualised under UV ligh t.
2.3.6 Purifica tion  o f DNA fragments from  agarose gels
DNA fragments were excised from  agarose gels and eluted from  
the gel slices by high-voltage electrophoresis in elution buffer. DNA was 
further purified by trea tm en t w ith  phenohchloroform (1:1, v/v) and 
chloroform, and p rec ip ita ted  w ith  isopropanol before use.
2*3.7 Polyacrylamide gel electrophoresis
DNA fragments (12-lOOObp in size) were separated on
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polyacrylamide slab gels containing 10% acrylamide crosslinked w ith  1 part 
in 30 (w/w) N-N '-m ethylene bis acrylam ide in TBE bu ffe r. Polymerisation 
was achieved by the addition of ammonium persulphate (0.006% w/v) and
N,N,N '-N '-tetramethylethylenediam ine (TEMED) (0.004% v/v) to the gel
solution just before pouring. Wells were formed w ith  te flon  combs. DNA 
fragments were separated by electrophoresis at 3V/cm overnight using TBE 
tank buffer.
2.4 Marker rescue
Marker rescue was performed essentially as described by Stow 
et al. (1978) w ith  the m odifica tions o f Preston (1981). Calcium chloride 
(final concentration 130mM) was added to a solution containing between 0.2 
and 0.7ug in tac t m utant v irion  DNA, HSV-1 DNA fragm ent (usually 5-10 
fold molar excess re la tive  to v irion  DNA) and lOug/m l ca lf thymus carrier 
DNA in HEBS. The samples were le ft  fo r 5min at RT to allow a fine 
suspension to develop. This suspension was added to drained BHK ce ll 
monolayers in 50mm dishes. A fte r  incubation at 37° fo r 45min, the cells
were overlaid w ith  EC5. A t 4h pi, the cells were treated fo r 4min w ith
25% (w/v) DMSO in HEBS. DMSO was removed from  the monolayers by 
washing the cells three tim es w ith  EC5 a fte r which incubation was 
continued at 31° fo r 3-4 days u n til extensive CPE had developed. The 
cells were scraped in to the growth medium, disrupted by sonication, and 
the virus yield at the PT and NPT determined.
2*4.1 Complementation yie ld test
In this assay, cells and medium were prewarmed to the NPT before 
use. BHK cells in 30mm dishes were in fected at a moi of 10 pfu per ce il 
(5 pfu per ce ll o f each of the ts mutants in the mixed infections). A fte r 
Ih adsorption at the NPT, the monolayers were washed w ith  EC5 to
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remove unadsorbed virus before incubation in this medium fo r 24h at the 
NPT. Virus-infected cells were scraped into the growth medium, sonicated 
and stored un til fu rthe r use at -70°. Virus yield was determined by 
titrating samples at the PT and NPT. Complementation indices (Cl) were 
calculated as described by Brown et al. (1973) using the follow ing form ula:
(X  + V )P T  .  ry  v^NPT
Cl =
& (X P T  + y P T ) _ (x N P T  + y N P T )
where (X + Y )^ ^  and (X + y)NPT represent the titre s  of progeny virus 
from a mixed in fection  of tsX and tsY titra te d  at the PT and NPT 
respectively. The denominator represents the sum of the yields from  the 
control single in fections t itra te d  at 31° and 38.5°. The denominator is 
halved to correct fo r the contro l cultures having received tw ice the 
number of pfu o f a given m utant compared w ith  the mixed infections. 
The (X + y)NPT fac to r corrects fo r any ^  recombinants in the progeny 
virus. The (X ^ P ^ + y ^ P ^ ) corrects fo r any reversion or leak-through of 
mutant virus at the NPT. Norm ally, complementation indices greater than 
five were considered positive.
2.4.2 Recombination test
BHK cells in 30mm dishes were in fected as fo r the 
complementation yie ld test except tha t the v irus-in fected cells were 
incubated fo r 24h at the PT instead o f the NPT. Virus progeny was 
titrated at the PT and NPT, and the recombination frequency calculated as 
described by Brown et al. (1973) using the follow ing form ula:
RF (%) = 100 X 2 x
(X + y)NPT 1 (xNPT yNPT")
— — X ------- +
(X + y)PT 2 (xPT yPT) ^
X and y  represent the ts mutants in the mixed in fection . (X + y)NPT
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and (X + Y)P^ represent t itre s  o f progeny virus titra te d  at the PT and the 
NPT. The
XNPT + yNPT
&
XPT YpT
factor corrects fo r reversion and leakiness of the parental ^  mutants. 
The equation is doubled on the assumption tha t the to ta l frequency of 
recombinants is tw ice  tha t of the selected progeny virus.
2.5 DNA BLOT H Y B R ID IS A TIO N
2.5.1 Transfer o f DNA fragments to nitrocellu lose
The procedure followed was essentially tha t of Southern (1975) in 
which single-stranded DNA is im m obilized on a nitrocellulose membrane. 
The agarose gel containing the separated DNA fragments was shaken gently 
in 0.2M HCl fo r 30min at RT to depurinate the DNA, treated w ith  gel
soak I fo r Ih  to denature the DNA and neutralized in gel soak II fo r Ih . 
The gel was then transferred onto two sheets of Whatman 3mm f i l te r  
paper which were in contact w ith , but not covered, by lOX SSC buffer. A 
sheet of n itrocellu lose moistened w ith  d is tilled  water was placed on top of
the gel, followed by four sheets o f 3mm paper cut 2mm smaller than gel
size. F inally, a weighted stack o f cut paper towels was laid on the
Whatman paper. The fo llow ing day, the nitrocellulose sheet was removed, 
rinsed in 2X SSC bu ffe r, a ir dried and baked in a vacuum oven at 72°, fo r 
2h. E ffic ien t transfer o f DNA fragments from  the gel was monitored by 
visualising b lo tted gels under UV ligh t.
2.5.2 In v itro  ^^P-labelling o f DNA by nick translation
DNA fragments were labelled in terna lly  w ith  32p essentially as 
described by Rigby et al. (1977). Plasmid DNA (0.25ug) in a 50ul 
reaction containing IX  nick translation bu ffe r, 40uM dATP, 40uM dTTP
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and lx lO "^m g /m l DNAase I, was incubated at 37° fo r 2min. The m ixture 
was then placed on ice and 30uCi each of -^^p .^G TP  and -^ ^ p .^ c y p  
plus 1 unit o f E. co li DNA polymerase I were added. Nick translation was 
carried out at 15° fo r 2h. The isotope incorporation was monitored by 
spotting 2ul samples onto f i l te r  discs, precip ita ting  the DNA w ith  5% TCA 
(w/v) and measuring the amount of rad ioac tiv ity  by Cherenkov counting. 
The reaction was term inated by extraction w ith  phenohchloroform (1:1). 
Unincorporated deoxyribonucleoside triphosphates were separated from  the 
32p_iabelled DNA by frac tiona tion  through a 10ml Sephadex G50 column 
equilibrated w ith  TE bu ffe r. The nick-translated DNA eluted w ith  the f irs t 
peak of rad io ac tiv ity  and was used d irec tly  in hybridisation experiments. 
The specific a c tiv ity  o f nick translated plasmid DNA was normally 1x10?- 
1x10® cpm per ug DNA.
2.5.3 DNA b lo t hybrid isation procedure
DNA hybrid isations, in aqueous solution under high stringency
conditions, were based on procedures described by Southern (1975) and 
Denhardt (1966). N itroce llu lose filte rs  were prehybridised fo r a minimum 
of 2h in 100ml 6X SSC containing 5X Denhardt’s bu ffe r, 0.1% (w/v) SDS 
and 20ug/ml denatured c a lf thymus carrie r DNA at 72° in sealed plastic
bags submerged in a shaking water bath. This solution was replaced by
the hybridisation solution which, in addition to the above reagents,
contained between 1x10? and 5x10^ cpm of denatured ^2p_]abelled DNA 
probe per m l o f hybrid isation m ix. The probe was denatured by incubation 
in 0.2N NaOH fo r lOm in at RT, and neutralised w ith  0.2N HCl. A fte r 
incubation overnight at 72°, n itrocellu lose sheets were removed and washed 
four times in 2X SSC, once in IX  SSC and once in 0.5X SSC, each fo r 
30min at 72°. A ll washes contained 0.36% SDS. Blots were air dried and 
placed in contact w ith  Kodak X-Omat XS-1 f ilm  in conjunction w ith  a
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Du Pont phosphotungstate in tensify ing screen at -70°. Exposures of l-2 h  
were required fo r blots of to ta l v irus-in fected ce ll DNA, and 2-4h fo r blots 
of encapsidated DNA.
2.6 RECO M B IN AN T D N A  TECHNIQ UES
2.6.1 Construction o f recom binant plasmids
Linearised plasmid vector pUC9 was treated w ith  ca lf in testina l 
phosphatase at a concentration o f 5 units per ug plasmid DNA. A fte r 
incubation at 37° fo r Ih , the DNA was extracted tw ice w ith
phenohchloroform (1:1, v /v ), once w ith  chloroform , and precip itated w ith  
ethanol in the presence o f 0.3M sodium acetate pH6.6. A lOX molar 
excess of purified HSV DNA fragm ent re la tive  to phosphatase-treated 
vector (lOng) was incubated overnight at 15° in a 20ul ligation reaction
containing 1 unit o f T4 DNA ligase in liga tion buffer.
2.6.2 DNA transfection
This procedure was based on a method described by Cohen et al.
(1972). E. coli K12 stra in  DH-1, grown in L-broth to an OD^^Onm ° f
approximately 0.3, was pelle ted at 3,000 rpm fo r 15min at 4° and
resuspended in 1/4 volume ice-cold lOOmM CaCl2. A fte r  incubation on ice
for Ih , the cells were re-pe lle ted and resuspended in 1/10 volume of
lOOmM CaCl2' The competence o f the bacteria in transfection was tested 
immediately using uncleaved vector DNA. 0.1ml CaCl2-treated cells were 
mixed w ith  lOng plasmid DNA and le f t  on ice fo r Ih . A fte r  heat 
treatment at 42° fo r 2min, the bacteria  were added to 1.5ml L-broth , and 
shaken at 37° fo r Ih  before being plated onto L-broth agar containing 
lOOug per ml am p ic illin . Plates were incubated overnight at 37°, 
Routinely >1x10^ colonies per ug plasmid vector DNA were obtained. 
Since the competence o f DH-1 bacteria is increased by incubation of
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bacteria  at 4° fo r 16-18h prior to addition of DNA, 
competent bacteria  were added to liga tion reactions 16h a fte r the cells 
had been prepared.
2.6.3 Small-scale preparation o f plasmid DNA from  bacteria l stocks
Bacteria from  a single colony were grown overnight in an orb ita l
shaker at 37° in 1.5ml L -bro th  containing lOOug/ml am pic illin . The cells 
were harvested by centrifugation  at 10,000 rpm fo r 2min. The pelle t was 
resuspended in 75ul STET bu ffe r and 6ul lysozyme (lOmg per ml) was 
added (Holmes and Quigley, 1981). This m ixture  was boiled fo r Im in  
before cen trifuga tion  at 10,000 rpm fo r lOmin at 4°. The supernatant, 
containing plasmid DNA, was extracted once w ith  phenohchloroform (1:1, 
v/v), once w ith  ch loro form  and the DNA precip ita ted  w ith  an equal volume 
of isopropanol a t RT in the presence o f 0.3M sodium acetate. The DNA 
was subsequently pelleted at 10,000 rpm fo r 5min, lyophilised and 
resuspended in 30ul lOmM Tris-H C l pH7.4.
2.6.4 Large-scale preparation o f plasmid DNA
The method used fo r large-scale preparation o f plasmid DNA was 
based on a procedure described by Godson and Vapnek (1973). A flask 
containing 500ml L -bro th , lOOug/ml am p ic illin  was inoculated w ith  10ml of 
an overnight cu ltu re  o f bacteria. This cu lture was incubated at 37° fo r 5- 
6h, at which point chloramphenicol was added to a fina l concentration o f 
25ug/ml. A fte r  a fu rthe r 12h incubation at 37°, the bacteria were
pelleted by cen trifuga tion  at 8,000 rpm fo r 5min at 4°, resuspended in 
12.5ml of 25% sucrose in 50mM Tris-H C l pH7.9, and incubated fo r 30min 
on ice in the presence o f 1.5mg/ml lysozyme. The m ixture was vortexed 
thoroughly, and le f t  on ice fo r 30min EDTA (pH7.9) and was added to a 
final concentration o f 50mM, and 5min la te r, NaCl and SDS were added to
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final concentrations o f 750mM and 2.5% (w/v) respectively. This viscous 
solution was incubated at 4° fo r 2-3h, then centrifuged at 20,000 rpm for 
Ih at 4° to remove debris and high molecular weight bacteria l DNA. The 
supernatant was extracted 4X w ith  phenohchloroform (1:1), treated IX  w ith 
chloroform and p rec ip ita ted  w ith  an equal volume of isopropanol in the 
presence of 0.3M sodium acetate. Plasmid DNA was pelleted, washed w ith  
70% ethanol, lyophilized and resuspended in 2ml lOmM Tris-HC l pH7.5 
containing lOug/m l RNAase I. A fte r  incubation overnight at RT, plasmid 
DNA was purified by equilibrium  centrifugation on caesium chloride- 
ethidium bromide gradients.
2.6.5 Caesium ch loride-eth id ium  bromide gradients
Plasmid DNA in a solution containing caesium chloride and ethidium 
bromide at fina l concentrations o f Ig /m l and 500ug/ml respectively (fina l
density 1.55g/ml), was centrifuged at 45,000 rpm fo r 18h at 15° in a
Beckman TV865 ro to r. Plasmid DNA bands were visualised by long-wave
UV irradiation (365nm) and the lower band, containing supercoiled DNA,
was collected by side puncture o f the tube w ith  a syringe. The ethidium 
bromide was removed from  the solution by sequential extractions w ith  
isopropanol which had been saturated w ith  caesium chloride. The DNA was 
dialysed overnight against TE buffe r and pelleted a fte r ethanol 
precipitation.
2.6.6 Storage o f recom binant bacteria l stocks
For long te rm  storage, concentrated bacteria were kept in 15% 
glycerol at -20°. Viable bacteria  were recovered from  these stocks by 
plating a sterile  loopful o f bacteria on L-broth agar containing IGGug/ml 
ampicillin.
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2.6.7 ^^P-labelling o f DNA te rm in i
Plasmid DNA was digested w ith  the desired restric tion  enzyme in 
T4 DNA polymerase bu ffe r. Three o f the four dNTPs were then added 
directly to the completed reaction m ixture , at a fina l concentration of 
80uM, together w ith  2uCi o f the fourth  -^2p_dfsjTP and 2 units o f T4 
DNA polymerase. A fte r  5min at 37°, the fourth  unlabelled dNTP was 
added to a fina l concentration o f SOuM and incubation continued fo r a 
further lOmin. The reaction was term inated by heating at 70° fo r 5min. 
A second res tric tio n  enzyme could then be added, i f  the m ixture was 
chilled for 5min. The end-labelled DNA fragments were separated by 
agarose gel electrophoresis. The fragments were identified by 
autoradiography o f the wet gel covered in c lin g -film . The fragment of
interest was excised and extracted as described in Section 2.3.6.
2.6.8 Partia l digestion o f ^^P-end-labelled DNA
Since a very small amount o f ^^P-end-labelled DNA fragment is
required fo r pa rtia l digestion, 'ca rrie r' DNA is added to the reactions to
control the rate at which the labelled fragment is digested (Smith and 
Birnstiel, 1976). Approxim ately 1x10^ cpm of labelled DNA fragment, 
together w ith  lug  ca lf thymus DNA, was digested w ith  1-2 units of the 
desired res tric tion  enzyme in a fina l volume of 20ul. Aliquots (2ul) of the 
reaction were w ithdrawn at 2, 5, 10, 15, 30 and 60min in to lOul of dye 
fico ll and DNA from  the combined reactions separated on a 10% 
polyacrylamide gel. A fte r  electrophoresis, the gels were dried under
vacuum and placed in contact w ith  X-Omat XS-1 film  at -70° to obtain an 
autoradiographic image o f the digest.
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2.7 ANALYSIS OF V IR U S -IN D U C E D  POLYPEPTIDES
2.7.1 Preparation o f radiolabelled v irus-in fected ce ll extracts
Unless otherwise stated, confluent monolayers of HFL cells in 
30mm dishes were in fected  at the required temperature w ith  a moi o f 20
pfu virus per ce ll. A fte r  Ih  adsorption, the cells were washed once w ith
EF2 to remove unadsorbed virus, and were overlaid w ith  growth medium 
until the appropriate labelling tim e.
2.7.2 Induction o f virus-induced im m ediate-early polypeptides
HFL cells were trea ted w ith  cyclohexim ide (lOOug/ml medium) fo r 
15min prior to in fec tion  at the required temperature w ith  100 pfu virus 
per cell. The virus inoculum also contained lOOug/ml cycloheximide.
A fter Ih  virus adsorption, the cells were washed once w ith  EF2 (containing 
lOOug/ml cyclohexim ide) and overlaid w ith  the same medium. A t 4.75h pi, 
actinomycin D was added to the cells a t a concentration of 25ug/ml, and 
the incubation was continued. F inally, at 5h pi, the cells were washed 
four times w ith  PBS and incubated in EF2, containing the appropriate 
radioactive isotope i f  required, fo r a fu rthe r 60min before harvesting.
2.7.3 Pulse-labelling polypeptides w ith  [ ^^S]-methionine
A t the required tim e, growth medium was removed from  cell 
monolayers and replaced w ith  PBS containing lOOuCi [ ^^S]-methionine per 
ml. Incubation was continued fo r 30min. Cells were then washed three 
times w ith  PBS and e ither harvested im m ediately by addition of the 
appropriate lysis bu ffe r, or a fte r a fu rthe r period o f incubation in EFIO.
2.7.4 Long labelling polypeptides w ith  [ ^^S]-methionine 
V irus-infected HFL cells incubated in medium containing one -fifth
the normal concentration o f methionine and 2% foe ta l ca lf serum, were
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labelled at the required tim e in the same medium containing [ 53- 
methionine at a concentration o f 50uC i/m l fo r periods of between 5h and 
12h. The monolayers were then washed three times w ith  PBS and 
harvested im m ediate ly by addition o f the appropriate lysis buffer.
2.7.5 Long labelling polypeptides w ith  [ ^2p]_prthophosphate 
V irus-infected HFL cells were incubated in phosphate-free medium
before incubation in the same medium containing 200uCi o f [ ^^P]- 
orthophosphate per ml fo r periods o f up to 5h.
2.7.6 Harvesting radiolabelled in fected ce ll extracts
Total v irus-in fected  ce ll extracts were harvested in 300ul disruption 
buffer per 30mm dish, and prepared fo r electrophoresis by boiling samples 
for 5min. Extracts fo r im m unoprécip itation analysis were prepared as 
described in Section 2.7.7. A ll radiolabelled in fected ce ll polypeptide 
samples were stored at -20° p rio r to analysis.
2.7.7 Im m unoprécipitation
Radiolabelled v irus-in fected cells from  30mm dishes were lysed by 
addition of 0.2ml RIPA bu ffe r, transferred to glass vials and sonicated to 
disrupt aggregates. A fte r incubation at 4° fo r Ih , ce ll debris was removed 
from the sample by centrifugation  at 10,000 rpm fo r 15min at 4°. The 
supernatants were stored at -20° u n til required. The im m unoprécipitation 
procedure was based on a method described by Kessler (1975). A volume 
of labelled antigen, equivalent to approximately lx lO & cpm, was pre­
incubated w ith  lOOul non-immune rabb it serum and 20ul Staphylococcus A 
to reduce non-specific antigen-antibody reactions. Bacteria were pelleted 
flt 10,000 rpm fo r 5min, and the pre-cleared ex trac t was reacted w ith  
monoclonal antibody fo r Ih  at 37°. Typically, 50ul a c itic  flu id  (1/40
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dilution) or ce ll cu lture supernatant (undiluted) was added, usually together 
with lOul rabb it anti-mouse immunoglobulin. Immune complexes were 
bound onto 60ul o f Protein-A-Sepharose (33% w /v suspension) at 37° fo r 
30min. Imm unoprecipitates were washed 4-6 tim es by centrifugation at 
10,000 rpm fo r 25sec followed by resuspension in 500ul lith ium  chloride 
washing bu ffe r. Samples were fina lly  resuspended in 50ul disruption bu ffe r, 
and heated at 100° fo r 5min. Protein-A-Sepharose was removed by 
centrifugation at 10,000 rpm fo r 25sec and the supernatant analysed using 
SDS-PAGE.
2.7.8 SDS polyacrylam ide gel electrophoresis
Polypeptides were separated on two types o f slab polyacrylam ide 
gels: (i) single concentration gels containing 8% or 9% acrylamide
crosslinked w ith  1 part in 40 (w/w) N-N'-methylenebisacrylam ide in
resolving gel bu ffe r, and (ii)  gradient gels composed of a 5-12% or 5-15% 
linear gradient o f acrylam ide crosslinked w ith  1 part in 20 (w/w) N -N '- 
methylnebisacrylamide in resolving gel bu ffe r. Gradient gels were formed 
using a proportioning pump (Technicon Ltd.). Polymerisation was achieved 
by the addition o f ammonium persulphate (0.006% w/v) and TEMED (0.004% 
v/v) to the gel solution just before pouring. The gel was overlaid carefu lly 
with either resolving gel bu ffe r (1/4 strength) or butan-2-o l, to ensure a 
smooth in terface on polym erisation. Stacking gels were prepared shortly 
before sample loading and contained 5% acrylam ide crosslinked w ith  1 part 
in 30 (w/w) N,N’-methylenebisacrylam ide in stacking gel bu ffe r. Wells 
were formed w ith  te flon  combs. Denatured polypeptides were separated by 
electrophoresis at e ithe r 0.45mA/cm^ fo r 3-4h or 0.09mA/cm^ fo r 18h, in 
freshly prepared tank bu ffe r.
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2.7.9 Fluorography
Gels were fixed fo r Ih  in m ethanol:water:acetic acid (50:50:1) 
followed by several washes in a solution containing 5% methanol, 7%
acetic acid. Gels were either dried down im m ediately, or were soaked in 
En^hance (New England Nuclear, Boston, USA) fo r Ih  at RT, and re­
hydrated by washing in several changes of water fo r 30min. Finally, gels 
were dried under vacuum at 80° onto a sheet of Whatman (3mm) f i lte r  
paper and placed in contact w ith  Kodak X-Omat XS-1 f ilm . Exposure tim e 
was typ ica lly  5x10^ counts per track  fo r 24h.
2.8 IM M UN O FLUO RESCENCE ASSAY
HFL cells on 13mm coverslips were infected at a moi of 5 pfu 
virus per ce ll. A t various times pi, coverslips were removed from  the 
growth medium, and the virus-in fected cells were fixed fo r lOmin in a 
solution of methanol:acetone (3:1) at -20° and air dried. V irus-infected
cells were pre-incubated w ith  50ul pre-immune rabbit serum fo r 30min at
RT and washed 2X w ith  PBS before the addition of 50ul monoclonal 
antibody.
A fte r a fu rthe r 30min at RT, the cells were washed 6X w ith  PBS, 
treated w ith  50ul fluorescent isothiocyanate-conjugated rabbit anti-mouse 
immunoglobulin (1/40 dilu tion) and incubated as above. The coverslips were 
finally washed 6X in PBS, IX  in d istilled  water and mounted in 50% 
glycerol on glass slides. Fluorescence was visualised under a Le itz  UV 
microscope.
2.9 ELECTRO N M ICROSCOPY
2.9.1 Preparation o f samples fo r th in  sectioning
Growth medium was removed from  mock- and virus-in fected HFL 
cells in 30mm dishes and the monolayers washed three times w ith  PBS.
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The cells were scraped in to 0.5ml PBS, transferred to Beem capsules and 
centrifuged at 5,000 rpm fo r lOmin. The supernatant from this step was 
replaced w ith  500ul 2.5% (v/v) glutaraldehyde in PBS. The pellets were
le ft at 4° overnight a fte r which they were washed three times w ith  PBS 
and post-fixed in 1% (w /v) osmium te trox ide (OSO4) fo r Ih . OSO4 was 
removed by three fu rthe r washes w ith  PBS and the cell pellets were
subsequently dehydrated through a series of increasing ethanol
concentrations (30%, 50%, 70%, 90% and 100% (v/v) in PBS). The pellets
were in it ia lly  in filtra te d  w ith  50% (v/v) epon resin in ethanol followed by 
two changes o f epon resin alone. F inally, the samples were incubated at
65° fo r three days to polymerise the resin.
2.9.2 Thin sectioning
Thin sections from  embedded ce ll pellets were cut e ither w ith  glass 
knives or w ith  a Rawlyer diamond knife  set in an LKB U ltratom e Type 4, 
and collected on parlodium-coated grids. Samples were stained fo r Ih  w ith  
saturated uranyl acetate in 50% (v/v) ethanol, rinsed in deionized water
and counter-stained fo r a fu rthe r Ih  w ith  lead c itra te  before being
examined at BOKV in a Jeol lOOS electron microscope.
C H A PTER  3
7 9
3.1 C H A R A C TE R IS A TIO N  OF A M U TA N T OF HSV-1 W ITH A 
TEM PER A TU R E-SEN SITIVE  DEFECT IN  PENETRATION OF 
CELLS
I n t r o d u c t i o n
HSV in itia tes  in fec tion  of cells by adsorption of virions onto the 
cell surface, fo llowed by penetration of the virus partic le into the 
cytoplasm, probably as a result o f fusion between the virus envelope and 
cell membrane. The v irion  polypeptides which mediate these processes 
have not yet been unequivocally identified , however, the envelope 
glycoproteins are most like ly  to be involved in such interactions w ith cell 
membrane receptors.
The fo llow ing section describes the characterisation of two ts 
mutants of HSV-1 which fa il to  complement each other. One of these 
mutants has a defect in a very early event in the virus replication cycle. 
Interestingly, the lesion in th is m utant does not map in any of the known 
glycoprotein genes, and appears to represent a novel HSV-1 
complementation group.
3.1.1 Tsl204 has a de fect in a very early function
Prelim inary e lectron microscopic observations on thin-section 
preparations of ^120 4 -in fe c te d  cells grown at the NPT (38.5°) revealed 
that more than 60% o f the cells showed no evidence of virus in fection, fo r 
example, nucleocapsid assembly, margination of host chromatin or 
alterations in nuclear membrane structure. Indirect immunofluorescence 
studies using a monoclonal antibody MA1147 directed against Vmwl36 
(ICP8), the major HSV DNA binding protein, confirmed this finding. 
Whereas greater than 95% of w ild-type virus-in fected cells gave bright 
nuclear fluorescence typ ica l w ith  this antibody (Fig. 13b), fewer than 40% 
of ^1204-in fected cells displayed this pattern of fluorescence. To
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FIG U RE 13
Demonstration tha t W 2 0 4  has an early defect, using indirect 
immunofluorescence assay. M ock-infected (MI) monolayers of HFL cells 
and cell monolayers in fected  at the NPT w ith  5 pfu of w ild-type HSV-1 or 
W204 per cell were harvested at 6h pi, unless otherwise stated, and 
prepared for ind irect immunofluorescence assay:
A l l  samples were in c u b e te d  a t  tb e  NPT u n le s s  o th e rw is e  s ta te d ,
(a) Mock-infected cells.
(b) Wild-type H S V -l-in fec ted  cells.
(c) Cells in fected w ith  _kl204 which was warmed to the NPT prior to 
infection.
(d) Cells in fected w ith  prewarmed ^120 4  at the NPT and shifted down 
to the PT at 2h pi fo r  a fu rthe r incubation o f 6h.
(e) Wiid-type H S V -l-in fec ted  cells treated w ith  cycloheximide. 
Cycloheximide was removed at 5h pi, replaced w ith  actinomycin D 
and incubation was continued fo r Ih  before harvesting.
(f) Tsl204-infected cells treated w ith  cyclohexim ide. Cycloheximide 
was removed at 5h pi, replaced w ith  actinomycin D and incubation 
was continued fo r Ih  before harvesting.
The monoclonal antibody used in (a), (b), (c) and (d) was MA1147 which 
was specific fo r Vm w l36, the major DNA binding protein of HSV-1. The 
monoclonal antibody used in (e) and (f) was MA1098 which was specific fo r 
Vmwl75 of HSV-1.
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investigate the possibility tha t Vmwl36, detected in cells infected w ith 
U1204 at the NPT, was synthesized as a result of leak-through of virus 
which had a defect in a very early function, the mutant inoculum was 
warmed to 38.5° fo r IGmin prior to addition to ceils. This treatm ent did 
not result in any s ign ificant loss of in fe c tiv ity  of virus when subsequently 
assayed at 31° (Matz et a l., 1983). Figure 13c shows that fewer than 1% 
of celis infected w ith  prewarmed W 204  at the NPT exhibited nuclear 
fluorescence, using MA1147 in the immunofluorescence test. The e ffec t of 
the mutation was reversible since a fte r downshift of m utant-infected ceils 
from 38.5° to 31° (PT) at 2h pi fo r a period of 6h, greater than 95% of 
ceiis showed nuclear immunofluorescence (Fig. 13d).
Although these experiments clearly showed that ^1204 did not 
synthesize detectable amounts of Vm wl36, an early polypeptide, at the 
NPT, it  was conceivable tha t virus-specified IE antigens were being 
synthesized. To investigate this possibility, IE polypeptides were induced in 
wild-type virus- and ^1204-in fec ted  cells at the NPT by cycloheximide 
treatment. IE mRNAs are synthesized normally in small amounts very 
early in w ild-type virus in fection (see Section 1.4.2), however, these 
transcripts can be induced in large amounts by treatm ent of virus-infected 
cells w ith cyclohexim ide. This protein synthesis inh ib itor, added from  the 
time of in fection, prevents the usual transition from  IE to E gene 
expression. Upon removal o f the cycloheximide block, these IE mRNAs 
can be translated in the presence o f actinomycin D to prevent fu rther 
mRNA synthesis (see Section 2.7.2). Under these conditions, IE antigens 
are easily detected in w ild -type virus-in fected cells by immunofluorescence 
assay w ith a monoclonal antibody directed against an IE polypeptide. 
Figure 13e shows tha t >95% of w ild -type virus-in fected cells treated in 
this manner gave nuclear fluorescence w ith  MA1098, a monoclonal
antibody specific fo r Vm wl75 (ICP4), one of the major IE polypeptides. By
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FIG U R E 14
Autoradiogram of polypeptides from  m ock-infected (MI) cells and cells 
infected w ith w ild -type HSV-1, tsK  or prewarmed J^1204 at the NPT in the 
presence or absence of cyclohexim ide trea tm ent at the NPT. A fte r 
removal of cyclohexim ide, samples were labelled fo r Ih  at 5h pi w ith
[ ^^S]-methionine in the presence o f actinom ycin D. Polypeptides were
analysed on a 5-12.5% gradient SDS polyacrylam ide gel.
Apparent MW of IE polypeptides are indicated.
+ = cyclohexim ide-treated samples.
- = untreated samples.
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contrast, no fluorescence was detected in ceils infected w ith prewarmed 
tsl204 (Fig. 13f), suggesting tha t no IE polypeptides were synthesized in 
mutant-infected cells at the NPT.
These results were confirm ed by SDS-polyacrylamide gel analysis of 
cycloheximide-treated v irus-in fected  ce ll polypeptides (Fig. 14). TsK, a 
mutant of HSV-1 which contains a lesion in Vmwl75, overproduces IE 
polypeptides at the NPT, and serves as a control in this experiment. 
Fig. 14 shows tha t IE polypeptides were produced in wiid-type virus- 
infected ceils which had been treated w ith  cycloheximide, and in tsK- 
infected cells. However, the polypeptide pro file  seen in cycloheximide- 
treated ceils which had been in fected w ith  prewarmed W 204 resembled a 
mock-infected ce li p ro file .
3.1.2 Tsl204 fa ils  to  induce virus-specific polypeptides at the NPT
Virus-infected HFL cells, incubated at 38.5°, were pulse-labelled 
with [ ^^S]-methionine fo r 30min at 6h pi, harvested, and the radioiabelled 
polypeptides were analysed by SDS-PAGE (Fig. 15). When cold (4°) _U1204 
inoculum was added to  cells at the NPT, the polypeptide pro file  was very 
similar to that seen in w ild -type  v irus-in fected cells. Reduced shut-o ff of 
host polypeptide synthesis was noted in _^1204-infected celis compared to 
wild-type v irus-in fected cells, although this varied between experiments. 
Since immunofluorescence studies had shown tha t approximately 60% of 
cells remained uninfected when cold ts l204  inoculum was used, this finding 
was not unexpected. However, when the mutant stock was warmed to the 
NPT prior to addition to cells, the polypeptide pro file  resembled that of 
mock-infected cells, although there was some inhib ition of host polypeptide 
synthesis, which again was variable from  experiment to experiment. Some 
differences were evident in the in tensity of severai host polypeptide bands 
in ^1204-infected and m ock-in fected ce ll extracts. For example, bands of
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FIG U R E 15
Autoradiogram of polypeptides induced in w iid -type HSV-1, W 204 and 
mock-infected (MI) HFL cells at 38.5°. V irus-infected cells were labelled 
for 30min at 6h pi w ith  [ ^^S]-m ethionine. Protein samples were analysed 
on a 5-15% gradient SDS polyacrylam ide gel. Wt HSV-1 and W 204 inocula 
were maintained at 4° p rio r to addition to cells. Tsl204 (prewarmed) 
inoculum was warmed to 38.5° fo r lOmin p rio r to addition to cells.
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approximately 57,000, 33,000 and 15,000 MW were among those which 
appeared to be increased in intensity in the W 204-in fected celi 
polypeptide p ro file , compared to the m ock-infected cell pro file . The 
possible significance o f these observations w ill be discussed la ter.
3.1.3 Tsl204 has a defect in penetration o f cells
Since previous experiments suggested that W 204-in fected ceiis 
faiied to synthesize any virus-specific  poiypeptides at the NPT, i t  seemed 
feasible that the m utant had a defect in e ither uncoating, penetration or 
adsorption. In order to investigate these possibilities, electron microscopic 
studies were carried out on th in-section preparations o f cells infected at a 
high moi (200 pfu per ce ll) o f prewarmed W 204  or w ild-type virus at the 
NPT. Celis were harvested a t 6h pi and prepared fo r electron microscopy 
as described in Section 2.9. No evidence o f in fection could be detected in 
the mutant v irus-in fected cells, however numerous enveloped particles 
containing DNA were observed around the ce ll surfaces (Fig. 16a). Many 
of these particles were in close association w ith  the cell membrane
(Fig. 16b). In contrast, no virions were seen on the surfaces of cells 
infected with 200 pfu per ce ll of w ild -type virus (Fig. 16c).
These observations indicated tha t ^1204  was defective either in
adsorption or penetration o f cells at the NPT. In order to distinguish
between these two possibilities, a series o f experiments was designed to 
compare the ab ilities  o f t s l2G4 and w ild-type virus to adsorb e ffic ie n tly  to 
cells at 4°, 31° and 38.5°, based on an adsorption assay fo r w ild-type virus 
described by DeLuca et al. (1981) (see Section 2.2.4). The mean resuits 
from two such experiments are shown in Fig. 17, where the unadsorbed 
virus has been expressed as a percentage o f the in it ia l virus inoculum at 
time zero. The 4°  serves as a contro l temperature at which w ild-type 
virus can absorb to cells (a temperature-independent process), but cannot
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FIG U R E 16
Electron micrographs o f th in  section preparations of HFL cells infected 
with 200 pfu of prewarmed _U1204 or w ild-type HSV-1 per ce ll. Samples 
were harvested a fte r incubation fo r 6h at the NPT.
(a) Enveloped ^120 4  virions on the surface of a cell.
(b) Enveloped ^1 2 0 4  v irion  in close association w ith  the cell
membrane.
(c) Surface and in te rio r o f a ce ll in fected w ith  w ild-type HSV-1.
Arrows indicate enveloped virions containing DNA.
The bar represents 0.5uM.
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FIG U R E 17
Kinetics of adsorption o f w ild -type  HSV-1 and W 204. HFL cell 
monolayers were in fected  w ith  0.01 pfu o f w ild -type HSV-1 or W 204 per 
cell at 4°, 31° and 38.5°. Samples (lOul) were w ithdrawn at 0, 15, 30, 45 
and 60min post addition o f virus to  cells and subsequently t itra te d  at 31°. 
Unadsorbed virus is expressed as a percentage o f the in it ia l virus inoculum 
at time zero. Open c irc les represent the percentage of unadsorbed tsl204 
virions. F illed c irc les represent the percentage unadsorbed w ild-type HSV-1 
virions. Figures represent the mean values from  two experiments.
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penetrate (a temperature-dependent process). A t a ll three temperatures, 
wild-type virus and W 204  exhibited very s im ilar adsorption kinetics 
(Fig. 17). Between 40% and 50% of the in it ia l w ild-type virus and tsl204 
inocula remained unadsorbed a fte r 60min at 4°, between 35% and 40% at 
31°, and approxim ately 35% fo r both viruses at 38.5°. Taken together 
with electron microscopic observations, these results indicate that at the 
NPT, ^1204 adsorbs norm ally to the ce ll surface but fa ils  to penetrate.
3.1.4 Enhancement o f in fection  by ts l204  at the NPT using PEG
As an additional confirm ation tha t W 204  virions attach to cellular 
receptors and remain bound, but fa il to penetrate the ce ll surface, an 
experiment was performed fo llow ing a procedure described by Sarmiento 
et al. (1979) (see Section 2.2.7). In this experiment, w ild-type virus and 
k l204-infected cells grown at the NPT were treated w ith  polyethylene 
glycol (PEG), a membrane fusion prom oter, in an attem pt to fa c ilita te  the 
entry of extrace llu la r bound virions. Contro l w ild -type virus and ts l204- 
infected cell monolayers were treated in the same manner, except that 
PEG was om itted from  a ll solutions. Immunofluorescence assay was 
performed using MA1147. As a consequence of PEG treatm ent, 
approximately 90% of ^1204 -in fec ted  cells exhibited typ ica l bright nuclear 
fluorescence (Fig. 18d). A sim ilar percentage of w ild-type virus-infected 
cells treated w ith  PEG also exhibited this pattern of fluorescence 
(Fig. 18b). In the absence of PEG, ts l204 -in fec ted  cells resembled mock- 
infected cells (Fig. 18c). These results confirm  the suggestion tha t ts l204 
binds to, but does not penetrate host cells at the NPT.
Nature o f tsl2G4 binding to cells
Since tsl2G4 remained on the ce ll surface at the NPT, i t  was of 
interest to determ ine whether tsl2G4 bound to specific ce llu lar receptors

FIG U RE 18
Demonstration tha t PEG enhances in fection of ceils by W 204 at the NPT, 
using indirect immunofluorescence assay. Monolayers of HFL cells were 
infected at the NPT w ith  5 pfu w ild-type HSV-1 or W 204 per cell, 
harvested at 6h pi and prepared fo r immunofluorescence assay.
(a) M ock-infected cells.
(b) W ild-type H S V -l-in fec ted  cells treated w ith  PEG.
(c) Cells in fected w ith  ^1 2 0 4  which was prewarmed to the NPT prior
to in fection.
(d) Tsl204-in fected cells treated w ith  PEG.
The monoclonal antibody used in a ll cases was MA1147 which was specific 
for Vmwl36, the major DNA binding protein of HSV-1.
*W ild —t ” pe v i r u s —in f e c te d  c e l l s ,  in th e  absence o f  PEG tre a tm e n t , gave 
b r ig h t  n u c le a r  f lu o re s c e n c e  i n  of' c e l l s .
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for HSV, or bound non-specifica lly to the cell membrane. To this end,
experiments were conducted in which w ild-type HSV-1 or HSV-2 were used
to superinfect cells which had been previously infected at the NPT w ith
prewarmed W 204  or at a moi of 200 pfu per ce ll. TsK has a
mutation in Vm wl75 (Preston, 1979; Preston, 1981) and serves as a 
control. A fte r Ih  adsorption at the NPT, unattached W 204 or UK virions 
were removed by washing the ce ll monolayers tw ice w ith  PBS. The cells 
were immediately superinfected w ith  10 pfu per ce ll of w ild-type HSV-1 or 
HSV-2. A fte r a fu rth e r Ih  adsorption tim e, the cells were washed once 
with PBS, overlaid w ith  growth medium and incubation was continued for 
6h at 38.5°, a fte r which tim e the cells were fixed and prepared for 
indirect immunofluorescence. Again, MA1147 was used in the assay and 
the presence of b righ t nuclear fluorescence was taken as evidence that 
penetration by w ild -type  virus had occurred. TsK, which penetrates cells 
normally at the NPT but induces only a lim ited  number of virus-specific 
polypeptides, did not synthesize Vmwl36. Cells in fected w ith  either this 
mutant or prewarmed ^120 4  resembled m ock-infected cells in the 
immunofluorescence assay (Figs. 19a and 19d). A fte r superinfection w ith
HSV-1 or HSV-2, b righ t nuclear fluorescence was observed in tsK-infected 
cells (Figs. 19e and 19f). By contrast, no specific Vmwl36 nuclear antigen 
was detected in _U1204-infected cells which had been superinfected w ith 
wild-type HSV-1 (Fig. 19b). If, on the other hand, the superinfecting virus 
was w ild-type HSV-2, nuclear fluorescence was detected in >90% of 
W 204-infected cells (F ig. 19c). These results were confirmed by analysis 
of radioiabelled v irus-in fected  ce ll polypeptides on SDS polyacrylamide gels 
(Fig. 20). The patte rn  o f polypeptides from  ^1204-in fected , HSV-1- 
superinfected cells resembled tha t o f m ock-infected cells, whereas the 
pattern of m utant v irus-in fected  cells superinfected w ith  HSV-2 was 
indistinguishable from  tha t of HSV-2 (Fig. 20). These results indicated that

FIG U R E 19
Demonstration tha t W 2 0 4  binds to H S V-l-specific  cellu lar receptors, using 
indirect immunofluorescence assay. Monolayers o f HFL cells infected w ith  
200 pfu of prewarmed j^ l2 0 4  or tsK per ce ll were harvested at 6h pi and 
prepared fo r ind irec t immunofluorescence assay. Cells were superinfected 
with 5 pfu o f w ild -type  HSV-1 or HSV-2 per ce ll Ih  a fte r the addition of 
k l204.
(a) Cells in fected w ith  200 pfu of ^1204  per ce ll.
(b) Cells in fected w ith  ^1 2 0 4  and superinfected w ith  w ild-type HSV-1.
(c) Cells in fected w ith  ^1 2 0 4  and superinfected w ith  w ild-type HSV-2.
(d) Cells in fected w ith  200 pfu o f tsK per ce ll.
(e) Cells in fected w ith  tsK  and superinfected w ith  w ild-type HSV-1.
(f) Cells in fected w ith  tsK  and superinfected w ith  w ild-type HSV-2.
The monoclonal antibody used in a ll cases was MA1147 which was specific 
for Vmwl36, the major DNA binding protein o f HSV-1 and the equivalent 
HSV-2 polypeptide.
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FIG URE 20
Autoradiogram of polypeptides induced in HFL cells in fected w ith  200 pfu 
of prewarmed ^1 2 0 4  per ce ll at the NPT. A fte r incubation fo r Ih  at 
38.5°, cells were superinfected w ith  5 pfu o f w ild -type HSV-1 or HSV-2 
per cell or were m ock-superinfected. Samples were labelled fo r 30min 
with [ ^^S]-methionine 7h a fte r in fection w ith  W 204. Polypeptides from  
mock-infected cells and cells in fected w ith  w ild-type HSV-1 or HSV-2 alone
were also labelled fo r 30min w ith  [ ^ ^S]-methionine at 7h pi. Samples
were then harvested and analysed on a 5-15% gradient SDS polyacrylamide 
gel.
The apparent MW o f HSV-1 (filled  squares) and HSV-2 (open circles)
polypeptide markers are indicated.
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W204 binds tig h tly  to ce llu la r receptors specific fo r HSV-1, and tha t HSV- 
1 and HSV-2 u tilize  d iffe re n t ce llu lar receptors.
Experiments to determ ine i f  U1204 can enter cells co-operatively 
with other viruses were also carried out. HFL cells on coverslips were 
CD-infected w ith  W 2 0 4  together w ith  W 213 , which has a defect in 
uncoating (V.G. Preston, unpublished result) or I^K . Since both these 
mutants are defective in stages of the replication cycle prior to E gene 
expression, the detection o f Vm wl36 in co-infected cells could be taken as 
evidence that ^1204  virions were able to penetrate cells co-operatively 
with other virions and in it ia te  a normal in fection. However, no nuclear 
Vmwl36 was observed in immunofluorescence tests on co-infected cells 
using MA1147 (data not shown). Therefore, this result indicated tha t 
U1204 cannot u tilize  ce llu la r receptors in conjunction w ith  other viruses 
which are capable of penetration.
3.1.6 Physical map location of the ts l204  lesion
The _^1204 lesion had been previously mapped to DNA sequences 
within fragment Kpnl ^  (map units 0.322-0.344) by Matz et al. (1983). 
Using separated Hpal fragments from  cloned HSV-1 EcoRI _f (plasmid 
pGX38) in marker rescue experiments, the map co-ordinates of ^1204  were 
refined. The m utation mapped w ith in  a 400bp region of BamHI u, shared 
by Hpal J_ and Kpnl ^  (Table 2, Fig. 21).
3.2 FURTHER C H A R A C TER IS A TIO N  OF TS1204 AND  
COM PARISON W ITH TS1208, A M UTANT W HICH FAILS TO  
COM PLEM ENT TS1204
3*2.1 Tsl204 has a second phenotypic defect
Prelim inary e lectron microscopic studies on ts l204-in fected cells at 
the NPT revealed tha t when the m utant inoculum was not warmed to 38.5°
TABLE 2
Summary of marker rescue results fo r _U1204 and tsl208.
Cloned EcoRI _f, digested w ith  Hpal, gave two fragments; a which 
contained sequences from  HSV-1 Hpal jy b and pACYC184, and b which 
contained sequences from  HSV-1 Hpal ^  only. These fragments were 
purified and used in m arker rescue experiments. The other DNA fragments 
were available as cloned DNAs and were digested w ith  the appropriate 
restriction endonuclease p rio r to transfection.
The relative e ffic iency  o f plating (eop NPT/PT) ^gg calculated from  the 
yield of progeny virus at the PT and NPT from  the transfected cells.
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FIG U RE 21
Marker rescue o f ts l204  and ^1208 . The solid lines represent the regions 
of HSV-1 DNA which rescue the mutants. Arrows indicate transcripts 
identified by Holland e t al. (1984) which map in th is region of the HSV-1 
genome.
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before addition to cells, about 40% of cells showed signs of in fection such 
as margination of host chromatin and production of capsids (data not 
shown). A s trik ing  feature  o f these cells was tha t low numbers of capsids 
were seen, none of which contained DNA. To investigate the possibility 
that k l2 0 4  had a second phenotypic defect, m utant virus was adsorbed for 
Ih at the PT instead o f 38.5° to allow the virus to enter the cells. A fte r 
this time the cells were transferred to 38.5° and incubation was continued 
for a further 9h. E lectron microscopic studies o f these cells showed that 
W204 appears to have a defect in assembly o f functional nucleocapsids 
since very few capsids were produced at the NPT, and none of these
capsids contained DNA (Fig. 22b).
3.2.2 Tsl204 contains a single lesion
One explanation fo r the finding tha t ^120 4  had defects both in 
penetration o f cells and in assembly o f functiona l capsids could be that the
virus contains m u ltip le  mutations. Since the ^  lesion in ^1204 was
rescued by a single HSV-1 DNA fragm ent (see Section 3.1.6) this
explanation seemed unlike ly, but to fu rther exclude this possibility, is.+ 
progeny virus was isolated from  marker rescue experiments in which cells 
were co-infected at 31° w ith  BamHI u and W 204 . This virus, and a 
revertant of ^120 4  (ts l204  rev-1), were tested fo r the ab ility  to in fect 
cells at the NPT. Both types of virus gave s im ilar results to w ild-type 
virus in ind irect immunofluorescence assay using MA1147 (data not shown).
In addition, the re la tive  e ffic iency of plaque form ation (eop) NPT/PT Qf
the marker rescue ts'*' progeny virus was comparable to w ild-type virus 
(data not shown). On the basis of these experiments, i t  was concluded
that W 204 contains only a single ^  mutation.
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FIG U R E 22
Electron micrographs o f th in-section preparations of HFL cells infected 
with 5 pfu of W 2 0 4 , W 208  or w ild -type HSV-1 per ce ll. The NPT in 
these experiments was 39.5°.
(a) Nucleus o f a ce ll in fected w ith  w ild-type HSV-1. Cells were
harvested a fte r a incubation at the NPT.
(b) Nucleus o f a ce ll in fected w ith  ^1204 . A fte r Ih  incubation at the
PT, cells were transferred to the NPT and harvested at Sh pi.
(c) Nucleus o f a ce ll in fected w ith  1^1208 at the NPT. Cells were
harvested a fte r Sh incubation at the NPT.
Filled arrows indicate fu ll capsids.
Open arrows indicate empty capsids.
The bar represents 0.5uM.
T A B LE  3
C o m p le m e n ta tio n  s tud ies  w ith  ts l2 0 4 ,  
ts l2 0 8 ,  ts l2 0 1  and ts A
Mutant ta l204 U1208 t^ l201 ^ A
W 204 1 1.56 24.32 101.6
W 208 1 42.7 88
W 201 1 98.4
tsA 1
TABLE 3
Complementation studies w ith  W 204 , W 208, W 201 and ^ A .
Complementation yie ld tests were performed as described in Section 2.4.1. 
The numbers in the table represent complementation indices calculated 
from the form ula used by Brown et al. (1973). Values greater than 4 were 
considered positive.
Tsl201 has a tem perature-sensitive lesion which maps w ith in  DNA fragment 
BamHI u.
TsA has a tem perature-sensitive lesion which maps in the glycoprotein gB 
gene (V.G. Preston, personal communication).
TABLE 4
Recombination studies with ts l204 , 
ts l208, ts l201 and tsA
Mutant W 204 W 208 U1201 _UA
U1204 <0.001 0.1 13.58 52.4
U1208 <0.001 11.9 85.3
W 201 <0.001 16.1
tsA <0.001
TABLE 4
Recombination studies w ith  1^1204, ^1208 , ^1201 and UA.
Recombination tests were performed as described in Section 2.4.2. The 
numbers in the table represent recombination frequencies which were 
calculated as described in Section 2.4.2.
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3.2.3 Tsl208 has a lesion w ith in  the same gene as tsl204
Providing U1204 was not prewarmed to the NPT, complementation 
and recombination tests could be used to determine whether the mutant
represented a new com plem entation group w ith in  EcoRI U Previous work 
by Metz et al. (1983) showed tha t U1204 would complement mutants in
other cistrons, including those which mapped in the glycoprotein gB gene. 
In this study, com plem entation tests revealed tha t a spontaneous mutant, 
U1208, fa iled to complement W 204 , and recombined at low frequency w ith 
this mutant (Tables 3 and 4). On the basis of these results, W 208 was
placed in the same c istron as ts l204.
3.2.4 The phenotypes o f ts l208  and ts l204 d iffe r
Although _kl208 fa iled  to complement ^1204 , prelim inary 
characterisation using in d irec t immunofluorescence assay revealed that, in 
contrast to ^120 4 , ^1 2 0 8  did not have a penetration defect since virus 
prewarmed to 39.5° in fec ted  a ll susceptible cells at the NPT (data not 
shown). 39.5° was used as the res tric tive  temperature in these 
experiments, because ts l208  was leaky at 38.5° w ith  respect to plaque 
formation. The observation tha t the mutant virus-in fected ce ll polypeptide 
profile at 39.5° resembled w ild-type virus-infected cell polypeptide 
(Fig. 23) confirm ed tha t ts l208  was able to in fect cells at the NPT. 
Finally, electron m icroscopic studies o f thin-section preparations of cells 
infected w ith  ^120 8  at the NPT revealed the presence of capsids which 
had some in te rna l s truc tu re  but lacked DNA (Fig. 22). Although 
approximately 15% more capsids were seen in tsl2Q8-infected cells than in 
k l204-in fected cells at 39.5°, there were s t ill fewer capsids than seen in 
wild-type v irus-in fected cells. Therefore, although ts l208 lies in the same 
cistron as W 204 , only the la tte r  mutant is unable to penetrate cells at 
the NPT. Both mutants, however, fa il to assemble functional nucleocapsids 
this temperature.
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FIG URE 23
Autoradiogram of polypeptides induced at the PT (31°) or NPT (39.5°) in 
HFL cells in fected w ith  w ild-type HSV-1 or J^1208 or in mock-infected 
cells. V irus-infected cells were labelled fo r 30min at 6h pi w ith [ ^^S]- 
methionine and harvested. Protein samples were analysed on a 9% single 
concentration SDS-polyacrylamide gel.
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3.2.5 Physical map location of the ts l208 mutation
The lesion in _U1208 had previously been mapped w ith in HSV-1 DNA 
fragment BamHI u (V.G. Preston, personal communication). Cloned HSV-1 
Kpnl fragments _t (pGX142), in which the U1204 lesion had been mapped, 
and m (pGX134) were screened fo r a b ility  to rescue the W 208 mutation 
(Table 2). The lesion was found to map w ith in  fragment Kpnl m. The 
kl208 lesion is there fo re  situated to the le ft  of the W 204 mutation 
within BamHI u (Fig. 21).
3.3 CHARACTERISATION OF VIRUS POLYPEPTIDES WHICH 
FORM THE HSV ATTACHMENT COMPLEX
3.3.1 Tsl204 provides a novel means of determ ining the receptor binding
(attachment) polypeptides
The ab ility  o f ts l204  to bind specifica lly  to ce llu lar receptors fo r 
HSV-1, thereby preventing penetration of cells by HSV-1 but not HSV-2, 
was utilized to determ ine the map location of HSV polypeptides involved in 
the recognition o f these receptors. Several HSV-l/HSV-2 in te rtyp ic  
recombinants w ith  crossovers at various points throughout the genome 
(Fig. 24) were used in superinfection experiments. HFL cells grown on 
coverslips were in fected w ith  ts l204 or tsK at 200 pfu per cell at the 
NPT. A fte r Ih  adsorption, the cell sheets were washed w ith  prewarmed 
PBS to remove unadsorbed virus and im m ediately superinfected w ith w ild - 
type viruses HSV-1 stra in  17 or HSV-2 strain HG52, or one of four 
intertypic recombinants, Bxl(31-2), Dxl(34-2), R12-3 and R12-1 (Fig. 24). 
After a 6h incubation a t the NPT, the coverslips were washed, the cells 
were fixed in methanohacetone (3:1) and screened fo r the presence of 
Vmwl36 using immunofluorescence assay w ith  monoclonal antibody MA1147. 
Under these conditions, the ab ility  o f a recombinant virus to penetrate 
cells and synthesize V m w l36 w ill be dependent on the presence of HSV-2 
envelope attachment polypeptides capable of recognising HSV-2-specific
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FIG U RE 24
Summary o f the genome structures o f the four HSV-l/HSV-2 recombinants 
used in this study. The genome arrangement o f HSV DNA is shown at the 
top of the figure . Map locations o f the major HSV glycoproteins are also 
indicated. V ertica l dotted lines correspond to  the ends o f the long and 
short repeat sequences o f the HSV genome. The sequences of the
recombinants derived from  the HSV-1 and HSV-2 parents are represented 
by continuous lines above and below the dotted line respectively. 
Crossover regions are indicated by cross-hatched boxes.

FIGURE 25
Investigation o f virus attachment polypeptides, using indirect
immunofluorescence assay. Monolayers o f HFL cells were infected w ith
200 pfu prewarmed ^1 2 0 4  per ce ll, superinfected at Ih  pi w ith  5 pfu w ild - 
type HSV-1, w ild -type  HSV-2, B x l (31-2), D x l (34-2), R12-3 or R12-1 per 
cell at the NPT (38.5°), harvested at 6h post superinfection and prepared 
for indirect immunofluorescence assay.
(a) Cells in fected w ith  ^120 4  and superinfected w ith  w ild -type HSV-1.
(b) Cells in fected w ith  ^120 4  and superinfected w ith  w ild-type HSV-2.
(c) Cells in fected w ith  ^120 4  and superinfected w ith  B x l (31-2).
(d) Cells in fected w ith  ^120 4  and superinfected w ith  D x l (34-2).
(a) Cells in fected w ith  ^120 4  and superinfected w ith  R12-3.
(f) Cells in fected w ith  ts l204  and superinfected w ith  R12-1.
The monoclonal antibody used in a ll cases was MA1147, which was specific 
for the major DNA binding protein of HSV-1 and the equivalent HSV-2 
polypeptide.
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cellular receptors. In a series o f repeat experiments, i t  was found tha t a ll 
the recombinant viruses tested had the a b ility  to penetrate cells previously 
infected w ith 200 pfu per ce ll o f U1204 at the NPT, and synthesize
Vmwl36 (Fig. 25 c, d, e and f). Contro l virus, w ild -type HSV-1, fa iled to
penetrate cells previously in fected w ith  saturating amounts of ts l204 at 
the NPT (Fig. 25a).
3.4 DISCUSSION
The previous section describes the iden tifica tion  of a mutant, 
U1204, which fa ils  to penetrate tissue culture cells. Electron microscopic 
observations of cells in fected at the NPT w ith  a moi of 200 pfu per ce ll 
of prewarmed J^1204 revealed large numbers of enveloped particles in close 
association w ith  the outside surface o f the cell membrane. Since the 
particletpfu ra tio  o f th is m utant is sim ilar to tha t o f w ild-type HSV-1 
(20:1), i t  was unlike ly tha t the ^120 4  stock contained many defective 
particles which were unable to penetrate the cells. Treatment of mutant 
virus-infected cells w ith  PEG enabled the virus to in fec t cells at the NPT, 
indicating tha t ^120 4  had a defect in fusion of the virus envelope w ith  
the cell membrane.
Cellular receptors fo r herpesviruses
The fa ilu re  o f ^1 2 0 4  to  penetrate cells appears to be independent 
of the cell type used since the same phenotype was observed in BHK clone 
13 cells as w ell as in HFL cells. In addition, on the basis of
superinfection experiments, ts l204  binds to ce llu lla r receptors which are 
specific fo r HSV-1. These results are o f in terest when considering the 
idea that virus attachm ent to cells is mediated by plasma membrane
receptors which are otherwise engaged in the normal homeostatic functions 
of the ce ll. The wide in v itro  and in vivo host range of HSV indicates
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either that th is virus binds to a receptor which is common to many
different ce ll types orig inating from  d iffe ren t organisms, or that HSV can
bind to more than one type of receptor. Interestingly, the results from
this and previous studies (Vahlne et a l., 1979) show that HSV-1 and HSV-2
utilize d iffe ren t ce llu la r receptors, at least in the ce ll lines tested. It is
probable that the in te raction  of viruses w ith  specific cellu lar receptors
plays an im portant role in determining the localisation of virus in fection
(tissue tropism). Support fo r this theory also comes from  work by Vahlne
n e u ro n a l p e r ik a r y a  
et al. (1978) who showed tha t /  from  rabbit, ra t or mouse brain
tissues contained fewer receptors fo r HSV than did synaptosomes. The
authors speculate tha t the presence o f receptors at the nerve term inals
may fa c ilita te  in itia tio n  o f HSV in fection in the CNS, and that scarcity of
receptors on the r.eor-on5^ may prevent the spread of in fection between
neoroos^ » and contribute to the development o f a la ten t in fection.
Further support fo r the idea tha t tissue tropism is determined by 
the ava ilab ility  o f specific cellu lar receptors has come from  the 
identification o f the ce ll surface receptor fo r EBV, a gammaherpesvirus. 
The EBV receptor is the human B-cell surface receptor CR2 which binds a 
cleavage product o f the th ird  component o f complement, C3d (Takada and 
Osato, 1981; Jonsonn et a l., 1982; Fingeroth et a l., 1984; Wells et a l., 
1984). This receptor is expressed on mature human B lymophocytes, which 
are one of the in vivo ta rge t cells fo r EBV, and on certa in B-cell lines 
which support the growth o f EBV in v itro . Identifica tion  of the normal 
function of ce llu lar receptors fo r viruses may provide clues about the 
mechanisms underlying d iffe ren t virus-ce ll in teractions.
Saturation binding of ts l204 to H S V-l-specific  ce ll receptors on 
HFL cell monolayers was obtained using a moi of 200 pfu per ce ll 
(approximately 4x10^ partic les per cell). Therefore, there appears to be 
roughly greater than 10^ receptors fo r HSV-1 on an HFL cell in monolayer.
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This figure is s im ila r to estimates of receptors fo r HSV-1 and HSV-2 on 
several ce ll lines by Vahlne et al. (1979). Saturatable binding sites fo r 
other enveloped viruses, such as vesicular stom atitis  virus (VSV) on Vero 
cells (Schlegel et a l., 1982), and rabies virus on cultured cells of both 
neural and non-neural orig in  (Wunner et a l., 1984), have been demonstrated 
(see also Lonberg-Holm et a l., 1976). The demonstration that binding sites 
for a virus can be saturated provides additional evidence that specific 
cellular receptors mediate attachm ent of that virus to the cell surface. 
One interesting finding obtained during work on ^1204  was that saturating 
amounts of HSV-1 m utant tsK , which penetrates cells normally, did not 
prevent subsequent in fec tion  by w ild-type HSV-1, Ih  la te r at the NPT. 
This result indicates tha t ce ll surface receptors are e ither re-usable, or 
rapidly replaced. In th is respect, i t  is noteworthy that an area of
membrane equivalent to the whole ce ll surface can be recycled by L-cells
every 125min, and by macrophages every 33min, during pinocytosis
(Steinman et a l., 1976).
Virus attachm ent proteins
Adsorption o f HSV onto the cell surface is a temperature-
independent process (Farnham and Newton, 1959; Duyckinck-Smith and de 
Harven, 1974). The adsorption profiles fo r HSV-1 and ^1204  in this study 
support the above findings since the kinetics o f adsorption fo r these viruses 
were sim ilar at 4° and 38.5°. The HSV envelope glycoproteins are thought 
to represent virus attachm ent proteins. Such proteins which mediate 
recognition of the ce llu la r receptor and subsequent binding of the virus to 
the cell surface have been the subject o f extensive investigation. Fu lle r 
and Spear (1985) demonstrated that polyclonal and monoclonal antibodies, 
specific fo r gD and gC o f HSV-1, were e ffective  in the inhib ition of virus 
adsorption to HEp-2 cells. In addition, Johnson et al. (1984) showed that
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binding of lip id  vesicles containing HSV-1 glycoproteins (virosomes) to cells 
was inhibited by polyclonal and monoclonal antibodies to gB. Taken 
together, these results indicate tha t HSV glycoproteins form  an attachment 
complex in the virus envelope, and suggest that stable attachment of the 
virus to the ce ll surface may be a result of m ultip le interactions of 
several glycoproteins w ith  the ce llu lar receptor(s).
This idea was supported by the results obtained from  receptor 
mapping experiments in this thesis. These experiments were designed on 
the basis tha t the a b ility  of a virus to penetrate cells previously infected 
with saturating amounts of W 204  at the NPT w ill depend on the presence 
of HSV-2 attachm ent proteins in the virus envelope, such that HSV-2- 
specific ce llu lar receptors can be u tilized .
As shown in figure 24, each o f the recombinants induced at least 
one HSV-2 glycoprote in. R12-3 contained sequences encoding gB-2, gC-2, 
gD-1 and gE-1. Bxl(31-2) contained sequences encoding gB-2, gC-1, gD-1
and gE-1. Dxl(34-2) contained sequences encoding gD-2, gB-2, gC-1 and
90-1. R12-1 contained sequences encoding gB-2, gC-2, gD-2 and gE-2.
Thus, no HSV-2 DNA sequences were common to a ll four recombinant 
viruses, although the possibility tha t any of the recombinants contained 
undetected crossovers cannot be ruled out. A ll the recombinant viruses 
were capable o f penetrating cells previously infected w ith  ^1204  at the 
NPT. Provided the recombinants did not contain undetected crossovers, 
this result indicates tha t recognition of, and successful binding to, a 
cellular receptor can be achieved by a v irion attachment complex which is 
composed of a m ixture  o f HSV-1 and HSV-2 glycoproteins. This 
preliminary conclusion could be unequivocally confirmed by recombining 
cloned HSV-2 glycoprote in genes, singly and in combination, into w ild-type 
HSV-1, thus e lim ina ting the possib ility of undetected crossovers at other 
glycoprotein loc i. The resulting recombinants could then be tested fo r the
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ability to u tilize  HSV-2-specific ce llu la r receptors.
Membrane fusion
G lycoprotein gB plays a centra l role in the fusion of the HSV 
envelope and ce ll membrane. Ts mutants o f HSV-1, ^ B 5  and _UJ12, which 
have lesions in the gB gene, produce progeny virions at the NPT which 
possess gB -defic ien t envelopes. These progeny virions are unable to 
penetrate cells (Sarmiento et a l., 1979; L it t le  et a l., 1981). G lycoprotein 
gD may also be involved in the fusion process. Fuller and Spear (1985) 
reported that polyclonal or monoclonal anti-gD  antibodies which exhibited 
potent virus neutralising a c tiv ity  were ine ffec tive  at blocking virus 
adsorption. However, these antibodies inhib ited HSV-induced ce ll-ce ll 
fusion (Noble et a l., 1983; Fuller and Spear, 1985). I t  is possible, 
therefore, tha t some anti-gD  antibodies a ffe c t virus neutralisation by 
preventing membrane fusion required fo r virus penetration.
In this study, a ll the in te rtyp ic  recombinants tested fo r ab ility  to 
utilize HSV-2-specific ce llu la r receptors contained either HSV-2 
glycoprotein gB or gD in the ir envelopes, and a ll the recombinants were 
successful in penetrating the ce ll surface. On the basis of this data, i t  
can be postulated tha t the virus polypeptides involved in the fusion process 
can act independently o f the ce llu la r receptor being used. In this case, an 
HSV-2 envelope glycoprote in could mediate fusion at an HSV-l-specific  
cellular receptor and vice versa. A lte rna tive ly , i f  the virus fusion 
polypeptides can act only at a homologous ce ll receptor, then this data 
suggests tha t e ithe r gD and gB alone can mediate the fusion process, 
provided tha t these glycoproteins play a d irec t role in penetration.
G lycoproteins have been iden tified  as the fusion proteins in other 
enveloped viruses, fo r example, the F prote in o f paramyxoviruses and the 
HA protein o f orthomyxoviruses. Analyses o f these glycoproteins have
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given clues about the mechanism of the virus envelope-cell membrane
fusion process. B r ie fly , cleavage of the fusion glycoprotein exposes 
hydrophobic regions (Hsu et a l., 1981; Skehel et a l., 1982) which are like ly 
to be im portant in the fusion process. Maeda et al. (1981) showed that 
influenza virus can fuse w ith  a r t if ic ia l liposomes which are devoid of
proteins or s ia lic acid-bearing cellu lar receptors. Therefore, i t  seems that 
the fusion process is a d irec t result of in teractions between the fusion 
peptide and ce ll membrane lipids. Enveloped viruses require such fusion
proteins in order to  elevate the low fusion incidence normally found
between membranes. This is because there is a repulsive force which 
opposes the close approach o f hydrated polar surfaces (Parsegian et a l.,
1979). Doms et al. (1985) suggest tha t the influenza virus HA and
presumably other virus fusion glycoproteins overcome this repulsion by 
integrating in to the ta rg e t membrane, and mechanically bringing the virus 
envelope and ce ll membrane close enough so tha t d irect in teraction 
between lip id  molecules in both membranes becomes possible.
Alterations in ce llu la r macromolecular synthesis
Analysis o f virus-induced polypeptides in ts l204-in fected  cells grown 
at the NPT showed th a t the pattern of polypeptide synthesis in these cells 
resembled tha t o f m ock-in fected cells, except fo r two observations: F irs t,
in ^1204-in fected cells, some inhib ition of host polypeptide synthesis was 
seen. Although a v irion  polypeptide has been im plicated in this process 
(Fenwick and Walker, 1978; see Section 1.3.3), i t  is unclear whether in 
this case the in h ib ition  was caused by a s tructura l component o f the 
virion, or was induced as a consequence of a lterations to the cellu lar 
membrane brought about by binding o f ts l204 virions to ce ll surface 
receptors. A ttachm ent o f HSV to the ce ll membrane results in a decrease 
in cell surface pro te in  m ob ility , an event which is presumably a
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consequence of crosslinking o f receptor proteins which in teract w ith  the 
cytoskeleton (Gall and Edelman, 1981; Rosenthal et a l., 1984). It is not 
known whether such disturbance o f the cytoskeleton could a ffe c t ce llu lar 
protein synthesis.
Secondly, several host polypeptide bands are increased in intensity 
in k l2 04 -in fec ted  ce ll polypeptide profiles compared to the m ock-infected 
cell profile , the most major one being a protein of approximately 57,000 
MW. This observation indicated tha t the expression of some cellu lar genes 
had been upregulated as a consequence of virions binding to the ce ll 
surface. Increases in the synthesis of specific cellu lar proteins in response 
to herpesvirus in fection  have previously been described and it  is possible 
that the proteins induced in W 204-in fected  HFL cells at the NPT may 
correspond to some of these. Infection of chick embryo fibroblast cells at 
the NPT w ith  HSV-1 m utant tsK results in the overproduction o f IE 
polypeptides. In addition, four major cellu lar stress proteins are 
synthesized, having apparent MWs of 90K, 70K, 35K and 25K (Notarianni 
and Preston, 1982). However, since synthesis of these proteins requires
both an inactive Vm wl75 and overproduction of the other IE polypeptides 
(C.M. Preston, personal communication), i t  is unlikely that they are 
analogous to any o f the upregulated cellu lar polypeptides seen in ts l204 - 
infected cells. Perhaps o f greater interest is the observation that the 
synthesis of several ce llu la r polypeptides is increased follow ing HSV-2 
infection of HFL cells (LaThangue et a l., 1984). Monoclonal antibodies 
specific fo r some of these polypeptides are available, and obviously provide 
3 means whereby any homologous polypeptides induced in ts l204-in fected  
cells could be detected. Superinfection o f lymphoblastoid cells w ith  EBV 
also results in enhanced production of cellu lar proteins and, in teresting ly, 
one of these has an apparent MW of 53,000 (Casareale et a l., 1984). 
Again, antiseiw iraised against th is polypeptide is available and i t  should be
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possible to investigate whether this protein is analogous to the 57,000 MW 
polypeptide induced in W 204-in fec ted  HFL cells. F inally, i t  is noteworthy 
that trea tm ent of cells w ith  in terferon results in the upregulation of 
cellular genes (Friedman et a l., 1984; Faltynek et a l., 1985), one of which
codes fo r a polypeptide o f apparent MW 56,000 (Chebath et a l., 1983;
Faltynek et a l., 1985). I t  would be o f great interest to determine whether 
the synthesis o f th is interferon-induced polypeptide is also upregulated 
following binding of HSV virions to the ce ll membrane. A lternative 
approaches to the investigation o f upregulated genes in W 204-in fected 
cells are discussed la te r.
Capsid assembly defect of ts l204 and ts l208
Provided ^120 4  was allowed to enter cells by a brie f incubation at
the PT before tem perature sh ift-up to the NPT, a second phenotype defect
became evident. In comparison w ith  w ild-type HSV-l-in fected cells, fewer 
capsids were produced and none of these contained DNA. Another mutant, 
^1208, which fa iled to  complement ^1204 , penetrated cells normally at 
the NPT. However, th is mutant also assembled fewer capsids than w ild - 
type HSV-1 a t the NPT and, like ^1204 , fa iled to package DNA. In this 
respect, W 2 0 4  and ^1 2 0 8  d iffe red from  unrelated mutants W 201 and 
^1203 (see Section 4) which made considerably more capsids at the 
restrictive tem perature than w ild-type virus.
Analyses o f ts^ virus, generated by marker rescue of ^1204  w ith  
cloned DNA fragm ent BamHI u from  w ild-type virus, and a revertant 
of tel204, suggest tha t W 204  has a single mutation that a ffects the 
ability of the m utant both to penetrate cells and assemble functional 
nucleocapsids at the NPT. Marker rescue and recombination experiments 
indicated tha t the k l2 0 4  and W 208 lesions are in close proxim ity . Thus, 
I^oth mutations m ight lie  in a m ultifunctiona l gene, a possibility which
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poses the question o f how one polypeptide m ight be involved in two 
apparently unrelated events in the virus replication cycle. The defect in 
penetration o f cells indicates tha t the ^  polypeptide is a component o f the 
infecting v irion , fo r example, an envelope fusion glycoprotein. However, i t  
is d iff ic u lt to envisage how such a polypeptide would be required fo r 
assembly of nucleocapsids. Therefore, i t  m ight be postulated tha t the ts 
gene product is a component o f the tegument which interacts both w ith 
the virus envelope and the nucleocapsid in a manner analogous to the M 
(matrix) protein o f influenza virus (Compans et a l., 1970; Gregoriades,
1980). In the in fec ting  v irion  this polypeptide m ight function to anchor
envelope glycoproteins in the correct receptor-binding complex form ation. 
In this case, in ^1 2 0 4  virions a t the NPT, the altered configuration of this 
polypeptide would result in a disturbance in the envelope attachment 
complex, such th a t the correct in teraction between virus envelope proteins 
and cell membrane components is prevented and fusion cannot occur. The 
mechanism whereby a tegument polypeptide is involved in capsid assembly 
requires fu rthe r consideration. The site o f HSV capsid assembly is thought 
to be the nuclear m a trix  (see Section 1.7.1). A sim ilar situation exists fo r 
the assembly o f icosahedral bacteriophage T4 capsids at the bacteria l cell 
inner membrane. A T4 gene product has been described which is involved 
in the in itia tio n  o f capsid assembly at the bacteria l membrane, and appears 
to anchor the m aturing capsids to the membrane (Onorato et a l., 1978;
Showe and Onarato, 1978; Black and Showe, 1983). A sim ilar role might 
be envisaged fo r the ts gene product in ts l204 and ts l208-in fected cells. 
Assuming tha t th is  polypeptide controls a ra te -lim itin g  capsid assembly 
initiation step, the process m ight be slowed at the NPT, thereby 
accounting fo r the low numbers o f capsids seen. A lte rna tive ly , the 
affected gene product m ight be a tegument polypeptide involved in
niaintenance o f capsid s ta b ility . In th is case, at the NPT in ts l204 - and
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tel208-infected cells capsid structures may be assembled but be unstable, 
such that few complete shells are seen at any tim e.
It  is also feasible tha t U1204 m ight contain a single m utation 
within the coding regions o f two overlapping genes and, as a consequence, 
have ^  defects in two gene products. In this situation, W 208 would have 
a mutation a ffec ting  the function of one of these genes only. I t  is 
noteworthy tha t genes w ith  overlapping coding regions have been described 
in the Ug region o f the HSV-1 genome (McGeoch et a l., 1985).
Holland e t al. (1984) have mapped five  mRNAs w ith in the DNA 
fragment BamHI u. Three o f these, 5.6-, 5.2- and 4.4- kb mRNAs 
hybridise to the region o f BamHI u where the W 204  and W 208 lesions lie 
(Fig. 21). Further investigation is required to determine the mRNA 
encoding the polypeptide(s) which is in ^120 4 - and ^120 8 - in fected 
cells. On the basis o f results from  in v itro  translation experiments, 
M illette and Clevland (personal communication) have identified  several 
polypeptides in th is region w ith  apparent MWs of 62,000, 51,000, 37,000 
and 27,000. As previously stated, i t  is probable tha t the ts l204 mutation 
lies w ith in a s truc tu ra l gene. However, the possibility that incorrect 
processing o f polypeptides at 31° caused a structura l polypeptide to 
become therm olabile cannot be excluded.
It  is o f in te rest to note tha t several polypeptides w ith  known or 
suspected roles in the process o f membrane fusion map near to the ts l204 
mutation. Two glycoproteins, gB and gH (see Section 1.2.2) map to the 
right and le f t  o f the ^1 2 0 4  lesion respectively. Although the involvement 
of gB in fusion o f virus envelope and ce ll membrane has been clearly 
documented, the role o f gH in the adsorption or penetration processes is 
purely speculative. M utants o f HSV-1 stra in 17 syn+ which have deletions 
in the 5' regulatory and coding regions o f the TK gene have a syncytia l 
plaque morphology (see Section 1.10.2). These deletions map w ith in  DNA
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sequences encoding the 5’ regions of the 5.6- and possibly the 5.2- kb 
mRNAs identified  by Holland et al. (1984) (Fig. 21). The significance, i f  
any, of this grouping of genes involved in membrane fusion events is at 
present obscure.
3.5 FUTURE PROSPECTS
Unequivocal demonstration that the W 204  phenotype results from  a 
single m utation can be achieved by cloning the DMA sequence which 
contains the ^120 4  lesion, and recombining this fragment into w ild -type 
virus. Any ^  progeny virus isolated from  such an experiment should be 
phenotypically identica l to W 204 . An altered phenotype, i.e. loss of the 
penetration defect or the capsid assembly defect, would indicate tha t 
k l204 contained more than one lesion.
I t  would be o f great intereist to iden tify  the gene product which is 
k  in ts l204-in fected  cells. Marker rescue experiments have localised the 
W204 mutation to a 400bp region in DMA fragment BamHI u. Cloning 
and sequencing of this fragm ent w ill enable the precise bp change of the 
^1204 m utation to be determined. Assignment o f the mutation to a 
specific gene should be possible from  DMA sequence analysis, and the 
amino acid sequence o f the polypeptide which is ^  in ^1204-in fected  cells 
can then be deduced. Analysis o f the amino acid sequence may provide 
clues as to the nature o f the protein and its  possible location in the 
virion. The next step would be the synthesis o f oligopeptides based on the 
amino acid sequence o f the polypeptide. Antisera raised against these 
peptides can be used to im m unoprecipitate the in ferred gene product from  
wild-type virus-in fected ce ll extracts. Successful use of this technique has 
already enabled Frame et al. (1985a, 1985b) to identify  several gene
products whose presence was in ferred by the DNA sequence of the Ug 
region of the HSV-1 genome.
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Using antisera specific  to the polypeptide, i t  should be possible to 
locate the polypeptide in the virus-infected ce ll and to determine whether 
it is a component o f the v irion .
Investigation o f the upregulated cellu lar genes in W 204-in fected 
cells is already underway. Synthesis of the 57,000 MW cellu lar protein 
may be cell-dependent since the polypeptide is detectable in several human 
fibroblast ce ll lines in fected  w ith  W 204 at the NPT, but is undetectable 
in W 204-in fected  BHK cells or CV-1 cells (V.G. Preston, personal 
communication). Investigation of whether any of the upregulated cellular 
genes in W 204 -in fe c ted  cells correspond to those seen in HSV-2-infected 
HFL cells or in te rfe ron -trea ted  cells w ill be of great in terest.
CHAPTER 4
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4.1 THE CHARACTERISATION OF TS1201 AND TS1203, TWO TS 
MUTANTS WITH DEFECTS IN ENCAPSIDATÏÔN OF VIRUS 
DNA
4.1.1 Introduction
The pathway of herpesvirus DNA encapsidation has not yet been 
characterised in any great deta il. The genetic and biochemical analyses of 
PRV mutants have provided valuable in form ation about virus DNA 
packaging. Ts m utants o f PRV which synthesize normal amounts of virus 
DNA at the NPT have been assigned to nine complementation groups 
(Ladin et a l., 1980). Members o f six of these cistrons produced capsids at 
the NPT, but fa iled  to package DNA. Viruses in the remaining three 
complementation groups did not assemble capsids or cleave concatemeric 
virus DNA in to  un it size. These results indicated tha t the process of DNA 
encapsidation was complex, and tha t capsid assembly and DNA maturation 
were genetically linked (Ladin et a l., 1980).
A t the s ta rt o f th is study, only one HSV-1 strain 17 mutant, 
W201, which produced capsids and virus DNA but was unable to 
encapsidate DNA at the NPT, had been identified  (Preston et a l., 1983). 
The following section describes the characterisation o f a new HSV-1 strain 
17 mutant, W 2 0 3 , which, like W 201 , has a defect in packaging virus DNA 
into capsids a t the re s tr ic tive  tem perature. In addition, observations made 
on ^1201 have been extended, and comparisons between the two mutants 
have been made wherever possible. The study was undertaken in an 
attempt to e lucidate the mechanism of HSV DNA encapsidation.
4.1.2 Phenotypic analysis of ts l203 using electron microscopy
Electron m icroscopic exam ination of thin-section preparations of 
^1203-in fected  cells grown at the NPT revealed th at the mutant assembled 
large numbers o f capsids which contained some internal structure but
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lacked the dense cores present in capsids containing mature virion DNA 
(compare Figs. 26a and 26c). In this respect, W 203 resembled tsl201 
which also assembled many in term edia te-type capsids at the res tric tive  
temperature (Preston et a l., 1983). However, whereas W 203 capsids were 
spread randomly throughout the nuclei (Fig. 26c), U1201 capsids were 
grouped in large crysta lline  arrays, usually positioned at the nuclear 
membrane (Fig. 26b). I t  was estimated tha t both W 201 and W 203 
assembled 20% more capsids than w ild -type HSV-1 at this temperature. A 
difference in core structure  was also apparent. The cores in tsl201 
capsids appeared to be less compact than those in ^1203  capsids (compare 
Figs. 26b and 26c). Since both these types o f electron-translucent core 
structure are seen in w ild -type virus capsids during a normal infection 
(Fig. 26a), i t  seemed like ly  tha t the ^1201  and ^1203 lesions affected 
different steps in the pathway of DNA encapsidation. Electron microscopic 
observations suggested tha t the lesion carried by ^1203  also had some 
effect on the e ffic iency o f DNA encapsidation by this mutant at the PT. 
Tsl203 assembled s im ila r numbers o f capsids to w ild-type virus at the PT, 
however, only approxim ately 12% of ^1203  capsids contained DNA 
compared w ith  30% o f w ild -type  virus capsids. No significant differences 
in the numbers o f fu ll capsids in ts l2 G l- and w ild-type virus-in fected cells 
could be detected at the PT.
The defect in DNA encapsidation observed in tsl2Q3-infected Cells 
was irreversible upon tem perature downshift at 9h pi, from  the NPT to the 
PT, in the presence o f cyclohexim ide to prevent fu rther protein synthesis. 
After a 4h incubation at the PT, no fu ll capsids could be detected 
(Fig. 26d). In contrast, the ts l201 defect was reversible under the same 
temperature shiftdown conditions: the large crysta lline arrays o f tsl201
capsids disaggregated, the uniform  core structure was lost, virus DNA was 
packaged and enveloped virions were produced (Preston et a l., 1983; see
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FIG URE 26
Electron micrographs o f thin-section preparations of HFL cells in fected
with 10 pfu of w ild -type HSV-1, W 201  or W 203 per cell at the NPT
(38.5°).
(a) Nucleus of a cell infected w ith  w ild-type HSV-1. Cells were
harvested a fte r a lOh incubation at the NPT.
(b) Nucleus of a ce ll infected w ith  ^1201 . Cells were harvested a fte r
a lOh incubation at the NPT.
(c) Nucleus o f a ce ll infected w ith  ^1203 . Cells were harvested a fte r
a lOh incubation at the NPT.
(d) Nucleus o f a ce ll in fected w ith  _^1203 at the NPT. A fte r 9h
incubation at th is temperature, cycloheximide was added, cells were
transferred to the PT and harvested at 12h pi.
(e) Nucleus of a ce ll infected w ith  ^1201 at the NPT. A fte r 9h
incubation at the NPT, cycloheximide was added, cells were 
transferred to the PT and harvested at 12h pi.
Long arrows indicate fu ll capsids. Short arrows represent empty or
intermediate capsids. The bar represents 0.5uM.
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FIGURE 27
Position of the ^1 2 0 3  m utation w ith in  HSV-1 DNA fragment Sali d, 
defined by marker rescue experiments. Fragments Sail d, Kpnl n and 
Kpnl 2 are indicated by the le tte rs  d, n and p respectively. Plasmid 
sequences (pAT153) are indicated by the le tte r a. The large (3200bp) Sall- 
BstEII fragment and the small (SOObp) Sall-BstEII fragment are indicated by 
the letters b and c respective ly. The position of the ^1203  mutation is 
represented by the hatched box.
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FIG URE 28
Genome locations of the mutations o f ^1201, ^1203, ts l204, ^1208 and 
other relevant HSV-1 ^  mutants. Details of the genes represented by 
these mutants, and c ita tions  fo r the ir isolation and mapping, are given in 
the text and in Table 7.
TABLE 5
Summary of marker rescue results for ts l203
HSV-1 DNA fragment eop NPT/PT 
(x 10-3)
Rescue
None <0.001 -
BamHI a 0.57 +
Kpnl (m + a) <0.001
n <0.001 -
E 3.2 +
t <0.001 -
V <0.001 -
Sail d 1.0 +
Sail a <0.001
b 3.4 +
c <0.001
TABLE 5
Summary o f marker rescue results fo r ts l203.
Cloned EcoRI f ,  digested w ith  Kpnl, gave five  fragments: Kpnl (m + a)
which contained sequences from  Kpnl m, a and pACYC184, and Kpnl n,
^  and y^ . Cloned Sail d, digested w ith  Sail plus BstEII, gave three 
fragments: a which contained sequences from  pAT153, b which contained
sequences from  the large (3200bp) Sall-BstEIl fragment, and c which 
contained sequences from  the small (800bp) Sall-BstEII fragment. A ll these 
fragments were purified  and used in marker rescue experiments. Plasmids 
containing the other DNA fragments were digested w ith  the appropriate 
restriction endonuclease prior to transfection.
The re lative e ffic iency  o f plating (eop NPT/PT) was calculated from  the 
yield of progeny virus at the PT and NPT from  the transfected cells.
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Fig. 26e).
4.1.3 Physical map location of the ts l203 lesion
The W 203  lesion was mapped by in tra typ ic  marker rescue. 
Experiments using separated Kpnl fragments from  cloned EcoRI ^  (plasmid 
pGX38) showed tha t the W 203  lesion mapped w ith in fragment Kpnl g  
(Table 5). This map location was fu rther refined using a cloned Sail 
fragment (plasmid pGX31), designated in this study Sail d, which mapped 
entirely w ith in  EcoRI ^  and rescued the W 203 lesion (Dr. V.G. Preston, 
personal communication). Sail d was cleaved w ith  restric tion  endonucleases 
Sail and BstEII. The resulting fragments o f 3556bp (plasmid vector 
pAT153), 3200bp (large Sall-BstEII fragment), and 800bp (small Sall-BstEII 
fragment) were screened fo r the ab ility  to rescue the W 203 mutation 
(Fig. 27, Table 5). Since the m utation was rescued by the large (3200bp) 
Sall-BstEII fragm ent, the ^1203  lesion must map w ith in a region of 
approximately 450bp defined by Kpnl and BstEII sites at mu 0.377-0.380 
respectively (Fig. 27). The W 201 lesion had previously been mapped to a 
region o f approxim ately 640bp w ith in  the HSV-1 DNA fragment BamHI u 
(0.330mu) (Preston e t a l., 1983). Thus, the J^1203 lesion maps to the righ t 
of the W 201  lesion w ith in  DNA fragment EcoRI U The map positions of 
these two mutations are shown in Fig. 28.
4.1.4 Tsl203 represents a new complementation group w ith in  DNA
fragm ent EcoRI f
Complementation experiments between ts l203 and other ^  mutants 
which map in DNA fragm ent EcoRI 2  were performed to determine 
whether ts l203 belonged to an existing complementation group. Details of 
the mutants used are given in Table 6, and Table 7 shows the results from  
a representative complementation experiment. Taking complementation 
indices o f greater than 4 as positive, mutant ts l203 is complemented by
TABLE 6
Mutant
Comple­
mentation
Group
Gene represented Reference
UZ47 1-33 Unknown
Defect in insertion 
o f glycoproteins 
in to ce ll membrane 
(mu 0.315-0.415)
Pancake et al. (1983) 
Mutant obtained from  
P.A. Schaffer
ts656 1-1 Major DNA binding 
protein (Vmwl36)
Hughes and Munyon (1975) 
M utant obtained from  
P.A. Schaffer
W-l 1-3*
1-4
DNA polymerase Stow and W ilkie (1978)
W 205 1-3*
1-4
DNA polymerase V.G. Preston, personal 
communication
1-9 Glycoproteins gB 
(mu 0.35-0.40)
Stow and W ilkie (1978) 
V.G. Preston, personal 
communication
TABLE 6
Details of ^  mutants used in complementation experiments w ith  ts l203. 
Complementation groups are as defined by P.A. Schaffer (personal 
communication).
Ts DNA polymerase mutants o f HSV-1 strain 17 fa il to complement 
mutants in e ither group 1-3 or 1-4 and in our laboratory mutants in groups 
1-3 and 1-4 fa il to complement each other (V.G. Preston, personal 
communication).
TABLE 7
Complementation between ts l203 and other ts mutants 
with lesions in HSV-1 DNA fragment EcoRI f
Mutant 1201 1203 Z47 656 H A 1205
1201 1 2116 89 402 90.4 33 14.19
1203 1 22.4 111.8 39.6 10.1 24.7
Z47 1 80.36 36.4 27.1 20
656 1 13.6 15.9 21.4
H 1 11.5 1.27
A 1 13.8
1205 1
TABLE 7
Complementation studies w ith  _U1203 and other ^  mutants w ith  lesions 
which map in HSV-1 DNA fragment EcoRI L  Details o f the ^  mutants 
used in this test are given in Table 6. Complementation yield tests were 
performed as described in Section 2.4.1. The values in the table represent 
complementation indices calculated from  the form ula used by Brown et al. 
(1973). Values greater than four were considered positive.
TsH and ^1205 each contain a mutation w ith in  the virus DNA polymerase 
gene (complementation group 1-3/1-4) and serve as negative controls in this 
experiment.
The results are representative of two such complementation experiments.
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all the other mutants tested. Thus, U12Q3 appears to represent a novel
complementation group w ith in  EcoRI f_,
4.1.5 DNA processing by tsl2G3 and ts l2G l
Electron m icroscopic observations on thin-section preparations of 
kl203- and W 2 G l-in fe c te d  cells revealed that mutant virus-infected cells 
grown at the re s tr ic tive  temperature did not contain dense cored capsids 
or mature virions. In order to confirm  that virus DNA was not
encapsidated at this tem perature, and to examine whether the unpackaged 
DNA was cleaved or not, virus DNA processing in W 2G3- and W 2G1- 
infected cells was investigated using the technique of Southern b lo tting as 
described below.
Total v irus-in fected ce ll DNA and encapsidated DNA (DNase- 
resistant DNA) were prepared from  HFL cells infected w ith  w ild-type 
virus, ^12G3 or ik l2 G l at the required temperatures (see Sections 2.3.2 and 
2.3.3; Stow et a l., 1983). These DNAs were cleaved w ith  BamHI which 
cleaves w ith in  both the short and long repeat sequences of the HSV
genome (Fig. 29b). The resulting fragments were separated on an agarose 
gel (Fig. 29a) and transferred to a nitrocellulose membrane. The term inal 
(£ and g) and joint-spanning (k) fragments in the samples were identified by 
hybridisation to a [ 32p]_iabelled BamHI k fragment probe (pGX2). The 
amounts of virus DNA cleavage and encapsidation were determined by 
densitometric analysis o f autoradiographs of the [ 32p]_iabelled bands 
representing joint-spanning and term inal fragments.
4.1.5a Rationale fo r the densitom etric quantitation of cleavage of virus 
DNA
Q uantitation o f the joint-spanning fragment, BamHI k, gives a 
representation o f the to ta l amount of virus DNA in the infected ce ll, i.e. 
both concatemeric and unit-length DNA, whereas quantita tion o f the
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FIG U RE 29
The physical map of HSV-1 fo r res tric tion  endonuclease BamHI, and an 
autoradiogram of the corresponding BamHI restric tion  digest pattern of 
[32p]_iabelled HSV-1 DNA.
(a) [ 32p]_iabeiled DNA samples were digested w ith  BamHI and
separated on 1.0% agarose gels. The le tters re fe r to specific HSV- 
1 DNA fragments, the physical map locations of which are shown 
in (b). Autoradiogram was supplied by Dr. V.G. Preston.
(b) Physical map of HSV-1 DNA fo r restric tion  endonuclease BamHI
was taken from  Davison (1981). The composition of the jo in t
fragment is given beside the map.
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terminal fragments, BamHI g and g, gives an estimate of unit-length DNA 
only. Theoretically, since BamHI cleaves w ith in  the repeat sequences of 
the HSV genome, fragm ents k, g  and g  should each be 1 molar in a BamHI 
digest of un it-length (encapsidated) DNA (Fig. 29). However, in this study, 
the BamHI k probe fragm ent was treated w ith  DNAase I prior to nick 
translation, and therefore  the amount of hybridisation of the probe to 
restriction endonuclease digest fragments should be proportional to both the 
size and m olarity o f the fragm ent.
Analysis o f w ild -type  virus encapsidated DNA revealed that the
formula k = q + s, where k, q and s represent the intensity of bands
BamHI k, g  and g  respective ly, was valid. It follows tha t the proportion
of 'endless' DNA which was cleaved to unit lengths can be calculated from
the following form ula;
% to ta l virus = q + s ^ ^gg
DNA cleaved k
It should be noted tha t, fo r the purpose of these quantitations, i t  
has been assumed tha t a ll the term ina l fragments detected have arisen as 
a result of s ite -spec ific  cleavage of concatemeric DNA prior to or during 
DNA encapsidation.
4.1.5b Analysis o f to ta l v irus-in fected ce ll DNA
The proportion o f 'endless' virus DNA which had been cleaved into 
genome length DNA was estimated from  the analysis o f to ta l v irus-in fected 
cell DNA. A representative autoradiograph of a Southern blot o f BamHI 
digested to ta l virus DNA is shown in Fig. 30. Densitom etric analysis of 
the proportion o f BamHI k, g  and g  present in each sample is shown in 
Table 8. The results show tha t at the PT, although w ild-type virus, ts l2G l 
3nd tsl203 a ll synthesized s im ila r amounts of DNA, the amount of DNA 
processed d iffe red  fo r each virus. Approxim ately 48% of w ild-type virus
17 syn* ts 1201 ts 1203
I I I
S r l l E i i  t i l
Bam HI k 
fragment
FIGURE 30
Autoradiogram of the analysis of to ta l v irus-in fected ce ll DNA. Unlabelled 
DNA was prepared from  HFL cells which had been infected w ith  a moi of 
5 pfu of w ild -type HSV-1, ^1201  or 1^1203 per ce ll as described in Section 
2.3.2. V irus-infected cells were incubated at the PT (31°) or NPT (38.5°) 
or were shifted down from  the NPT to the PT in the presence of 
cycloheximide a t lOh pi prior to harvesting at 18h pi. One-tenth of the 
sample from  a 50mm pe tri dish was cleaved w ith  BamHI and the resulting 
fragments were separated by electrophoresis through a 0.8% agarose gel. 
The fragments were transferred to a nitrocellulose sheet and hybridised to 
in vitro labelled [ 32p]_pQX2 DNA (contains HSV-1 fragment BamHI kL
TABLE 8
Densitometric analysis of to ta l virus-infected cell DNA
(a) Permissive temperature
Virus wt HSV-1 W 201 U1203
Amount of 
DNA synthesized
100.00*
100.00
100.00
110.27*
80.27
194.52
100.32*
119.77
99.40
Proportion of 
'endless' DNA 
cleaved to un it- 
length genomes
48.63*
58.97
31.41
39.90*
35.91
29.91
9 .92 *
18.63
13.28
(b) Non-permissive temperature
Virus w t HSV-1 U1201 ^1203
Amount of 
DNA synthesized
100.00*
100.00
100.00
124.44*
99.30
115.40
72 .21*
129.32
121.20
Proportion of 
'endless' DNA 
cleaved to un it- 
length genomes
36.00*
40.50
20.06
<1.00*
2.25
<1.00
<1.00*
<1.00
<1.00
(c) Temperature downshift
Virus w t HSV-1 W 201 U1203
Amount of 
DNA synthesized
100.00 
100.00 (100)
142.82
121.01 (131.91)
159.10
97.59 (128.45)
Proportion of 
'endless' DNA 
cleaved to un it- 
length genomes
44.73
43.54 (44.13)
22.71
39.88 (31.29)
<1.00
<1.00 (<1 .00)
TABLE 8
Densitometric analysis o f Southern blots o f to ta l virus-infected cell DNA. 
The amount of DNA synthesized by each mutant (represented by the 
amount o f [ ^^P]-labelled probe which hybridised to the jo in t fragment 
BamHl k) was expressed as a percentage of the amount of DNA 
synthesized by w t HSV-1. The proportion of 'endless' DNA which had been 
cleaved to un it-length  genomes by each virus was calculated as described 
in Section 4.1.5a. In the case o f samples incubated at the PT or NPT, the 
results of three experiments are given and the case of temperature 
downshift samples, the results o f two experiments are given. The figures 
in brackets represent the average of these results. Cells were harvested 
at 18h pi.
* These samples were not treated w ith  cycloheximide from  10-18h pi.
(a) Analysis o f to ta l v irus-in fected ce ll DNA at the PT.
(b) Analysis o f to ta l v irus-in fected ce ll DNA at the NPT.
(c) Analysis o f to ta l v irus-in fected ce ll DNA a fte r temperature
downshift from  the NPT to the PT at lOh pi.
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DNA and 39% o f ^1 2 0 1  DNA had been cleaved into unit length genomes 
by 18h pi, whereas only 9% of W 203 DNA had been processed under the 
same conditions. These results were consistent in repeated experiments.
A t the NPT, a ll three viruses again synthesized sim ilar amounts of 
DNA. Cleavage o f w ild -type  DNA was less e ffic ien t at 38.5° than at 31°, 
with approximately 36% of to ta l virus DNA in the form  of unit length 
genomes at the NPT, compared w ith  48% at the PT (Fig. 30, Table 8). 
However, <1% of to ta l W 201 and W 203 DNA was cleaved at the NPT. 
This result indicates th a t the mutant DNAs were 'frozen' in the form  of
circles or concatemers, but does not distinguish between the two
possibilities. On longer exposure o f the blots to film , term inal BamHI 
fragments £  and £  could be detected, and these bands may represent a
background level o f cleavage of both mutant DNAs.
Experiments in which virus-in fected cells were shifted from  the 
NPT to the PT at lOh pi in the presence of cycloheximide and incubated 
for a fu rther 8h revealed tha t approximately 44% of w ild-type virus DNA 
and 31% o f W 201  DNA was cleaved. However, a corresponding increase 
in the cleavage of to ta l ts l203-in fected  ce ll DNA was not seen. These 
results confirm  e lectron microscopic observations tha t the tsl203 defect is 
irreversible in the absence of protein synthesis, in contrast to the defect 
of W 201 which is fu lly  reversible under these conditions.
4.1.5c Analysis o f encapsidated (DNase-resistant) DNA
Hybridisation o f the probe to BamHI digested DNase-resistant DNA 
gives an estim ate o f the amount of genomic DNA which was encapsidated. 
Figure 31 shows a representative autoradiogram of a Southern b lot of 
BamHI digested encapsidated DNA. Table 9 shows the densitometric 
analysis o f BamHI k, £  and £ in each sample. These results confirm  the 
findings from  the analysis o f to ta l v irus-in fected ce ll DNA.
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FIG U RE 31
Autoradiogram of the analysis o f encapsidated (DNase-resistant) DNA.
Unlabelled DNase-resistant DNA was prepared from  HFL cells infected
with w ild-type HSV-1, ^120 1  or ^1203  (mol 5 pfu per cell) as described in 
Section 2.3.3). V irus-in fected cells were incubated at the PT (31°) or NPT 
(38.5°) or were sh ifted down from  the NPT to the PT in the presence of 
cycloheximide at lOh pi p rio r to harvesting at 18h pi. One-twentieth of 
the sample from  a 50mm p e tri dish was cleaved w ith  BamHI, and the
resulting fragments were separated by electrophoresis through a 0.8%
agarose gel. The fragm ents were transferred to a nitrocellulose sheet and 
hybridised to in v itro  labelled [ ^^P]-pGX2 DNA (contains HSV-1 fragment 
BamHI k). Tracks 4a, 6a and 9a are longer exposures of tracks 4, 6 and 9 
respectively.
TABLE 9
Densitometric analysis of encapsidated DNA
(a) Permissive temperature
Virus w t HSV-1 W 201 U1203
Amount of 100.00* 84.89* 17.34*
encapsidated 100.00 115.91 34.37
DNA
(b) Non-permissive temperature
Virus w t HSV-1 U1201 ^120 3
Amount of 100.00* <1.00* <1.00*
encapsidated 100.00 <1.00 <1.00
DNA
(c) Temperature downshift
Virus w t HSV-1 U1201 U1203
Amount of 100.00 49.24 <1.00
encapsidated 100.00 (100) 54.44 (5 1 .8 4 )) <1.00 (<1 .00)
DNA
TABLE 9
Densitometric analysis of Southern blots of encapsidated (DNase-resistant) 
DNA. The amount o f DNA encapsidated by each mutant (represented by 
the amount o f [ ^Zp]-labelled probe hybridised to fragment BamHI k) was 
expressed as a percentage o f the DNA encapsidated by w t HSV-1. The 
results of two experiments are given in each case. A ll samples were 
harvested at 18h pi.
* These samples were not treated w ith  cycloheximide from  10-18h pi.
(a) Amount o f DNA encapsidated at the PT.
(b) Amount o f DNA encapsidated at the NPT.
(c) Amount o f DNA encapsidated a fte r temperature downshift from  the
NPT to the PT at lOh pi.
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A t the PT, a s im ila r amount of virus DNA was encapsidated in 
wild-type virus and W 201-in fec ted  cells, whereas the amount of DNA 
packaged in 1^1203-infected cells was only 17% of that seen in w ild-type 
virus-infected cells.
A t the NPT, the amount o f DNA encapsidated by both W 201 and 
W203 was <1% of the DNA packaged by w ild-type virus (Fig. 31, 
Table 9). On longer exposure of the blots to f ilm , background levels of 
encapsidation were detected fo r both mutants (Fig. 31, tracks 49, 6a and 
9a). On tem perature downshift o f v irus-infected cells from  38.5° to 31° 
at lOh pi in the presence o f cycloheximide, the amount of virus DNA 
encapsidated in _^1201-infected cells a fte r an 8h incubation at the PT was 
approximately 52% o f tha t seen in w ild-type virus-in fected cells. However, 
no increase in the amount of DNA packaged in ^1203-in fected  cells was 
seen, confirm ing tha t the defect of this mutant is irreversible in the 
absence of prote in synthesis.
A fa in t band which m igrated slightly faster than fragment BamHI £ 
was often noted during these experiments. Since the BamHI k probe has a 
high (G+C) content, this band may have arisen as a result of spurious 
hybridisation between the probe and a DNA fragment which also has a high 
(G+C) content.
4.1.6 Processing of p40 in ts l203-in fected  cells
Previously, Preston et al. (1983) showed tha t ts l201 was unable to 
process p40 co rrec tly  to its  lower MW forms at the NPT, and suggested 
that this defect m ight be linked to the fa ilu re  o f U1201 to encapsidate 
DNA. Since t£ l203 also fa ils  to package DNA at the NPT, i t  was of 
interest to investigate processing o f p40 in cells in fected w ith  this mutant.
Im m unoprécipitation experiments were performed using a monoclonal 
antibody MA5010B, which was specific fo r p40. V irus-infected cells.
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FIG U RE 32
Autoradiograms of immune precip ita tes of p40 from  HFL cells infected at 
(A) 31° and (B) 38.5° w ith  w ild -type HSV-1, W 201 or W 203. Virus- 
infected ce ll polypeptides were pulse-labelled w ith  [ ^^S]-methionine at 5h 
pi for 30min. Cells were e ither harvested immediately, or a fte r incubation 
for a fu rthe r 5h in EFIO containing cycloheximide. Immunoprécipitation 
was performed as described in Section 2.7.7, using MA5010B which was 
specific fo r p40 o f HSV-1. Pre-immune samples were w ild-type virus- 
infected ce ll extracts which were incubated w ith  control non-immune rabbit 
serum in place o f MA5010B. The immunoprecipitated polypeptides were 
analysed on an 8% SDS polyacrylam ide gel.
p = pulse-labelled
pc = pulse-labelled followed by chase period
PI = pre-immune sample
e = m ock-infected or w ild-type virus-infected cell extract
i = im m unoprecipitate
filled squares = high MW form s of p40
open circles = lower MW form s o f p40
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incubated at the PT or NPT, were pulse-labelled w ith  [ ^^S]-methionine fo r 
30min at 5h pi as described in Section 2.7.3. The cells were either 
harvested im m ediate ly or a fte r a 5h 'chase' period in the absence of [^ ^ ] -  
methionine in medium containing cyclohexim ide to prevent fu rther protein 
synthesis. The results o f the im m unoprécipitation experiment are shown in 
Fig. 32. This data demonstrates tha t both W 203  and W 201 process p40 
correctly to its  lower MW form s at the PT (Fig. 32a). A t least five  
virus-specific polpeptides were resolved, ranging in MW from  approximately 
35,000 to 45,000. A t the NPT, ts l203 behaved as w ild-type virus, 
producing a ll form s of p40 (Fig. 32b). This is in contrast to ^1201 , which 
failed to process p40 co rrec tly  to its  lower MW forms at the res tr ic tive  
temperature (Fig. 32b). One explanation fo r this finding is that ^1203  is 
defective in a la te r stage of DNA encapsidation than ^1201. In addition, 
this result indicates tha t processing of p40 must represent only one stage 
in packaging o f virus DNA.
4.1.7 The fo llow ing two experiments were performed to investigate why 
p4G was not processed to its  lower MW forms in ts l201-in fected cells at 
the NPT:
4.1.7a Phosphorylation of p40
Previous reports had demonstrated that p40 synthesized in cells 
infected w ith  HSV-1 strains M AL (Heilman, 1982) and F (Braun et a l., 
1984b) was phosphorylated. However, i t  is noteworthy that the extent of 
p4G phosphorylation detected by Braun et al. (1984b) was variable. Since 
it was possible tha t phosphorylation o f p40 is a pre-requisite to cleavage, 
an experiment was performed to determ ine whether or not the high MW 
forms of p40 synthesized in W 201-in fec ted  cells at the NPT were 
phosphorylated. W ild-type virus- and W 201-in fec ted  cell polypeptides were
Ml HSV-117syiT tsl20l Ml HSV-1 17syn  ^ tsl20l
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FIG U RE 33
Autoradiogram of immune precip itates o f p40 from  HFL cells infected at 
38.5° w ith w ild -type  HSV-1 or ^1201 . V irus-infected ce ll polypeptides 
were labelled w ith  [ ^^S]-methionine or [ ^^P]-orthophosphate from  either 
6-12h pi or 12-18h pi. Cells were harvested in RIPA buffer and 
immunoprécipitation was performed as described in Section 2.7.7, using 
MA5010B which was specific fo r p40 of HSV-1. Pre-immune samples were 
wild-type v irus-in fected ce ll extracts which were incubated w ith  control 
non-immune rabb it serum in place of MA5010B. The immunoprecipitated 
polypeptides were analysed on an 8% SDS polyacrylam ide gel.
e = m ock-infected or w ild -type v irus-in fected cell extract.
i = im m unoprecipitate.
Tracks 1 to 7 = v irus-in fected ce ll polypeptides labelled w ith  [^^S ]-
methionine.
Tracks 8 to 14 = V irus-infected ce ll polypeptides labelled w ith  [ ^^P]-
orthophosphate.
Tracks 1 and 8 = m ock-infected ce ll ex trac t.
Tracks 2 and 9 = w ild -type virus-in fected ce ll ex trac t.
Track 3 and 10 = pre-immune sample.
Track 4 and 11 = w ild -type virus-in fected ce ll polypeptides labelled from
6-12h pi.
Tracks 5 and 12 = w ild -type virus-in fected ce ll polypeptides labelled from
12-18h pi.
Tracks 6 and 13 = ts l201 -in fected  ce ll polypeptides labelled from  6-12h
pi.
Tracks 7 and 14 = ts l2G l-in fec ted  ce ll polypeptides labelled from  12-18h
pT.
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radiolabelled w ith  e ither [ ^^S]-methionine or [ ^^P]-orthophosphate from  6- 
12h pi or 12-18h pi at the NPT. [ ^^]-methionine-labelled and 
phosphorylated form s of p40 were detected by im munoprécipitation of 
virus-infected ce ll extracts w ith anti-p40 antibody MA5010B, and 
electrophoresis o f im munoprecipitates on an SDS polyacrylamide gel. 
Figure 33 shows tha t although p40 was synthesized in both w ild-type virus 
and W 201-in fec ted  cells (Fig. 33, tracks 4, 5, 6 and 7), neither the 
processed nor unprocessed forms of p40 contained detectable amounts of 
phosphate (Fig. 33, tracks 11, 12, 13 and 14). Since this experiment was 
performed only in HFL cells, the possibility that phosphorylation of p40 is 
dependent on the host ce ll type cannot be ruled out. A lte rna tive ly , i t  is 
conceivable tha t monoclonal antibody MA5010B fa ils  to recognise the 
phosphorylated form s of p40. However, this prelim inary result indicates 
that p40 synthesized in w t HSV-1 strain 17-infected HFL cells does not 
contain detectable amounts o f phosphate. Thus, phosphorylation o f p40 is 
probably not a prerequisite fo r cleavage of the polypeptide in this virus 
strain, and therefore the fa ilu re  to phosphorylate p40 is unlikely to account 
for the processing defect o f ts l201.
4.1.8 High MW form s of p40 in ts l201-in fected cells are translocated to
the nucleus
Braun et al. (1984b) reported on the basis of ce ll fractionation 
experiments tha t the higher MW forms of p40 were the cytoplasmic 
precursors to nuclear products. Assuming that the processing site was 
within the nucleus, i t  was possible that p40 synthesized in ts l201-in fected 
cells at the NPT was not processed to its  lower MW forms because the 
polypeptide was not transported from  cytoplasm to nucleus.
Immunofluroescence assays were performed to determine the 
intracellular location of p40 synthesized by w ild-type virus and ts l201.
%
FIG U RE 34
Localisation o f p40 in ^1201  and w t H SV-l-in fected cells. Monolayers of 
HFL cells were in fected w ith  5 pfu o f w ild -type HSV-1, W 201 per ce ll or 
mock-infected. Cells were harvested at lOh pi and prepared fo r ind irect 
immunofluorescence assay.
(a) M ock-infected cells.
(b) Cells in fected w ith  w ild -type HSV-1 at 38.5°.
(c) Cells in fected w ith  1^1201 at 31°.
(d) Cells in fected w ith  ^1201  at 38.5°.
The monoclonal antibody used in a ll cases was MA5010B, which was 
specific fo r p40 o f HSV-1.
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Virus-infected HFL cells on coverslips were incubated fo r lOh at the NPT, 
at which point the cells were washed and fixed in preparation for 
immunofluorescence. The in trace llu la r d istribu tion of p40 was detected 
with monoclonal antibody MA5G10B. Figures 34b and 34d show that p40 
was localised in the nucleus in both w ild-type virus- and W 201-in fected 
cells at the NPT, ind ica ting tha t aberrant processing of p4G does not result 
from a fa ilu re  to transport the higher MW polypeptides from  the cytoplasm 
to the ce ll nucleus. I t  is interesting tha t the fluorescence observed w ith 
MA5G1GB was granular in appearance, and was occasionally localised in 
distinct areas o f the nucleus. Although this e ffe c t may result from  the 
fixation procedure, i t  is tem pting to speculate tha t this pattern of 
fluorescence re fle c ts  the association of p4G w ith  groups o f nucleocapsids.
4.1.9 p4G is associated w ith  tsl2G3 and ts l2 G l capsids at the NPT
On the basis o f experiments in which HSV nucleocapsids were 
isolated using detergent trea tm ent of v irus-in fected cell nuclei, i t  was 
suggested tha t the processed forms of p4G were present in w ild-type virus 
capsids which contained DNA, but not in empty capsids (Gibson and 
Roizman, 1974; Braun et a l., 1984b). In view of this data, i t  was of
interest to determ ine whether p4G was associated w ith  empty capsids in 
W 2G3-infected ce lls a t the NPT, and i f  so whether the high MW forms of 
p4G were associated w ith  ^12G1 capsids.
To this end, an a ttem pt was made to isolate and purify  capsids
from w ild -type v irus-, ts l2 G l- and tsl2G 3-infected cells at the NPT as 
described in Section 2.2.6. Capsids, obtained by this procedure and 
visualised under the electron microscope a fte r negative staining, appeared 
re lative ly free o f contam inating ce ll debris. However, analysis o f capsid 
proteins by SDS-PAGE revealed tha t the samples were heavily 
contaminated w ith  other v irus-in fected ce ll polypeptides. A ttem pts to
FIG U RE 35
Localisation o f p40 on w ild -type virus, W 201  and U1203 capsids by 
immune electron m icroscopy. Monolayers o f HFL cells were infected at 
38.5° w ith  5 pfu o f w t HSV-1, ^1201  or ^1203  per ce ll. V irus-infected 
cells were harvested a t lOh pi when ha lf ô f each sample was embedded in 
epon resin (B, D and F) (Section 2.9.1) and ha lf in Low icry l resin (A, C 
and E). Immune electron microscopy was performed on thin-section 
preparations o f the Lowicryl-embedded samples by Dr. F.J. Rixon. These 
thin-sections were trea ted  w ith  a monoclonal antibody specific fo r p40 
(MA5010B), and then w ith  a protein A -collo ida l gold conjugate, before 
viewing in the e lectron microscope.
A and B, nuclei o f cells in fected w ith  w t HSV-1.
C and D, nuclei o f cells in fected w ith  ts l201.
E and F, nuclei o f cells in fected w ith  ts l203.
Full, pa rtia lly  cored and empty capsids are indicated.
The bars represent 0.5um.
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isolate nucleocapsids from  HFL cells, or the use of sucrose ve locity  
gradients to band capsids, fa iled  to improve purifica tion .
As an a lte rna tive  approach, the technique of immune electron 
microscopy was used to investigate whether p40 was associated w ith  ts l203 
capsids at the NPT. These experiments, performed in collaboration w ith  
Dr. F.J. Rixon, involved the trea tm ent of thin-section preparations of 
virus-infected cells w ith  anti-p40 monoclonal antibody, followed by 
treatment w ith  a prote in A -co llo ida l gold partic le  conjugate. When viewed 
under the electron microscope, the collo idal gold particles were easily 
visualised and the location o f p40 in the ce ll could be deduced. From 
Fig. 35 (a, c and e) i t  is clear tha t p40 was associated w ith  capsid 
structures in w ild -type v irus-, W 2 0 1 - and ^1203-in fec ted  cells. I t  was 
d ifficu lt to distinguish between d iffe ren t types o f capsids in these samples, 
which had been embedded in a hydrophilic, acry lic  resin (Low icryl). 
However, duplicate samples, which were embedded in epon resin (see 
Section 2.9.1), confirm ed tha t DNA encapsidation did not occur in e ither 
W 203- or W 201-in fec ted  cells (Fig. 35b, d and f).
4.1.10 Cloning o f DNA sequences containing the tsl203 m utation
As the f irs t  step in determining the a ltera tion in the DNA 
sequence responsible fo r the ts l203  phenotype, the Sail fragm ent containing 
the ^1203 m utation, and the corresponding fragment from  ^1203-rev  1 (a 
spontaneous revertan t o f ts l203), were cloned in to plasmid vector pUC9. 
The res tric tion  endonuclease digestion patterns o f these two recombinant 
plasmids (designated p C A l and pCA2 respectively) were compared w ith  tha t 
of plasmid pGX31, which contains the corresponding Sail fragm ent from  w t 
HSV-1 (Fig. 36, tracks 2, 3 and 4). Digestion of a ll three plasmids w ith  
Sail plus BstEII gave three corresponding bands as expected (compare 
Figs. 27 and 36, tracks 5, 6 and 7), and digestion w ith  Kpnl plus BstEII
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FIGURE 36
Restriction analysis o f pGX31, p C A l and pCA2. Plasmid DNAs (lug) were 
digested w ith  the appropriate restric tion  endonucleases under standard 
conditions. D igestion products were analysed by electrophoresis on a 0.8% 
agarose gel.
Tracks 1 and 11 = Uncut pGX31.
Tracks 2, 3 and 4 = pGX31, p C A l and pCA2 respectively, cleaved w ith
Sail.
Tracks 5, 6 and 7 = pGX31, pC A l and pCA2 respectively, cleaved w ith
Sail plus BstEII.
Tracks 8, 9 and 10 = pGX31, pC A l and pCA2 respectively, cleaved w ith
Kpnl plus BstEII.
The arrow indicates the 450bp KpnI-BstEII DNA fragm ent in which the 
W 203 m utation maps.
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showed tha t the plasmids contained the 450bp fragment in which the
U1203 m utation had been mapped (Fig. 36, tracks 8, 9 and 10). The
plasmids were tested in marker rescue experiments w ith  ^1203  DNA
(Table 10). The fa ilu re  of cloned W 203 Sail d to give i&+ progeny
indicated tha t the m utant DNA sequence had been cloned. The Sail d 
sequence cloned from  W 2 0 3 -re v -l successfully rescued the W 203
mutation. These results indicated that the correct Sail fragment had been 
cloned in each case.
4.1.11 Mapping re s tr ic tio n  endonuclease sites by pa rtia l digestion
R estric tion  enzymes, which could be used to cleave the cloned
DNAs in to small fragm ents suitable fo r subcloning in to the single-stranded 
phage vector M13 p rio r to sequencing by the dideoxy chain term ination 
method, were iden tified  (Sanger et a l., 1980). R estriction endonuclease 
sites w ith in  the 45Gbp KpnI/BstEII fragment were mapped by 3* end-
labelling o f the fragm ent w ith  partia l digestion w ith  [ and
polyacrylamide gel electrophoresis of the digestion products. An 
autoradiogram of [ ^^P]-labelled partia l digestion products of cleavage of
the 45Gbp fragm ent w ith  restric tion  enzymes A lu l, Haelll, Hpall, Smal and 
Thai is shown in Fig. 37. Three sites were recognised by A lu l, two sites 
by Haelll, two sites by Hpall and at least eight sites by Thai. No sites 
for Smal cleavage were contained in the 45Gbp fragment. Thus, 
overlapping DNA fragm ents suitable fo r sequencing could be obtained by 
cleavage o f the 45Gbp KpnI/BstEII fragment singly w ith  A lu l and Haelll.
4.2 DISCUSSION
The previous section describes the characterisation of W2G3 which, 
like W 2G1, fa ils  to  package DNA into capsids at the res tr ic tive  
temperature. B iochemical and genetic analyses o f the two mutants
TABLE 10
Marker rescue of ts l203 using pGX31, p C A l and pCA2
Plasmid
DNA
eop NPT/PT 
(x 10-3)
None <0.001
pGX31 0.69
pC A l <0.001
pCA2 0.22
TABLE 10
Marker rescue o f W 203  using pGX31, pC A l and pCA2. Plasmid DNAs 
pGX31 (contains HSV-1 DNA fragment Sail d), p C A l (contains W 203 DNA 
fragment Sail d) and pCA2 (contains ^1203  rev-1 DNA fragment Sail ÿ  
were cleaved w ith  Sail and used in marker rescue experiments.
The re la tive  e ffic iency  of plating (eop NPT/PT) was calculated from  the 
yield of progeny virus at the PT and NPT from  the transfected cells.
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FIGURE 37
Mapping o f re s tr ic tio n  endonuclease sites w ith in  the 450bp KpnI/BstEII 
fragment by p a rtia l digestion. An amount o f 3 '-term inaIly [ ^^P]-labelled 
Kpn/BstEII fragm ent, equivalent to 1x10^ cpm, was pa rtia lly  digested w ith  
restriction enzymes A lu l, Haelll, Hpall, Smal or Thai. Partia l digestion 
products were separated on a 10% polyacrylam ide gel. 3 '-term ina lly  
[ ^^P]-labelled H pall fragments of pBR322 were used as size markers. The 
arrow marks the undigested 45Gbp KpnI/BstEII fragm ent.
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indicated tha t ^1 2 0 3  and ts l2Q l were blocked at d iffe ren t steps in the 
pathway of herpesvirus DNA encapsidation.
Genetic analysis o f ts l203
The lesion in ts l203  maps w ith in  a 450bp fragment located between 
mu 0.377-0.380 on the HSV genome. This m utation is to the righ t of the 
k l2 0 1  lesion (mu 0.33) w ith in  HSV DNA fragment EcoRI f.
Several other mutants of HSV w ith  s tructura l defects map in 
this region o f the genome (Fig. 28). Tsl204 and U1208 both have a defect 
in assembly o f functiona l nucleocapsids at the NPT, and map w ith in  HSV 
DNA fragm ent EcoRI _f (Addison et a l., 1984; see Section 3.2). TsN20 
(mu 0.445-0.448) assembles many empty and pa rtia l cored capsids at the 
restric tive  tem perature, as well as a small number o f 'aberrant capsid'
structures and fu ll capsids (Schaffer et a l., 1974; Coen et a l., 1984).
Another m utant, tsZ47 (mu 0.312-0.415), maps w ith in  HSV DNA fragment 
EcoRI ^  and has been characterised as an immune cyto lysis-resistant 
mutant. Although tsZ47 synthesizes w ild-type amounts of DNA at the 
NPT, i t  is not ye t known whether this mutant also has a capsid assembly 
defect. Further analyses would be required to determ ine whether these 
mutants, together w ith  W 203  and W 201, represent a cluster of essential 
structural genes on the HSV genome.
Several mutants o f PRV w ith defects in DNA encapsidation have
been isolated (Ben-Porat et a l., 1982; Ladin et a l., 1982). The lesions
in these mutants map in the righ t hand end of the region of the PRV 
genome, and include tsN, W E13 and ts lO l (mu 0.19-0.27), tsUH3 and ts l06  
(mu 0.09-0.19) (Ihara e t a l., 1982). DNA homology studies have indicated 
that the HSV and PRV genomes are essentially colinear, except fo r the 
region between mu 0.1-0.4 which appears to be inverted (Davison and 
Wilkie, 1983). I t  would be of in terest to determ ine, fo r example, by
1 1 4
cross-hybridisation studies, whether any of the genes represented by these 
PRV mutants are analogous to the HSV gene in which the U1203 m utation 
lies.
Processing of virus DNA
Analysis of v irus-in fected cell DNA by Southern b lo tting revealed 
that although 3b'|, o f DNA synthesized by w ild-type virus at the NPT was 
cleaved to un it length genomes, greater than 99% of the DNA synthesized 
by both ts l203  and ts l201  was ’endless' at this temperature. This result 
supports data obtained by Ladin et al. (1980), in a study of PRV ^  
mutants which fa iled  to package virus DNA into capsids at the NPT. 
Using sedimentation analysis of v irus-in fected ce ll DNA on sucrose 
gradients, these workers demonstrated tha t mutant DNA synthesized at the 
NPT was in a rap id ly  sedimenting form , quite d is tinct from  tha t of mature 
virion DNA. In addition, restric tion  enzyme digestion profiles of these
mutant DNAs revealed the under-representation of term ina l fragments and 
the appearance o f a new jo in t fragment. On the basis of these results, 
the authors reported that at the NPT, the mutant DNAs were in
concatemeric structures consisting of tandem arrays o f the virus genome. 
The use o f the Southern b lotting technique in th is study to detect HSV 
joint-spanning and te rm ina l fragments provides additional evidence tha t the
DNA synthesized by mutants which fa il to encapsidate DNA is in an
endless fo rm . A lthough no sedimentation analysis o f ^1201 or W 203  
mutant virus DNA was performed, i t  is reasonable to assume tha t the
unpackaged m utant virus DNA is in the form  of concatemers.
The ts l201  defect was reversible since, upon shift-down o f in fected 
cells from  the NPT to  the PT in the absence of fu rthe r protein synthesis, 
W 201 DNA was cleaved and packaged in to capsids. These results suggest 
that DNA cleavage occurs concurrently w ith  DNA packaging. However,
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less DNA was cleaved in ts lZO l-in fected  cells than in w ild-type virus- 
infected cells under these conditions. It  is possible that this d ifference 
could be accounted fo r by the amount of w ild-type virus DNA already 
cleaved at the NPT before temperature downshift. During this period, 
cleavage o f ts lZO l DNA would not occur. In contrast to the result 
obtained w ith  W 201 , an increase in the amount of cleavage of W 203  
DNA was not seen upon temperature downshift in the presence of 
cycloheximide. This finding indicates tha t the W 203 defect is irreversib le 
in the absence o f de novo protein synthesis. It is also notable tha t DNA 
encapsidation was less e ffic ie n t in ^1203-in fected  cells at the PT than in 
cells infected w ith  w ild-type virus or ^1201 . This defect is probably 
reflected in the small plaque size of W 203 (data not shown).
Although the amount of DNA synthesized by w ild -type virus at 
38.5° was comparable to the amount synthesized at 31°, DNA m aturation 
in w ild-type virus-in fected cells at the high temperature was less e ffic ie n t 
than at the lower temperature. This may be a consequence of the 
therm olability o f a virus polypeptide(s) involved in the DNA encapsidation 
process.
I t  is not known whether the in itia tio n  of a ro lling  c irc le  method of 
DNA replication occurs at a specific sequence on the HSV genome, or is 
the result of random nicks along the DNA strand. Therefore, i t  fo llows 
that i t  is unknown whether concatemeric DNA molecules contain random or 
specific term inal sequences, fo r example, an a sequence or an o ri-  
containing sequence. However, i t  is interesting to note tha t plasmids 
containing ori sequences, but lacking an a sequence, are capable o f form ing 
concatemers (Stow, 1982), a finding which supports the idea tha t in itia tio n  
of a ro lling c irc le  mode of DNA replication occurs at one o f the ori^ 
sequences. This result suggests tha t concatemeric HSV DNA molecules are 
unlikely to end specifica lly in an a sequence. For th is reason, i t  was
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assumed tha t low levels of term inal fragments detected in m utant virus- 
infected ce ll DNA samples at the NPT arise as a result of specific 
cleavage of DNA at the a sequence during encapsidation. Q uantita tion of 
the re la tive  proportions of 'endless' and cleaved DNA in virus-in fected cells 
has therefore been possible. As expected, the quantitation of cleavage of 
'endless' DNA correlated well w ith  estimates of encapsidated DNA. 
Clearly, some experimental error in such a m ulti-step process is 
unavoidable, however, the quantitations are valid in so fa r as the results 
obtained were reproducible in several experiments. These analyses also 
provided confirm ation of electron microscopic observations on thin-sections 
of mutant v irus-in fected cells.
Irrevers ib ility  o f the tsl2Q3 defect
The ^  defect of W 203 was irreversible upon temperature
downshift to the PT in the presence of cyclohexim ide. There are three
possible explanations fo r this finding. F irs tly , the ^  m utation in ts l203  
may have resulted in the synthesis of a polypeptide which is unstable, fo r 
example, the protein may have an altered configuration at the NPT which 
renders i t  susceptible to degradation. A lte rna tive ly , the mutated
polypeptide may be stable at the NPT, but may be unable to  regain a 
functional configuration upon temperature downshift to the PT. In both 
these cases, de novo synthesis of the mutant polypeptide would be required 
at the PT before the encapsidation process could proceed. Th ird ly , the 
capsids assembled at the NPT may be aberrant and incapable o f packaging 
virus DNA even i f  the mutant polypeptide regains a functiona l
conformation upon temperature downshift to the PT. This possib ility w ill 
be discussed in more detail la te r. I t  is feasible tha t the m utant 
polypeptide m ight have impaired function at the PT, as a consequence of a 
less com patib le  amino acid substitution, compared to the w ild -type prote in.
1 1 7
Virus-induced protein profiles failed to reveal any remarkable 
differences between W 203 and w ild-type virus at the NPT (data not 
shown). A lte rna tive  approaches to identifica tion  of the a ffected gene 
product w ill be indicated la ter.
Association o f p40 w ith  empty capsids
To determ ine whether or not the lower MW forms of p40 in 
^1203-in f ected cells grown at the NPT were associated w ith  the 
intermediate capsids assembled by this mutant, attem pts were made to 
purify the m utant virus capsids. These experiments, however, were 
unsuccessful. There were a variety of reasons fo r this fa ilu re . F irs t, the 
yield o f capsids was generally low and, in some instances, no capsid band 
could be detected in the Percoll gradient. This problem could be pa rtia lly  
overcome by using low-passage cells to propagate the virus. Second, 
capsid preparations were often heavily contaminated w ith  non-structural 
virus polypeptides, and w ith  cell debris. Further trea tm ent of these capsid 
preparations w ith  detergents followed by rebanding o f capsids on Percoll or 
sucrose gradients did not resolve this problem. It  is possible tha t the 
contaminating m ateria l could be reduced by using a d iffe ren t ce ll type to 
propagate the virus. Third, problems were encountered in isolating the 
capsid band from  the gradient. On several occasions, a capsid band which 
was c learly visib le on a Percoll gradient was not detected as a radioactive 
peak, fo llow ing frac tiona tion  of the gradient. Again, this problem could, in 
part, be due to  a low yield of capsids from  the mutant v irus-in fected 
cells. However, i t  was fe lt  that improvement could be made to the 
fractionation system.
Immune electron microscopy, performed in collaboration w ith  
Dr. F.J. Rixon, provided a successful a lterna tive  method to determ ine 
whether or f io t p40 was associated w ith  HSV capsids which did not contain
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DNA. In the ligh t o f previous data, the results obtained during these 
experiments are o f great in terest. It had been shown that p40 was absent 
from capsids lacking a DNA core which had been isolated by detergent 
treatm ent o f in fected ce ll nuclei (Gibson and Roizman, 1972; Braun et a l., 
1984b). However, using ^  mutants which fa il to encapsidate DNA, immune 
electron microscopy data has shown unequivocally tha t p40 is associated 
with in term ediate capsids. Recently, Braun et al. (1984b) reported that 
only the lower MW form s of p40 were associated w ith  detergent-extracted, 
fu ll capsids. Our results did not agree w ith  the ir findings. Immune 
electron m icroscopic observations on W 201-in fected  cells at the NPT 
clearly demonstrated tha t the high MW forms of p40 become associated 
with capsids p rio r to  DNA encapsidation. One explanation fo r these 
conflicting results is th a t p40 may be in it ia lly  loosely associated w ith  the 
capsid surface, and tha t a strong attachment is only made once DNA 
encapsidation has occurred. Thus, during detergent trea tm ent, p40 is 
removed from  empty capsids, whereas w ith  the technique of immune 
microscopy, p40 remains loosely associated w ith  the capsids. These results 
have been corroborated by the findings of Irm iere and Gibson (1983, 1985) 
in a study o f s truc tu ra l polypeptides in HCMV 'A ' capsids which lack DNA 
and any in terna l s tructu re , B capsids which lack DNA but contain some 
internal structure , and non-infectious enveloped partic les (NIEPS) which 
appear to be enveloped B capsids. These workers detected an HCMV 
36,000 MW 'assembly prote in ' in B capsids and in NIEPS, but not in A 
capsids. I t  is notable tha t these B capsids were isolated by freeze-thaw 
treatm ent o f in fected  ce ll nuclei, and not by the use o f detergents. 
Assuming tha t the HCMV 'assembly protein ' and the HSV p40 are 
analogous, these results demonstrate tha t (i) p40/36K becomes a capsid 
component before DNA packaging, and before processing o f the polypeptide 
to lower MW species occurs, (ii) processing o f p40 occurs before DNA
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encapsidation, and ( iii)  removal o f p40 is not required fo r envelopment of 
the capsid. W ith regard to the fina l point, i t  should be noted tha t NIEPS 
which lack DNA, have not yet been reported in HSV-infected cells.
General models fo r DNA encapsidation
The exact functions o f the polypeptides which are ts in ts l203 - and 
^1201-in fected cells are unknown. However, a b rie f review of DNA 
packaging models proposed fo r other virus systems may provide some basis 
for speculation.
The pathways o f DNA encapsidation fo r the bacteriophage A , T4 
and P22, have been studied in detail, and share several features in common 
with the encapsidation o f herpesvirus DNA. These bacteriophage have an 
icosahedral-shaped head or capsid, into which ds DNA, taken from  a pool 
of concatemeric molecules, is packaged. The ava ilab ility  o f in v itro  DNA 
packaging systems fo r these bacteriophage has fa c ilita te d  the elucidation of 
the DNA encapsidation pathway, which is summarised below.
The co rrec t assembly o f immature capsid shells is probably directed 
by 'scaffolding' or 'assembly core' proteins which are absent from  the 
mature pa rtic le  (Casjens and King, 1975; Murialdo and Becker, 1978; 
Earnshaw and Casjens, 1980). The DNA is replicated in the form  of 
concatemers, and a specific  recognition step is required to ensure tha t only 
virus DNA is packaged in to the empty capsids. In the phage system, this 
involves the in te rac tion  o f a phage-specified enzyme called 'term inase' w ith  
a specific phage DNA sequence designated cos (Emmons, 1984; Feiss and 
Becker, 1983). The HSV a sequence is probably involved in an analogous 
process. This prote in ;D N A complex makes specific contact w ith  a 
cylindrica l 'connector' structure  which, in the phage system, is situated at 
the capsid vertex where the ta il attaches (Serwer, 1976; Coombs and 
Eiserling, 1977). This prote in structure forms the entrance through which
"D
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FIGURE 38
Scanning fo r the te rm ina l cos site o f phage A DNA, showing part o f a
nearly f ille d  head. The 'terminase' protein is shown positioned at the 
connector structure o f the capsid vertex. The DNA strand is being 
'scanned' by terminase un til the cos site (fille d  triangle) is encountered, 
and cut. This model is taken from  Feiss and Becker (1983). Details are 
given in the te x t.
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DNA is packaged in to  the capsid shell (Fig. 39). The structure and 
position of the entrance in to herpesvirus capsids is not known. Analysis of 
in v itro  A packaging systems has demonstrated tha t energy (in the form  
of ATP) is required to drive DNA encapsidation. On the basis of X-ray 
crystallography observations, Earnshaw et al. (1976) reported tha t the DNA 
in phage P22 heads was packed as an ordered toro ida l superhelix. I t  is 
postulated tha t because of its stiffness and charged nature, the DNA seeks 
a radius o f maximum curvature on entering the head. Thus, the newly 
packaged DNA makes contact w ith the inner wall of the capsid, and 
coiling proceeds inwards. Polyamines are thought to stabilize the DNA 
within the phage capsid shell (Earnshaw and Casjens, 1980) and have also 
been found associated w ith packaged HSV DNA (Gibson and Roizman, 
1971). Term ination o f packaging is achieved in the A system by scanning 
of the DNA strand un til the next cos site is recognised by terminase 
(Fig. 38). A t th is point, the DNA is cleaved by the in troduction o f 
staggered, single-strand nicks (Feiss and Widner, 1982). A s im ilar model 
whereby the HSV DNA strand is scanned fo r a sequences, is easily 
envisaged. Indeed, a staggered nick-repair mechanism for cleavage and 
packaging of HSV DNA was recently proposed by Varmuza and Smiley 
(1985) (Fig. 8). In th is model, the L and S te rm in i o f HSV DNA arise by 
staggered single-stranded nicks, the positions o f which are d irected by 
signals w ith in  the a sequence. Repair synthesis produces the two te rm in i, 
each bearing an a sequence.
Poffenberger and Roizman (1985) proposed an addition to  the 
"scanning”  model o f DNA packaging, based on the analysis of m utant HSV- 
1(F) 1358, which has a non-inverting genome due to a 15kbp deletion 
spanning the L-S junction. These workers showed tha t a small percentage 
(5% or less) o f packaged 1358 DNA was in the form  of covalently closed 
circles. In addition, a large fraction  (30-40%) of 1358 DNA formed
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covalent head-to -ta il linkages soon a fte r in fection, and in the absence of 
de novo v ira l protein synthesis. The authors proposed that the cleaved 
term ini o f fu ll length HSV DNA molecules are held together during 
packaging, probably by proteins bound to the a sequence. A small frac tion  
of the te rm in i would be covalently linked during or a fte r packaging.
Whether this model is generally predictive fo r standard HSV DNA is open 
to question and d if f ic u lt  to authenticate, since all four possible head-to -ta il 
junctions are produced in abundance during isomérisation o f the genome, 
and are represented in standard HSV virion DNA. Furthermore, th is model 
requires a mechanism to achieve the juxtaposition o f two term in i fo llow ing 
cleavage of the un it-length molecule from  the DNA concatemer, and 
before packaging is complete. Perhaps an a lterna tive  in te rpre ta tion  o f 
these results would be tha t cleavage and packaging of the HSV genome
occurs by a mechanism sim ilar to that proposed fo r phage , and tha t the 
term inal proteins are bound to the DNA e ither prior to or during
encapsidation. The small percentage of c ircu la r molecules seen by 
Poffenberger and Roizman (1985) in packaged 1358 DNA could be formed 
fortu itously once the DNA was encapsidated.
The insertion o f virus DNA into a preformed capsid shell has also 
been proposed fo r adenovirus. Adenovirus DNA is replicated by strand- 
displacement o f c ircu la r unit-length molecules (Lechner and K e lly , 1977; 
Sussenbach and K u ijk , 1978). Again, a specific recognition step, s im ilar to 
that involving the phage DNA cos sequence and the HSV DNA a sequence, 
has been proposed as one of the in it ia l steps in adenovirus DNA
encapsidation (Hammarskjold and Winberg, 1980). However, a detailed 
pathway of adenovirus DNA packaging is not known.
An a lte rna tive  model of nucleocapsid assembly has been proposed 
for both herpesviruses and adenovirus. In this model, capsids are formed 
around a nucleoprotein core in a stepwise assembly process, which results
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in the accum ulation o f structures of increasing sedimentation value. Weber 
Gf (1985) demonstrated that concurrent adenovirus DNA synthesis was 
essential fo r virus assembly. Sedimentation ve locity analysis in sucrose 
gradients of nucleoprotein complexes (NPCs) isolated from  in fected ce ll 
nuclei, revealed tha t virus structural proteins and Sl-sensitive virus DNA 
were present in a broad peak throughout the gradient. On the basis of 
these results, the authors suggested tha t capsid assembly and DNA 
synthesis were physically linked, and tha t stepwise assembly of capsids 
around the genome was occurring. A sim ilar proposal was made by 
Pignatti and Cassai (1980) who isolated NCPs from  HSV-infected cells using 
non-ionic detergent trea tm ent. Electron microscopic examination of 
sucrose grad ien t-purified  NPCs revealed tha t they consisted o f hexagonal 
capsules (110-12Gnm diameter) containing electron dense cores which 
resembled extended nucleocapsid structures. The authors postulated tha t 
the NPCs were capsid assembly intermediates, and tha t addition o f other 
structural polypeptides resulted in the production o f mature nucleocapsids. 
However, the possib ility that the NPCs were degraded nucleocapsid 
structures was not addressed in these experiments, and unequivocal 
evidence tha t any structura l polypeptides were absent from  these 
complexes has not been presented.
Function o f the gene product which is ts in ts l201 -in fec ted  cells
A t the NPT, W 201 fa ils  both to process p40 to its  lower MW 
forms and to encapsidate virus DNA. The reason p4G remains unprocessed 
in W 2 G l-in fe c te d  cells in unclear. Braun et al. (1984b), on the basis of 
cell frac tiona tion  experiments, reported tha t the higher MW forms of p4G 
were cytoplasm ic precursors to the lower MW nuclear products. Therefore, 
the possibility existed tha t the processing defect in W2G1 resulted from  a 
failure to transport the prim ary p4G translation products to the nucleus.
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Immunofluorescence experiments, however, revealed tha t the high MW 
forms of p40 synthesized in U1201-infected cells at the NPT accumulated 
in the nucleus, a finding which contradicts the results o f Braun et al. 
(1984b). One explanation fo r these con flic ting  results m ight be tha t the 
high MW form s of p40 are loosely associated w ith  the nucleus, and 'leak 
out' in to the cytoplasm ic extract during ce ll fractiona tion . C learly, 
immunofluorescence assay of fixed infected cells is a be tte r method of 
determining the in trace llu la r location of virus polypeptides.
An a lte rna tive  reason fo r the tsl201 processing defect was 
suggested by previous reports tha t p40 synthesized in cells in fected w ith  
HSV-1 strains M AL (Heilman, 1982) and F (Braun et a l., 1984b), was 
phosphorylated. Thus, i t  was possible tha t phosphorylation of p40 was a 
prerequisite fo r cleavage, and tha t p40 synthesized in ^1201 -in fec ted  cells 
at the NPT was unphosphorylated. However, im m unoprécipitation 
experiments fa iled  to detect any phosphorylation o f p40 synthesized either 
by w t HSV-1 stra in  17, or W 201 . Since processing o f p40 to its  lower 
MW forms occurs norm ally in HSV-1 strain 17-infected cells, i t  is unlikely 
that phosphorylation o f the polypeptide is required fo r conversion to the 
lower MW form s in th is virus strain. The remaining possib ility, tha t at the 
NPT the m utant p40 adopts a configuration which is unable to be 
processed to lower MW form s, has not been investigated.
C learly, the characterisation of W 201 shows tha t processing o f p40 
is a prerequisite fo r HSV DNA encapsidation. However, analysis o f ts l203 
suggests tha t events a d d i t io n a l  to p40 m odifica tion are required
before DNA packaging can occur. Perhaps m odifica tion o f p40 on the 
capsid surface acts as a signal fo r the attachm ent o f other tegument 
polypeptides, one or several of which m ight be involved in the virus DNA 
attachment/cleavage/packaging process. It  is tem pting to speculate tha t 
acquisition o f tegum ent polypeptides on the capsid surface results in the
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disaggregation of the crysta lline arrays of capsids seen in ts l201 -in fec ted  
cells at the NPT to the random distribution of capsids seen in U1203- 
infected cells at th is temperature. A lte rna tive ly , m odifica tion o f p40 
itself m ight be responsible fo r this e ffe c t.
Function o f the gene product which is ts in ts l203 -in fected  cells
Since the gene product which is ^  in ^1203-in fec ted  cells has not 
yet been iden tified , any predictions of its  function must be purely 
speculative. On one hand, the polypeptide m ight be involved in capsid 
shell assembly, i.e. a scaffolding protein. In this case, aberrant capsids 
would be assembled such tha t DNA encapsidation was impossible, both at 
the NPT, and upon temperature downshift to the PT. A lte rna tive ly , the 
polypeptide m ight be contro lling a step in the DNA encapsidation pathway
per se. In this case the polypeptide could be involved in a sequence
recognition in a manner analogous to the phage terminase enzyme, or
perhaps have a role in linkage of DNA to the capsid, or be required fo r 
insertion of the DNA into the capsid. Functional analysis must obviously 
await iden tifica tion  o f the gene product.
4.3 FU TU R E PROSPECTS
The u ltim a te  aim of the characterisation o f HSV ^  mutants is the 
determination o f the function of virus gene products. As w ith  W 204 , the 
early steps in th is process have been completed fo r the gene product which 
is ^  in ^120 3 -in fec te d  cells. Marker rescue experiments have localised 
the W 203 lesion to a 450bp region in DNA fragm ent BamHI £. 
Additionally, th is fragm ent, and the corresponding fragm ent from  W 203  
rev-1 DNA have been cloned, and are available fo r DNA sequence analysis 
to determine the precise bp change which is responsible fo r the W 203  
phenotype. As detailed fo r ^120 4 , the use o f synthetic oligopeptide
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technology to produce antisera against the affected gene product should 
allow iden tifica tion  of the polypeptide in w t v irus-in fected ce ll extracts. 
Such gene-specific antisera would be useful fo r determining the DNA- 
binding properties of the protein. In addition, i t  would be im portant to 
investigate whether the protein was structura l or non-structural. Such 
experiments m ight eventually lead to fu rthe r defin ition o f steps in the 
pathway of herpesvirus DNA encapsidation.
It  would be of in terest to investigate the possibility tha t p40 is 
processed by a specific cleavage event. Thus, the ab ility  of protease 
inhibitors such as TPCK or PMSF to prevent processing o f p40 would be 
indicative tha t a specific cleavage step was involved. Further analysis 
might involve production of antisera against oligopeptides from  the N- or 
C-terminus o f the predicted polypeptide. Use o f these antisera to 
immunoprecipitate p40 would indicate which forms, i f  any, had arisen from  
a cleavage event. Thus, cleavage products lacking either the N- or C- 
terminus would not be immunoprecipitated by the corresponding antiserum.
The function o f p40 m ight be fu rthe r elucidated by determ ining 
whether or not the protein has DNA-binding properties. Bayliss e t al. 
(1975) showed tha t several proteins of approximately 40,000 MW bound to 
DNA:cellulose columns. Braun et al. (1984a), however, using a f i l te r -  
binding assay to analyse the DNA-binding properties of capsid polypeptides, 
reported tha t only capsid polypeptide VP19C (Vmw50) could bind DNA. It  
might be o f value to determine whether the eluate of DNAicellulose 
columns contains p40, fo r example, by the technique o f Western b lo tting . 
These experiments m ight then indicate whether p40 was involved in 
proteinrprotein in teractions in the capsid tegument ra ther than proteinzDNA 
interactions, in the DNA encapsidation process.
This study has clearly shown the advantages of com parative 
detailed analyses of ^  mutants which, on prelim inary exam ination, have
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similar phenotypic defects. The isolation and characterisation of other ^  
mutants defective in DNA encapsidation is required both to define 
additional parameters by which mutants can be analysed, and to fu rthe r 
identify steps in the herpesvirus DNA encapsidation process.
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Characterisation of a Herpes Simplex Virus Type 1 Mutant Which Has a 
Temperature-Sensitive Defect in Penetration of Cells 
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CAROLINE ADDISON/ FRAZER J. RIXON, JOHN W. PALFREYMAN, 
MAUREEN O’HARA,2 a n d  VALERIE G. PRESTON
Medical Research Council Virology Unit, Institute o f Virology, University o f Glasgow,
Church Street, Glasgow G ll  5JR, Scotland
Received M ay 15, 1981^  accepted July 5, 198U
A herpes simplex virus type 1 (HSV-1) mutant, tsl204, which has a temperature- 
sensitive Its) mutation located within genome map coordinates 0.318 to 0.324, close to 
but outside the coding sequences of the glycoprotein gB gene, has been characterised.
Although this mutant adsorbed to the cell surface at the nonpermissive temperature 
(NPT), it failed to penetrate the cell membrane. As a consequence of this defect, high 
multiplicities of infection of tsl204 blocked subsequent infection of cells by wild-type 
HSV-1. By contrast, at the NPT, superinfection of cells with HSV-2 was not inhibited 
by prior infection with tsl204. The penetration defect could be overcome either by brief 
incubation of mutant virus-infected cells at the permissive temperature, or by treatment 
of the cells with polyethylene glycol, a compound which promotes fusion of membranes.
Upon continued incubation of tel204-infected cells at the NPT, low numbers of capsids 
were assembled. Although these capsids all had some internal structure, they did not 
contain DNA. Another mutant, tel208, which lies in the same complementation group 
as tsl204, penetrated cells normally at the NPT, but like tel204, had a defect in the 
formation of functional capsids. Evidence presented in this paper suggests that the 
gene in which the tsl204 and tel208 lesions map encodes a structural polypeptide. © i9S4
Academic Press, Inc.
INTRODUCTION proteins which have been implicated in
virus attachment and penetration.
The virion of herpes simplex virus type Evidence that glycoprotein gB is in- 
1 (HSV-1) has a complex structure con- volved in virus penetration of host cells
sisting of an icosahedral-shaped capsid is based largely on the analysis of two
within an envelope. Inside the capsid is a HSV-1 mutants, tsB5 and teJ12, belonging
cylindrical core around which DNA is to complementation group 1-9 (Schaffer
wound (Furlong et a l, 1972). Between the et a l, 1978; Sarmiento et a l, 1979; Little
envelope and the nucleocapsid is an ill- et a l, 1981; DeLuca et a l, 1982). These
defined structure known as the tegument mutants fail to process gB to its mature
(Roizman and Furlong, 1974). Although forms at the nonpermissive temperature
over 30 structural polypeptides have been (NPT) and, ^s a consequence, produce
identified in the HSV virion (Heine et a l, virions that adsorb to cells but are unable
1974; Marsden et a l, 1978) the functions to penetrate. Treatment of these virus-
of very few are known. The best charac- infected cells with polyethylene glycol
terised of these are the envelope glyco- (PEG), an agent which promotes mem­
brane fusion, enabled the aberrant virions
■To whom requoste for reprints should be ad- «eUs and replicate. These tern-
perature-sensitive (te) mutations, together
* Present address: The Beatson Institute for Can- with the syncytial lesion in teB5 and a
cer Research, Garscube Estate, Switchback Road, locus affecting the rate of entry of virus,
Bearsden, Glasgow G 61IBD, Scotland. map within the Structural gene of gB
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(Little et a l, 1981; DeLuca et a l, 1982; 
Holland et a l, 1983; Bzik et a l, 1984). 
Recent work by Epstein et a l (1984) has 
suggested that glycoprotein gC may also 
have a role in cell fusion. These workers 
found that HSV-1 strains which synthe­
sized low levels of gC relative to gB in a 
permissive cell line were able to penetrate 
the nonpermissive rat cell line XC whereas 
viruses which induced large amounts of 
gC remained on the cell surface. The above 
findings strongly support the view that 
HSV penetrates cells by fusion of the 
virus envelope with the cellular membrane 
(Morgan et a l, 1968) rather than by 
phagocytosis (Dales and Silverberg, 1969).
Once inside the cell, the nucleocapsids 
accumulate at the nuclear pores where 
the virus DNA is released (Becker et a l, 
1969; Batterson et a l, 1983). New capsids 
are assembled in the nucleus and repli­
cated concatemeric virus DNA is cleaved 
as it is packaged into capsids (Vlazny et 
a l, 1982; Stow et a l, 1983). Two structural 
proteins, p40 (ICP35, VP22a) and VP21, 
which are absent from empty capsids, are 
associated with capsids containing DNA 
(Gibson and Roizman, 1972; Heilman et 
a l, 1979; Braun et a l, 1984). The p40 is 
thought to be required for DNA encapsi­
dation since a mutant, tel201, is unable 
to package DNA at the NPT and fails to 
process p40 to its mature lower molecular 
weight forms (Preston et a l, 1983). It is 
not known, however, whether this poly­
peptide has a direct or indirect role in 
packaging of virus DNA.
In this paper we describe the charac­
terisation of the mutant, tel204, which 
lies in a newly identified complementation 
group of HSV-1 (Matz et a l, 1983). This 
mutant has two defects at the restrictive 
temperature, one in virus penetration of 
the host cell and the other in assembly of 
functional capsids. A second mutant 
tel208, which fails to complement tel204, 
has a defect in the latter process only.
MATERIALS AND METHODS
Cells. BHK-21 clone 13 cells were used 
for virus propagation and titration. In all 
other experiments, a cell line of human
foetal lung (HFL) fibroblasts (Flow Lab­
oratories 2002) was used unless otherwise 
stated. These cells were grown in Eagle’s 
medium supplemented with 10% foetal 
calf serum and 1% nonessential amino 
acids.
Virus. The wild-type HSV-1 stock was 
strain 17. The isolation of wild-type HSV- 
1 strain 17 and tsA. (Brown et a l, 1973), 
and tsK (Preston, 1979) has been described 
previously. A nonsyncytial (syrC) form of 
teK, obtained from the cross tsKsyn 
X strain llsyn^, was used in this paper. 
The mutants, 17teVP1201, 17teVP1204, and 
17teVP1208 were all derived from strain 
llsyn^  and formed nonsyncytial plaques 
on BHK cells. For brevity, these mutants 
are referred to as tel201, tel204, and tel208, 
respectively. The origin of tel201 has been 
described previously by Preston et a l 
(1983). tel204 and tel208 were isolated 
from experiments in which in vitro mu- 
tagenised cloned fragments of HSV-1 
DNA were recombined into the wild-type 
virus genome. Since the ts lesions of tel204 
and tel208 did not map in the mutagenised 
fragments, they were considered to have 
arisen spontaneously. The revertant for 
growth at the NPT, tel204 rev-1, was 
derived from a plaque-purified, low-pas- 
sage stock of tel204. The particle:PFU 
ratios of all virus stocks used in this study 
were approximately 20:1.
Electron microscopy. Cells (2 X 10® per 
dish) were infected with virus at a m.o.i. 
of 5 PFU per cell unless otherwise stated. 
At various times after infection, samples 
were harvested. The cells were washed 
with phosphate-buffered saline (PBS), 
scraped into 0.5 ml of PBS, pelleted by 
low-speed centrifugation, and resuspended 
in PBS containing 2.5% glutaraldehyde. 
The samples were subsequently treated 
as described by Atkinson et a l (1978), 
except that hydroxypropylmethacrylate 
was used instead of propylene oxide.
Indirect immuTioJluorescence. At various 
times postinfection with mutant virus, 
subconfiuent HFL cells on coverslips were 
fixed for 10 min in a methanol-acetone 
mixture (3 parts to 1 part) at —20°, and 
air-dried. Cells were then preincubated 
with normal rabbit serum before addition
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of a 1/40 dilution of ascites fluid contain­
ing the appropriate monoclonal antibody. 
After a 30-min incubation at room tem­
perature (RT), the cells were extensively 
washed in PBS and treated with fluo­
rescent isothiocyanate-conjugated rabbit 
anti-mouse immunoglobulin (Miles Labo­
ratories) for 30 min at RT. Nonspecifically 
bound fluorescent label was removed by 
washing the cells extensively in PBS. The 
coverslips were rinsed once in deionised 
water and mounted in 50% glycerol on 
glass slides.
M arker rescue. Marker rescue was per­
formed as described by Stow et a l (1978) 
with the modifications of Preston (1981). 
Cloned DNAs, pGX56 (contains HSV-1 
B am U l u), pGX134 (contains HSV-1 K jm \ 
m), pGX142 (contains HSV-1 K jm l t) and 
pGX38 (contains HSV-1 EcoRl f ) ,  were 
cleaved with the appropriate restriction 
endonuclease before being used in the 
marker rescue experiments. The plasmid 
vector pAT153 was present in all clones 
except pGX38 which contained the vector 
pACYC184. The genome map coordinates 
for these HSV-1 DNA fragments are 
shown in Fig. 7.
Treatment o f virus-infected cells with  
PEG. This treatment was performed es­
sentially as described by Sarmiento et a l 
(1979). Briefly, sparsely seeded HFL cells 
on coverslips were infected with 5 PFU 
of virus per cell. After adsorption for 1 
hr at 38.5°, the inocula were removed by 
washing monolayers once with PBS. The 
virus-infected cell monolayers were then 
treated with PBS containing PEG (50% 
w/v) for 1 min. Subsequent washes with 
PBS containing PEG were carried out as 
described by Sarmiento et a l  (1979). Fol­
lowing this treatment, the cells were in­
cubated at the NPT for 6 hr in medium 
containing 10% foetal calf serum before 
being fixed in methanol-acetone for im­
munofluorescence assay. Control virus-in­
fected and mock-infected cell monolayers 
were processed in the same manner as 
above except that PEG was omitted from 
all solutions.
Virus-infected cell polypeptide synthesis. 
Cells (2 X 10® per dish) were infected at 
a m.o.i. of 20 PFU per cell, washed twice
with cell culture medium at 1 hr postin­
fection, and overlaid with 2 ml of medium 
per dish. Virus-infected cell polypeptides 
were radiolabelled by incubation in PBS 
containing 100 pCi of [“ S]methionine/ml. 
After 30 min, samples were harvested and 
virus-infected cell polypeptide samples 
were analysed on 5 to 15% linear gradient 
sodium dodecyl sulphate (SDS) poly­
acrylamide gels with a 5% polyacrylamide 
stacking gel as described by Marsden et 
a l (1978).
Virus-indîiced immediate-early (IE ) poly­
peptides. IE polypeptides were induced in 
wild-type and tel204 virus-infected cells 
as described by Preston et a l  (1978).
Monoclonal antibodies. These were pre­
pared essentially as described by Palfrey- 
man et a l (1983), except that the SP2/0- 
Agl4 cell line (Shulman et a l, 1978) was 
used as the parental myeloma cell in 
fusion. MA1147 was specific for the major 
DNA binding protein, Vmwl36 (ICP8) of 
HSV-1 and the equivalent polypeptide of 
HSV-2. MA1098 was specific for the IE 
polypeptide Vmwl75 (ICP4) of HSV-1.
RESULTS
tsl20Jf has a defect in a very early func­
tion. Preliminary electron microscopic ob­
servations of thin sections of cells infected 
with tel204 at the NPT revealed that more 
than 60% of the cells showed no evidence 
of virus infection. Indirect immunofluo­
rescence studies using the monoclonal 
antibody MA1147 specific for Vmwl36 
(ICP8), the major DNA binding protein 
of HSV-1, supported this finding. Greater 
than 95% of wild-type virus-infected cells 
showed typical bright nuclear fluorescence 
(Fig. lb), whereas fewer than 40% of cells 
infected with tel204 displayed this fluo­
rescence. The remaining mutant virus- 
infected cells resembled mock-infected 
cells. To investigate the possibility that 
Vmwl36 detected in cells infected with 
tel204 at the NPT was produced by leak- 
through of virus which had a defect in a 
very early function, the tel204 inoculum 
was warmed to 38.5° prior to addition to 
cells. This treatment did not result in any 
significant loss of virus infectivity at 31°
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F ig . 1. Monolayers of HFL cells, infected with 5 PFU wild-type HSV-1 or tel204, were harvested 
at 6 hr p.i. at the NPT and prepared for the indirect immunofluorescence assay, (a) Mock-infected 
cells, (b) Wild-type HSV-1 infected cells, (c) Cells infected with <sl204 which was warmed to the 
NPT prior to infection, (d) Cells infected with tsl204 at the NPT and shifted down to the PT at 
2 hr p.i. (e) Wild-type HSV-1 infected cells treated with cycloheximide. (f) tsl204-infected cells 
treated with cycloheximide. The monoclonal antibody used in (a), (b), (c), and (d) was MA1147 
which was specific for Vmwl36, the major DNA binding protein of HSV-1. The monoclonal 
antibody used in (e) and (f) was MA1098 which was specific for Vmwl75 of HSV-1.
(Matz et a l, 1983). The results show that 
fewer than 1% of cells infected with pre- 
warmed tel204 at the NPT exhibited nu­
clear fluorescence (Fig. Ic). The effect of 
the mutation was reversible upon down­
shift of mutant-infected cells from 38.5 to 
31° at 1 hr p.i. After 6 hr incubation at 
the permissive temperature (PT), all cells
showed nuclear immunofluorescence when 
tested with MA1147 (Fig. Id). Although 
it was clear from these experiments that 
tel204 did not synthesize detectable 
amounts of the major DNA binding pro­
tein, an early antigen, at the NPT, it was 
possible that virus-specified IE polypep­
tides were synthesized. In order to test
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this possibility, IE polypeptides were in­
duced in wild-type and tel204 virus-in­
fected cells at the NPT by cycloheximide 
treatment. Although IE mRNAs are nor­
mally made in small amounts very early 
in wild-type virus infection, these tran­
scripts can be induced in large amounts 
by treatment of virus-infected cells with 
cycloheximide, a protein synthesis inhib­
itor, added from the time of infection. 
Upon removal of cycloheximide, these IE 
mRNAs can be translated in the presence 
of actinomycin D which prevents further 
mRNA synthesis. Wild-type virus-infected 
cells treated in this manner at the NPT, 
gave bright nuclear fluorescence in the 
indirect immunofluorescence test using 
MA1098, specific for Vmwl75 (ICP4). By 
contrast, no fluorescence was detected in 
tel204-infected cells, suggesting that no 
IE polypeptides were synthesized in mu­
tant-infected cells (Figs. le  and f).
tsl20If fails  to induce virus-specific poly­
peptides at the NPT. Virus-infected cells, 
incubated at 38.5°, were pulse-labelled 
with [^®S]methionine for 30 min at 6 hr 
p.i., harvested, and analysed by SDS 
polyacrylamide gel electrophoresis (Fig.
2). When cold (4°) mutant inoculum was 
added to cells at the NPT, the polypeptide 
profile of tel204-infected cells was similar 
to the pattern obtained for wild-type vi­
rus-infected cells except that there was 
reduced shutoff of host protein synthesis. 
If, on the other hand, the mutant was 
prewarmed to the NPT prior to addition 
to cells, the polypeptide profile resembled 
mock-infected cells, although there was 
an overall reduction in polypeptide syn­
thesis. Some differences were seen in the 
intensity of several host polypeptides 
bands, but the significance of these obser­
vations is not yet understood.
tsl20Jt has a defect in penetration of cells. 
Immunofluorescence studies and polypep­
tides profiles suggested that tel204-in- 
fected cells failed to synthesize virus- 
specific polypeptides at the NPT. These 
findings indicated that the mutant had a 
defect in adsorption, penetration, or un­
coating. In order to distinguish between 
these possibilities, electron microscopic 
studies were performed using a high m.o.i.
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F ig . 2. Autoradiogram of polypeptides induced by 
wild-type HSV-1, tel204, and mock-infected HFL 
cells at 38.5°. Virus-infected cells were labelled for 
30 min at 6 br p.i. witb PS]metbionine. Protein 
samples were analysed on a 5-15% gradient SDS 
polyacrylamide gel.
(200 PFU per cell) of tel204 to infect cells 
at the NPT. Cell cultures were harvested 
at 6 hr p.i. and prepared for electron 
microscopy. No evidence of infection was 
detected in thin sections of the mutant 
virus-infected cells. Many enveloped virus 
particles containing DNA, however, were 
observed, closely associated with the out­
side surface of the cell membrane (Fig. 
3). By contrast, no enveloped virions were 
seen on the surface of cells infected with 
200 PFU per cell of wild-type virus at 
the NPT.
Enhancement of infection by tsl204 at 
the N P T  using PEG. Electron microscopic 
studies suggested that tel204 was unable 
to penetrate host cells at the NPT. There
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Fig. 3. Electron micrographs of thin sections of HFL cells infected with 200 PFU of <sl204 or 
wild-type HSV-1. Samples were harvested after incubation for 6 br at the NPT. (a) Enveloped 
fsl204 virions on the surface of a cell, (b) Enveloped tsl204 virion in close association witb the 
cell membrane, (c) Surface and interior of a cell infected witb wild-type HSV-1. Arrows indicate 
enveloped virions containing DNA. The bar represents 0.5 fiM.
are two alternative explanations for this 
finding. The virions either failed to attach 
to cellular receptors, or bound to the 
receptors but failed to penetrate the cells. 
Electron microscopic data supported the 
latter explanation since many tel204 virus 
particles appeared to adhere to the cell
surface (Fig. 3). To investigate these pos­
sibilities, cells infected with 5 PFU of 
tel204 per cell at the NPT were treated 
with PEG. The proportion of cells infected 
with virus was determined by indirect 
immunofluorescence using MA1147. As a 
consequence of this treatment, 90% of
252 ADDISON ET AL.
tel204-infected cells showed nuclear’fluo­
rescence (Fig. 4). A similar proportion of 
wild-type virus-infected cells treated un­
der the same conditions exhibited this 
pattern of fluorescence. In the absence 
of PEG, tel204-infected cells resembled 
mock-infected cells. This result indicates 
that tel204 attached to, but did not pen­
etrate, host cells at the NPT.
Nature of tsl20J  ^ binding to cells. The 
previous findings showed that tel204 re­
mained on the cell surface at the NPT. 
Superinfection experiments using wild- 
type HSV-1 or HSV-2 were conducted in 
order to determine whether tel204 bound 
to specific cellular receptors for HSV, or 
bound nonspecifically to cells at 38.5°. 
Cells were infected at the NPT with a 
high m.o.i. (200 PFU per cell) of teK, 
which has a mutation in Vmwl75 (Preston, 
1979, Preston, 1981), or tel204. After 1 hr 
incubation at 38.5°, unattached virus was
removed by washing the cell monolayers 
extensively with PBS. The cells were then 
superinfected with 10 PFU per cell of 
HSV-1 wild-type strain 17 or HSV-2 wild- 
type strain HG52, and incubated for 1 hr 
at the NPT to allow for virus adsorption. 
After this time, cells were overlaid with 
tissue culture medium and incubation was 
continued for 6 hr at 38.5° before cells 
were fixed and prepared for indirect im­
munofluorescence. The presence of the nu­
clear virus antigen Vmwl36, detected us­
ing MA1147, was taken as evidence that 
virus had entered the cell. teK, which 
penetrates cells normally but induces a 
very limited number of virus-specific 
polypeptides at the NPT (Preston, 1979), 
did not synthesize Vmwl36 at this tem­
perature. Cells infected with this mutant 
resembled mock-infected cells in the im­
munofluorescence test. After superinfec­
tion with wild-type HSV-1, bright nuclear
Fig. 4. Monolayers of HFL cells, infected with 5 PFU wild-type HSV-1 or <sl204 and harvested 
at 6 hr p.i. at the NPT and prepared for immunofluorescence assay, (a) Mock-infected cells, (b) 
Wild-type infected HSV-1 infected cells treated with PEG. (c) Cells infected with <sl204 which 
was prewarmed to the NPT prior to infection, (d) tsl204-infected cells treated with PEG. The 
monoclonal antibody used in all cases was MAI 147 which was specific for Vmwl36, the major 
DNA binding protein of HSV-1.
PENETRATION MUTANT OF HSV-1 253
fluorescence was observed in teK-infected 
cells, indicating that HSV-1 strain 17 was 
able to penetrate the cell surface (Figs. 
5d and e). By contrast, no specific Vmwl36 
nuclear antigen was detected in tel204- 
infected cells when the superinfecting vi­
rus was wild-type HSV-1 (Fig. 5b). If, 
however, the superinfecting virus was
HSV-2 strain HG52, nuclear fluorescence 
was seen in greater than 90% of tel204- 
infected cells (Fig. 5c). These results were 
confirmed by analysis of radiolabelled vi­
rus-infected cell polypeptides on SDS 
polyacrylamide gels. The pattern of poly­
peptides from tel204-infected cells super­
infected with wild-type HSV-1 resembled
F ig . 5. Monolayers of HFL cells infected with 200 PFU tel204 or tsK and superinfected with 5 
PFU wild-type HSV-1 or wild-type HSV-2. (a) Cells infected with 200 PFU tsl204, prewarmed to 
the NPT, as a control, (b) Cells infected with tel204 and superinfected with wild-type HSV-1. (c) 
Cells infected with tsl204 and superinfected with wild-type HSV-2. (d) Cells infected with 200 
PFU tsK as a control, (e) Cells infected with tsK and superinfected with wild-type HSV-1. (f) 
Cells infected with tsK  and superinfected with wild-type HSV-2. The monoclonal antibody used 
in all cases was MA1147 which was specific for Vmwl36, the major DNA binding protein of 
HSV-1.
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that of mock-infected cells, whereas the 
pattern of mutant virus-infected cells su­
perinfected with HSV-2 was indistin­
guishable from that of HSV-2 (data not 
shown). These results indicated that tel204 
binds in a specific manner to cellular 
receptors at the NPT.
tsl20Jt has a second phenotypic defect. 
Electron microscopic studies on tel204- 
infected cells grown at the NPT revealed 
that when the virus inoculum was not 
warmed before addition to cells, about 
40% of cells showed signs of infection, 
such as margination of host chromatin 
and production of capsids in the nuclei 
(data not shown). A striking feature of 
these cells was that low numbers of cap­
sids were seen, none of which contained 
dense cores. This observation suggested 
that tel204 had a second phenotypic defect. 
To confirm this finding, virus was adsorbed 
to cells for 1 hr at the PT instead of 38.5° 
to enable the mutant to penetrate the 
cells. After this time, the cell cultures 
were transferred to 38.5° and incubation 
was continued for 9 hr. Electron micro­
scopic examination of these cells showed 
that tel204 appears to have a defect in 
capsid assembly, since very few capsids 
were produced at the NPT, and unlike 
wild-type HSV-1 (Fig. 6a), none of these 
contained DNA (Fig. 6b).
Characterisation o f tsl208, a mutant 
which fails  to complement tsl20Ih Previous 
work by Matz et a l (1983) showed that 
tel204 would complement mutants in other 
cistrons, including those which had mu­
tations in the gB gene. In these experi­
ments, however, tel204 was not prewarmed 
to 38.5° prior to virus infection. Recent 
tests revealed that a spontaneous mutant, 
tel208, failed to complement tel204 (Table 
1), and recombined at low frequency with 
tel204 (Table 2). On the basis of these 
results, tel208 was placed in the same 
cistron as tel204. In contrast to tel204, 
this mutant did not have a penetration 
defect since virus prewarmed to 39.5° 
infected cells normally at the NPT. (39.5° 
was used as the restrictive temperature 
in these experiments because tel208 was 
leaky at 38.5°). The mutant virus-infected 
cell polypeptides analysed by SDS poly­
acrylamide gel electrophoresis resembled 
wild-type virus-infected cell polypeptide 
profiles (data not shown). Electron micro­
scopic studies of thin sections of tel208- 
infected cells grown at the NPT, however, 
revealed that tel208 produced more cap­
sids than tel204, although there were still 
fewer than seen in wild-type virus-infected 
cells. Again, only empty capsids were 
present in all tel208-infected cells (Fig. 
6c). Upon temperature shiftdown at 6 hr 
p.i. from 39.5 to 31°, the virus DNA was 
packaged and enveloped virions produced. 
tel208 therefore has a te lesion which 
affects assembly of functional capsids at 
the NPT. Interestingly, the capsids present 
in tel204- and tel208-infected cells at the 
NPT were different in appearance from 
those produced at the same temperature 
by tel201, an unrelated mutant (Fig. 6d). 
The internal structure of the tel201 cap­
sids appeared to be less compact than the 
structure present in the capsids of other 
two mutants.
Physical map location o f the tsl20U and 
tsl208 mutations. The tel204 lesion had 
been previously mapped to DNA sequences 
within fragment K pnl t (map units 0.322- 
0.344), by Matz et a l (1983). Using sepa­
rated H p al fragments from cloned EcoRl 
f  (plasmid pGX38) in marker rescue ex­
periments, the map coordinates of this 
lesion were refined. The mutation mapped 
within a 400-bp region shared by H p al i  
and Kpnl t within B am H l u of HSV-1 
(Fig. 7). The lesion in tel208 also mapped 
within HSV-1 DNA fragment B am H l u. 
When, however, cloned HSV-1 K pnl frag­
ments t and m  were screened for the 
ability to rescue the tel208 lesion, the 
mutation mapped within K pnl m  (Table
3). The tel208 lesion is therefore situated 
to the left of the tel204 mutation within 
BamHI u (Fig. 7).
tsl204 contains a single lesion. One ex­
planation for the finding that tel204 had 
defects in penetration of cells and in as­
sembly of capsids is that the virus con­
tained multiple mutations. In order to 
exclude this possibility, te  ^ progeny virus, 
isolated from marker rescue experiments 
in which cells were coinfected at 31° with 
BamHI u and tel204, was tested for the
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F ig . 6. Electron micrographs of thin sections HFL cells infected with 5 PFU of tsl204, (81208, 
(81201, or wild-type HSV-1. (a) Nucleus of a cell infected with wild-type HSV-1, harvested after 
6 hr incubation at the NPT. (b) Nucleus of a cell infected with (81204. After 1 hr incubation at 
the PT, cells were transferred to the NPT and harvested at 6 hr p.i. (c) Nucleus of a cell infected 
with (81208 at the NPT. Cells were harvested after 6 hr incubation at the NPT. (d) Nucleus of a 
cell infected with (81201 at the NPT. Cells were harvested at 10 hr p.i. Broad arrows indicate full 
capsids, narrow arrows indicate empty capsids. The bar represents 0.5 yM.
ability to infect cells at the NPT. A ts  ^
revertant of tel204 was also screened. 
Both types of virus gave similar results 
to wild-type virus in indirect immunoflu­
orescence assay using MA1147. In addi­
tion, the relative efficiency of plaque for­
mation (e.o.p.)^^''^ of the marker-rescued 
te"^  virus was comparable to wild-type 
virus (data not shown), tel204 therefore 
appeared to contain a single ts mutation.
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TABLE 1
COMPLEMENTATION BETWEEN («1204, 1208, 
1201, AND A “
F ra c tio n a l genom e
0.31
Mutant (81204 (81208 (81201 tsA ”
(81204 1 1.56 24.32 101.6
(81208 1 42.7 88
(81201 1 98.4
(sA 1
° Complementation tests were performed as de­
scribed by Brown et a i  (1973). Complementation in­
dices greater than 4 were considered positive.
’ tsA  has a temperature-sensitive mutation which 
maps in the glycoprotein gB gene. (V. G. Preston, 
personal communication).
DISCUSSION
We have identified a mutant, tel204, 
which fails to penetrate tissue culture 
cells at the NPT. Treatment of these mu­
tant-infected cells with PEG enabled the 
virus to infect cells at the NPT, indicating 
that this mutant has a defect in fusion of 
the virus envelope with the cell membrane. 
The failure of tel204 to penetrate cells 
appears to be independent of the cell type 
used. The same phenotype was observed 
when either BHK clone 13 cells or HFL 
cells were infected with the mutant (data 
not shown). Our experiments indicate that 
tel204 binds to cell receptors specific for 
HSV-1. This conclusion is based on the 
finding that cells infected at high m.o.i. 
of tel204 (200 PFU per cell) at the NPT 
could be superinfected with wild-type 
HSV-2 but not HSV-1. These results are 
in agreement with previous work by 
Vahlne et a l  (1979), who showed that 
HSV-1 and HSV-2 attached to different 
cellular receptors. Our data also indicate
TABLE 2
Recombination between (81204, 1208, 1201, and A “
Mutant (81204 (81208 (81201 tsA
(81204 <0.001 0.1 13.58 52.4
(81208 <0.001 11.9 85.3
(81201 <0.001 16.1
tsA <0.001
“ Recombination frequencies (%) were calculated 
as described by Brown et a i  (1973).
Hpml ____
5.2K B -S Y
T ra n s c r ip ts 4 .4K B -Y
2 .4 K B -»
1.4KB-BV
F ig . 7. Marker rescue of (sl204 and (sl208. The 
solid lines represent the regions of HSV-1 DNA 
which rescue the mutants. Arrows indicate tran­
scripts identified by Holland et a l  (1984), which map 
in this region of the HSV-1 genome.
that tel204 virions bind very tightly to 
cellular receptors at the NPT and cannot 
be removed by competition with wild-type 
HSV-1 or by extensive washing of the cell 
monolayer.
TABLE 3
Summary of Marker Rescue Results
Mutant
DNA
fragment”
e.o.p.*^/"
X 10“*'’
(81204 None <0.001
K pnl t 2.8
K pnl m <0.001
BamHl u 1.4
H pal a 9.8
H pal b <0.001
(81208 None <0.001
Kpnl t <0.001
Kpnl m 5.4
BamHl u 10
“ Cloned i7coRI / ,  digested with H pal, gave two 
fragments; a which contained sequences from H pal 
i, b and pAcycl84, and b which contained sequences 
from H pal t only. These fragments were purified and 
used in marker rescue experiments. The other DNA 
fragments were available as cloned DNAs and were 
digested with the appropriate restriction endonuclease 
prior to transfection.
* The relative efficiency of plating (e.o.p.*^” '^ ’'’') was 
calculated from the yield of progeny virus at the PT 
and NPT from the transfected cells.
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vestigation is required to determine the 
polypeptide involved and its precise func­
tion.
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Saturation binding of tel204 to HSV-1 
specific cell receptors on HFL cell mono­
layers was obtained using a m.o.i. of 200 
PFU per cell (approximately 4 X 10^  par­
ticles per cell). Therefore, there appears 
to be roughly greater than 10^  HSV-1 
receptors on an HFL cell in monolayer. 
This figure is similar to estimates of re­
ceptors for HSV-1 and HSV-2 (Vahlne et 
a l, 1979), and other viruses (Lonberg- 
Holm et a l, 1976). One interesting finding 
we obtained was that saturating amounts 
of the HSV-1 mutant teK, which pene­
trates cells normally, did not prevent sub­
sequent infection by wild-type HSV-1, 1 
hr later, at the NPT. This result indicates 
either that cell surface receptors are reus­
able or rapidly replaced.
Analysis of virus-induced polypeptides 
in tel204-infected cells grown at the NPT 
supported the conclusion that the mutant 
was unable to penetrate cells at this tem­
perature. The pattern of polypeptide syn­
thesis obtained from these cells was sim­
ilar to the mock-infected cell polypeptide 
profile except that some inhibition of host 
polypeptide synthesis was observed. Al­
though a virion polypeptide has been im­
plicated in this process (Fenwick and 
Walker, 1978), we do not know whether, 
in this case, the inhibition was caused by 
a specific structural protein or induced as 
a consequence of alterations to the cellular 
membrane by virions unable to penetrate.
Provided tel204 was allowed to enter 
cells by a brief incubation at the PT 
before shiftup to the NPT, a second phe­
notypic defect became evident. In compar­
ison with wild-type HSV-1 infected cells, 
fewer capsids were produced, and none 
contained DNA. Another mutant, tel208, 
which did not complement tel204, also 
failed to package DNA, but unlike tel204, 
this mutant penetrated cells normally at 
the NPT. tel208-infected cells produced 
fewer capsids than wild-type HSV-l-in- 
fected cells at the NPT, although there 
were consistently more present than in 
tel204-infected cells. In this respect, tel204 
and tel208 differed from tel201, an unre­
lated mutant, which made considerably 
more capsids at the restrictive tempera­
ture than wild-type virus (Preston et a l,
1983). Although the tel208 defect could be 
overcome by shifting the virus-infected 
cells to the PT, it is not clear whether the 
empty capsids produced at 39.5° are able 
to package DNA subsequently at 31°.
Analysis of te  ^ virus, generated by 
marker rescue of tel204 with cloned 
B am H l u from wild-type virus, and a te  ^
revertant of tel204, suggest that tel204 
has a single mutation that affects the 
ability of the mutant to penetrate cells 
and assemble functional capsids at the 
NPT. Marker rescue and recombination 
experiments indicate that the tel204 lesion 
mapped close to the tel208 lesion. Both 
these mutations might lie within a mul­
tifunctional gene. Alternatively, tel204 
might contain a single mutation within 
the coding regions of two overlapping 
genes and, as a consequence, have te de­
fects in two gene products. In this situa­
tion, tel208 would have a mutation affect­
ing the function of one of these genes 
only.
Holland et a l  (1984) have mapped five 
mRNAs within B am H l u. Three of these,
5.6-, 5.2-, and 4.4-kb mRNAs hybridise to 
the region of B am H l u where the tel204 
and tel208 lesions lie (Fig. 7). Further 
investigation is required to determine 
which mRNA encodes the te gene products. 
It is of interest to note that mutants of 
HSV-1 strain lls y v f, which have deletions 
in the 5' regulatory and coding regions of 
the thymidine kinase gene, have a syncy­
tial plaque morphology (Sanders et a l, 
1982). These deletions map within DNA 
sequences encoding the 5' regions of the
5.6-kb and possibly the 5.2-kb mRNAs. 
More work is needed, however, to show 
whether these deletions affect the gene in 
which the tel204 and tel208 mutations map.
To date no polypeptide has been as­
signed to the region of B am H l u in which 
the tel204 and tel208 defects have been 
located. Since tel204 virions which failed 
to penetrate cells at 38.5° were fully in­
fectious at 31°, the mutation probably lies 
within a structural gene. We cannot, how­
ever, exclude the possibility that there 
was incorrect processing of polypeptides 
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